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 This thesis summarizes our efforts in the development of methodologies aimed at remote 
C(sp3)–H functionalization of aliphatic amines. Amines are an important functional group 
present in a variety of biologically relevant molecules; however, examples of remote C–H 
functionalization of unprotected amines remain scarce. Many of the challenges associated with 
the remote functionalization of amines are related to the susceptibility of C–H functionalization 
proximal to the nitrogen center.  Chapter 1 provides a perspective and summary of the field and 
Chapters 2-5 cover strategies we have developed to perform selective, remote C(sp3)–H 
functionalization of aliphatic amines.  
 We have employed protonation as a strategy in combination with platinum-catalysis to 
achieve terminal-selective functionalization of aliphatic amines (Chapter 2). This strategy is 
based on the in situ formation of an ammonium salt to deactivate the C–H bonds proximal to 
nitrogen. Similarly, Chapter 3 describes the remote oxidation of 2º and 3º C–H bonds of 
protonated aliphatic amines mediated by potassium persulfate.  
 In contrast to Chapters 2 and 3, Chapters 4 and 5 describe our efforts on the palladium-
catalyzed, directed method that takes advantage of the basic nitrogen atom to enable 
transannular C–H functionalization of biologically relevant cyclic amine scaffolds. In Chapter 
4, we optimized conditions to accelerate functionalization and directing group removal steps to 
enable the rapid generation of fragments. Chapter 5 describes the ligand-effects that led to our 
second-generation conditions for transannular C‒H arylation that allowed for the 
functionalization of pharmaceutically relevant bicyclic amines. Mechanistic studies are 







1.1. C(sp3)–H Functionalization of Aliphatic Amines 
 
The area of C–H functionalization is a rapidly expanding field that utilizes the 
ubiquitous C–H bonds found in small molecules to install new functionality, increasing their 
complexity and, often, their value.1 Many examples from this field involve the use of a 
transition metal (e.g., Pd, Ir, Rh) to catalyze this process (Scheme 1.1a). In these cases, the 
transition metal inserts into a specific C–H bond (C–H activation) with selectivity that is 
controlled by sterics, electronics or an intramolecular directing group. This C–H activated 
intermediate undergoes further functionalization in the catalytic cycle, often in the presence of 
an oxidant and/or nucleophile, to form a carbon-carbon or carbon-heteroatom bond (e.g., C–X, 
where X = C, N, O, halide) as shown in Scheme 1.1b. A variety of other mechanisms that 
enable selective C–H functionalization are referenced.2  
Scheme 1.1. (a) Metal Mediated C–H Bond Functionalization (b) Concise Catalytic Cycle 
 
This thesis summarizes our work on of remote C(sp3)–H functionalization reactions of 
aliphatic amines, predominantly focusing on transition metal catalyzed processes. Our 
developments in this area are outlined in chapters 2 through 5. The central theme of chapters 2 
 2 
and 3 is the use of protonated amines to access remote C–H oxidation products through Pt-
catalysis (Chapter 2) and a persulfate-mediated oxidation (Chapter 3) (Scheme 1.2). Chapter 4 
highlights research completed in collaboration with AbbVie, during which we focused on 
applying a C(sp3)–H arylation methodology for the synthesis of cyclic amine fragments 
(Scheme 1.2). Lastly, Chapter 5 outlines our work to further develop the Pd-catalyzed 
transannular C–H functionalization of cyclic amines through the study of ligand effects 
(Scheme 1.2).3  
Scheme 1.2. Overview of Work on Remote C(sp3)–H Functionalization of Aliphatic Amines  
 
The first section of Chapter 1 will focus on C(sp3)–H bond functionalization and the 
general strategies researchers have employed to enable this transformation with high efficiency 
and site-selectivity. The second half of the introduction will outline the relevant properties of 
amines that have led to exhaustive studies of C(α)–H functionalization. Additionally, chemists 
have been able to harness the amine functional group and access site-selective functionalization 
at remote C–H sites through a variety of directed and non-directed pathways. These advances 
provided the groundwork for the developments that we report in chapters 2 through 5.  
1.2. C(sp3)–H Functionalization 
 
C–H bonds are typically thought of as inert sites that rarely undergo functional group 
transformations. However, over the past decade, the field of C–H functionalization has 
expanded such that the synthetic toolbox includes a multitude of catalysts, directing groups, 
oxidants, and reagents that enable the cleavage of a C–H bond and installation of new 
functional group.2 Within this field, researchers have examined the activation of both C(sp2)–
 3 
H and C(sp3)–H bonds. The following discussion will focus on developments in the area of 
C(sp3)–H bond functionalization as it pertains to the work described in this thesis.  
Table 1.1. Bond Dissociation Energies and pKa of C–H Bonds4,5,6 
 
The activation of C(sp3)–H bonds is challenging and often best characterized by bond 
dissociation energies that are between 85–100 kcal/mol (BDE, homolytic cleavage) and pKa 
values in excess of 50 (heterolytic cleavage).4,5,6 For example, the BDE of the C–H bond in 
methane is around 105 kcal/mol, and this molecule has a pKa of approximately 56 (Table 1.1, 
entry 1).4,5 The BDE of the primary (1º) C–H bonds of ethane and extended alkyl chains is 
closer to 100 kcal/mol (Table 1.1, entry 2).4 Secondary (2º) C–H bonds and tertiary (3º) C–H 
bonds have lower BDEs of approximately 98.1 kcal/mol and 95.7 kcal/mol respectively (Table 
1.1, entries 3,4).4 As such, these undergo more facile homolytic cleavage relative to 1º C–H 
bonds. An aromatic or π-system adjacent to a C(sp3)–H bond often leads to a decrease in the 
BDE as seen in the case of toluene and propene (Table 1.1, entries 5,6).4 Compared to C(sp3)–
H bonds, C(sp2)–H bonds have significantly higher BDEs, but are considerably more acidic 
than a typical C(sp3)–H bond (pKa benzene ~43).4,5  
Figure 1.1. Highlighting C–H Bonds in Valsartan (antihypertensive)  
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In addition to the relative inertness of C–H bonds4, another major challenge in C–H 
functionalization is site-selectivity. As exemplified in Figure 1.1 with Valsartan, there are 
often many different types of C(sp3)–H and C(sp2)–H bonds in a given organic molecule. 
Developing methods to selectively target the activation of a specific C–H bond has been 
achieved by the use of directing groups and/or catalyst/reagent-controlled selectivity, occurring 
through a variety of mechanisms.2 In Chapter 2, we describe the development of a Pt-catalyzed 
1º-selective C(sp3)–H oxidation. Chapter 3 summarizes our efforts to activate weaker 2º and 3º 
C(sp3)–H bonds mediated by potassium persulfate. Lastly, a directing group approach is 
utilized in Chapters 4 and 5 to selectively functionalize remote 2º-C(sp3)–H bonds on alicyclic 
amine scaffolds.  
Scheme 1.3. Directed C‒H Bond Activation 
 
To overcome the relative inertness of C–H bonds and enable site-selective 
functionalization, one key strategy that researchers have employed is the use of transition 
metals in combination with a tethered directing group (Scheme 1.3).2e,f This process involves 
reversible binding between the transition metal and the directing group, placing the catalyst in 
close proximity to the C–H bond of interest, and thus allowing for site-selective C–H 
activation. An early example by Murai and co-workers demonstrated this concept in the context 
of the Ru-catalyzed C–H alkylation of aromatic ketones (Scheme 1.4). The carbonyl oxygen 
functions as a directing group for Ru, facilitating ortho activation and subsequent addition into 
the olefin to forge a new C–C bond.7 Subsequently, numerous other groups have contributed 




Scheme 1.4. Ru-catalyzed C(sp2)–H Functionalization Enabled by Ketone Directing Group7 
 
In the late 1990s, the stoichiometric and, subsequently, catalytic C–H borylation of 
alkanes was demonstrated with transition metal catalysts.2g,h,8 Scheme 1.5 describes the 
conditions for a Re-catalyzed C(sp3)–H borylation of n-pentane.9 High selectivity for 1º C–H 
borylation is dictated by the steric properties of the substrate/catalyst. Subsequently, the use of 
Ir and Rh for the non-directed C(sp3)–H borylation of aliphatic small molecules was reported. 
2g,h,10 While these catalyst systems enable the selective formation of terminal C(sp3)–H 
borylation products, the transformations are largely limited to the use of simple alkanes under 
neat conditions.  
Scheme 1.5. Re-catalyzed C(sp3)–H Borylation of Alkanes 9 
 
An alternative approach involves the introduction of directing groups to enable C(sp3)–
H functionalization (analogous to C(sp2)–H functionalization). The reports of Pd-catalyzed, 
directed C(sp3)–H functionalization by Yu, Daugulis, as well as our group, expanded the field 
to include diverse transformations of more complex molecules.11 In 2004, our group 
demonstrated a Pd-catalyzed, oxime-ether directed acetoxylation of C(sp3)–H bonds in the 
presence of PhI(OAc)2 as the stoichiometric oxidant (Scheme 1.6).
12 This reaction proceeds 
through a concerted metalation-deprotonation (CMD) mechanism,13 leading to formation of a 
five-membered palladacycle, which plays a key role in site selectivity (Scheme 1.6). Following 





Scheme 1.6. PdII/IV-catalyzed, Heteroatom Directed C(sp3)–H Acetoxylation12 
 
While this area of research has expanded to encompass synthetically relevant scaffolds 
and transformations, many limitations and challenges remain. First, within the area of directed 
functionalization, there is major room for further exploration of substrate scaffolds and site-
selectivity. Second, a directed method is inherently limited to substrates containing an existing 
directing group (or one that can be easily appended) in proximity to the C–H bond of interest. 
With these limitations in mind, we sought to develop new strategies for the functionalization 
of aliphatic amines, which represent a challenging class of substrates for remote C(sp3)–H 
functionalization (vide infra). In particular, we were interested in accessing site-selectivity 
patterns that were inaccessible with modern methods. This next section will outline the 
chemistry of aliphatic amines and their common reactivity patterns.  
1.3. Chemistry of Aliphatic Amines 
 
Properties of Aliphatic Amines Relevant to C–H Bond Functionalization 
Figure 1.2. Aliphatic Amines in Commodity Chemicals and Bioactive Molecules 
 
Aliphatic amines are present in a variety of bioactive molecules, materials, and 
commodity chemicals (Figure 1.2). They represent an important and versatile functional group 
that can undergo a variety of transformations.14 We were especially intrigued by their 
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prevalence in bioactive molecules and sought to develop new methodologies that could 
facilitate their rapid derivatization. For example, C–H functionalized products could 
potentially be utilized for the study of metabolites (Chapters 2 and 3).15 Additionally, C–H 
functionalization could also facilitate the synthesis and exploration of small molecules for early 
stage discovery efforts as well as find applications in the late-stage modification of drug-like 
molecules (Chapters 4 and 5).  
Challenges of Aliphatic Amine Functionalization in C(sp3)–H Bond Functionalization 
Figure 1.3. C–H BDE of Piperidine and Cyclohexane 4 
 
 Aliphatic amines contain an electron-rich, Lewis basic nitrogen atom with weak C(α)–
H bonds. In the case of piperidine, the BDE of the 2º C(α)–H is approximately 92.2 kcal/mol, 
while the analogous 2º C–H in cyclohexane is >5 kcal/mol stronger (Figure 1.3).4 Binding of 
the amine to a metal can lead to catalyst deactivation and/or β–H elimination (Scheme 1.7a, 
b). Additionally, C–H functionalization reactions often require the use of strong oxidants, 
which are often incompatible with electron-rich amines as they can promote oxidative 
functionalization and dealkylation (Scheme 1.7c, d). Due to these properties, functionalization 
at the C(α)–H has been well-studied; however, transition metal-mediated, remote C–H 








Scheme 1.7. Reactions of Aliphatic Amines with Metals and Oxidants 
 
C(α)–H Functionalization of Aliphatic Amines 
Leveraging these properties, the C–H functionalization of aliphatic amines has 
traditionally been limited to the exploration of C(α)–H bond reactivity. For instance, a well-
established method for C(α)–H bond functionalization involves lithiation of N–Boc-protected 
cyclic amines such as piperidine and pyrrolidine and subsequent addition of an electrophile. 
This transformation can be rendered enantioselective by chiral reagents.16 In addition to 
deprotonation, the activation of C(α)–H bonds has been functionalized in reactions such as 
oxidation, oxidative dealkylation, and cross-coupling.17  
As stated above, amines can bind to metals and undergo β–H elimination to form 
iminium species, which react readily with nucleophiles such as water. The hemiaminal 
intermediate can be further oxidized to an amide (Scheme 1.8a).18 The iminium can also 
undergo hydrolysis to furnish a secondary amine and aliphatic aldehyde (Scheme 1.8b).19 This 
type of reactivity has also been demonstrated for more complex molecules such as oxycodone 





Scheme 1.8. Oxidative Functionalization of C(α)–H Bonds in Aliphatic Amines 18,19,20  
 
Many groups have also utilized amines as coupling partners in photoredox catalysis by 
intercepting the stabilized C(α) radical. Scheme 1.9a depicts the coupling of pyrrolidine to 
electron-poor arenes reported by MacMillan and co-workers. In this example, the 
photoexcicted Ir(ppy)3 oxidizes the tertiary amine, which undergoes deprotonation to generate 
a C(α) radical.21 Work by Hashmi and co-workers demonstrated similar reactivity in the 
context of cyclic and linear amines, where they used alkynes as the radical coupling partner to 
generate a net C–H alkynylation product (Scheme 1.9b).22   
Scheme 1.9. Single Electron Functionalization of C(α)–H Bonds in Aliphatic Amines 21,22 
 
Davies and co-workers reported a carbene insertion into the C(α)–H bond of protected 
cyclic amines.23 Their methodology was recently further applied in the context of unprotected 
aliphatic amines, demonstrating similar reactivity at the N-Me C(α)–H bond of complex, 
bioactive amines (Scheme 1.10).24  
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Scheme 1.10. Rh-catalyzed Functionalization of C(α)–H Bonds in Aliphatic Amines 24 
 
Additionally, the attachment of a directing group such as pyridine, has enabled Ru- 
catalyzed C–C bond formation (Scheme 1.11).25 Reports by Sames26, Maes27, Yu28, Shibata29, 
and Ackermann30 have developed this type of reaction through introduction of various directing 
groups, catalysts, and coupling partners. As summarized here, much research has been devoted 
to the study of C(α)–H functionalization reactions of amines. However, in recent years, our 
group and others have sought to develop strategies to override the inherent reactivity of these 
C(α)–H sites in order to access remote C–H bonds. These endeavors are outlined in the 
following section.  
Scheme 1.11. Ru-catalyzed, Directed C(α)–H Bond Functionalization 25 
 
1.4. Strategies for Remote C–H Functionalization of Amines 
 
Directed Functionalization  
The directing group strategy has also been employed extensively in the context of 
remote functionalization of aliphatic amines. First introduced by the Daugulis group, the 
picolinamide motif has found many applications in the functionalization of primary amines.31 
These reactions occur through bidentate chelation with the amide and pyridine nitrogen atoms 
and subsequent directed C–H activation, leading to the intermediate in Scheme 1.12a. This 
strategy has since been applied to cyclic and bicyclic primary amines, including privileged 
scaffolds such as 3-pinanamine32 and 3-amino piperidine (Scheme 1.12b).33 Furthermore, a 
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variety of functionalizations can be accomplished with this directing group including 
alkenylation,34 etherification,35 acetoxylation,36 and alkylation.37 In all cases, the requirement 
for a primary amine remains a limiting factor.  
Scheme 1.12. Pd-catalyzed, Directed Functionalization of Primary Amines 31,32,33 
 
Another drawback of this directed functionalization is the need to install and cleave the 
directing group while preserving the integrity of the functionalized product. Cleavage of the 
directing group is integral to accessing the desired molecule, and we address this in the context 
of our work in Chapter 4. To circumvent this step, chemists have also explored the use of 
transient directing groups that can be generated in situ.38 A report by Ge and co-workers takes 
advantage of the facile condensation between a primary amine and glyoxic acid to generate a 
bis-chelating directing group for γ-C–H arylation of amines (Scheme 1.13).39 Although an 
elegant approach, a major limitation is the need for primary amines bearing a dimethyl group 
at C(α), which the authors attribute to both the Thorpe-Ingold effect and the need to avoid 
C(α)–H oxidation.  
Scheme 1.13. Pd-catalyzed Arylation with Transient Directing Group 39 
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While the area of directed functionalization has been widely explored in the context of 
protected amines, far fewer examples demonstrate free amine-directed C–H bond 
functionalization. An early example from 2001 applied Pt-catalysis for the functionalization of 
amino acids.40 The Sames group utilized free amino acids as chelating functional groups to 
direct C–H bond activation (Scheme 1.14). Although low isolated yields and moderate 
selectivities were achieved, this work was a seminal demonstration of amine-directed C–H 
functionalization.  
Scheme 1.14. Amino Acid Directed, Pt-catalyzed C–H Oxidation 40 
 
More than a decade later, pioneering work from the Gaunt group explored secondary 
amine-directed C–H bond functionalization. Their first report in this area described amine-
directed β-C–H bond activation to access an unusual 4-membered palladacycle intermediate 
(Scheme 1.15).41 Reductive elimination from this strained palladacycle provided aziridine 
products. This model was further explored for the C–H arylation, acetoxylation, carbonylation, 
and alkenylation of amines.42 
Scheme 1.15. Secondary Amine Directed β C–H Functionalization 41 
 
In these examples of protected and free amine-directed methodologies, 
functionalization occurs at 1º or 2º C–H bonds in linear systems. In Chapters 4 and 5, we sought 
to leverage the directing group ability of amines to access C–H bonds in biologically relevant, 
cyclic amine scaffolds. At that time, the functionalization of remote 2º C–H bonds in cyclic 
amines was an unsolved challenge. Our contribution was in the use of cyclic tertiary amines to 
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access remote C–H bonds through an amine-directed, transannular pathway (Figure 1.4).43 
This work laid the foundation for its application in the synthesis of fragments (Chapter 4) and 
for our studies of ligand effects (Chapter 5).   
Figure 1.4. Directed C–H of Aliphatic Amines 31,41,43 
 
Non-Directed Functionalization  
All of the above examples of remote amine functionalization utilized a directing group 
consisting of either a protected or free amine. This necessitates the correct positioning between 
the directing group and C–H bond of interest. Due to steric hindrance, reactivity is typically 
limited to 1º and 2º C–H bonds. In contrast, non-directed functionalization, in which the 
nitrogen atom does not participate through a binding event, can enable complementary 
reactivity. This strategy requires deactivation of the amine, which is often achieved through 
the formation of an amide bond. Additionally, many non-directed methods target hindered, 
homolytically weak 3º C–H bonds.  




Dioxiranes, which operate through C–H insertion pathways and single electron radical 
processes, are known to selectively target 3º C–H bonds in the presence of stronger 1º and 2º 
C–H sites.44 With the use of N-Boc protected peptides, selective 3º oxidation is possible with 
dimethyldioxiirane (DMDO) (Scheme 1.16).45 The use of stronger oxidants such as TFDO 
leads to additional side-products such as N-oxidation.46 Other types of protecting groups such 
as phthalimide47 and trifluoroacetamide48 function similarly to deactivate the amine and thus 
enable remote functionalization (Scheme 1.17).  
Scheme 1.17. Examples of Remote Functionalization at Tertiary C‒H Bonds 47,48 
 
 
 Asensio and co-workers were the first to explore amine protonation as an alternate 
strategy to deactivate C–H sites proximal to nitrogen.49 They showed that protonation with 
HBF4 to form an ammonium species deactivates the C(α)–H bonds and thus allows for selective 
oxidation at remote sites. In this study, the oxidation of linear and cyclic amines at remote 2º 
and 3º C–H bonds was achieved using TFDO (Scheme 1.18). 
Scheme 1.18. TFDO Remote Oxidation of Protonated Amines 49 
 
We applied the protonation strategy in the context of Pt-catalysis (Chapter 2) and in the 
persulfate-mediated oxidation (Chapter 3) to achieve complementary reactivity patterns. 
Recently, Bietti and co-workers quantified the deactivation of protonated amines through rate 
studies of C–H abstraction with cumyloxy radicals.50 The rate of hydrogen atom abstraction 
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was found to be nearly three orders of magnitude higher with the free amine (Scheme 1.19). 
In the case of the protonated pentylamine, the observed rate corresponds to C–H abstraction at 
the remote methylene.  
Scheme 1.19. Hydrogen Atom Abstraction from Free and Protonated Amines 50 
 
Another example of non-directed, remote C–H bond functionalization of free amines is 
in the Rh51 and Ir-catalyzed borylation52 of terminal aliphatic amines pioneered by the Hartwig 
group (Scheme 1.20). Here, the terminal selectivity is sterically-controlled, and activation 
occurs at the most sterically accessible C–H bond with a strong preference for β-C–H 
borylation (compared to α and C–H bonds further removed). While this reaction is tolerant of 
free amines, it is limited to the use of tertiary amines and is biased towards activation at the 
C(β)–H bond.  
Scheme 1.20. Rh-catalyzed C–H Borylation of Tertiary Amines 51 
 
Based on our assessment of the field at the onset of these studies, we saw many 
opportunities for methods development in the area of amine functionalization. As described 
above, the traditional reactivity of aliphatic amines was largely limited to functionalization at 
C(α)–H sites. Very few studies effectively addressed the inherent challenges associated with 
the remote C–H functionalization of primary, secondary, and tertiary aliphatic amines. To this 
end, we took two approaches: (1) non-directed functionalization of protonated primary, 
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secondary, and tertiary amines (Chapters 2 and 3) and (2) amine-directed functionalization of 
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Chapter 2 focuses on the Pt-catalyzed terminal C(sp3)–H oxidation of protonated 
amines. We were interested in developing a method for the selective functionalization of strong 
1º C(sp3)–H bonds in the presence of weaker 3º and 2º C(sp3)–H bonds.2,3,4 The Pt-catalyzed 
oxidation of alkanes offers a promising approach to this challenge.5 Shilov and others have 
demonstrated that aqueous solutions of PtII (catalyst) and PtIV (oxidant) salts can be used to 
promote the C–H hydroxylation of alkanes (Scheme 2.1).6 Furthermore, these reactions have 
been shown to proceed with moderate selectivity for stronger (but less hindered) 1º C–H bonds 
over weaker (but more hindered) 2º C–H bonds.6,7 Pt-catalyzed H/D exchange studies have 
also demonstrated higher deuterium incorporation at less hindered 1º C–H sites versus more 
hindered 2º C–H bonds.8  
Scheme 2.1. Platinum Catalyzed C‒H Chlorination of Pentane 6c 
 
Despite the great promise of Pt catalysis in the functionalization of C(sp3)–H bonds, Pt-
catalyzed C–H oxidation has found minimal application in organic synthesis over the past 40 
years.9 This is due to three significant limitations: (1) the substrate scope was historically 
limited to simple water soluble organic molecules, (2) the selectivity is generally modest (1º 
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vs 2º C(sp3)–H bond selectivity generally ranges from 1.5:1 to 3:1), and (3) expensive PtIV salts 
are typically used as the terminal oxidant, rendering the reactions impractical on even small 
scale.  
We hypothesized that these challenges could be addressed in the context of the Pt-
catalyzed C(sp3)–H oxidation of aliphatic amines. Aliphatic amines functional groups appear 
in diverse organic materials, natural products, and bioactive molecules.10 Most existing 
methods for the C(sp3)–H functionalization of aliphatic amines involve either (1) 
functionalization at the highly activated C–H bond α-to nitrogen11 or (2) the use of the amine 
nitrogen as the directing group.9c,12,13  
Scheme 2.2. Protonation Strategy to Achieve Remote Functionalization 
 
We sought to achieve terminal-selective C–H functionalization at sites remote to 
nitrogen, providing access to complementary reactivity without the use of a directing group.14 
We hypothesized that protonation of the amine substrates could lead to terminal-selective C–
H oxidation, by addressing two of the underlying challenges associated with Pt catalysis 
(Scheme 2.2). First, quaternization of the amine substrates should increase their aqueous 
solubility. Second, the inductive electron-withdrawing effect of the ammonium cation15 is 
expected to electronically deactivate C–H sites proximal to the nitrogen atom, increasing 
selectivity for 1º C(sp3)–H activation.16 We also noted that previous work by Sames9c and Sen9d 
had shown that CuII salts and O2 can serve as the terminal oxidants for Shilov-type reactions in 
place of the costly PtIV salts (Scheme 2.3).
17 Our protonation strategy is also crucial in this 
context because free amines are known to undergo undesired reactions with CuII salts.18 
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Scheme 2.3. C–H Functionalization of Water Soluble Substrates with CuII Oxidant 8d 
 
2.2. Results and Discussion 
Protonation Strategy and Reaction Optimization 
Our initial investigations focused on the PtII-catalyzed C–H hydroxylation of 
dipropylamine, which contains three types of C(sp3)–H bonds, allowing us to probe selectivity 
and reactivity. We began with traditional Shilov conditions, using 10 mol % of K2PtCl4, 1 equiv 
of K2PtCl6 as the terminal oxidant (and limiting reagent), and 2 equiv of the amine H2SO4 salt 
(protonated in situ with 2.2 equiv of H2SO4) at 120 ºC. These conditions afforded the C(sp
3)–
H hydroxylation product with high terminal selectivity (>10:1 ratio of 1 to 1a) but only modest 
yield (36%) over 48 h (Table 2.1, entry 1). Notably, early on in our investigations, we also 
explored the use of HCl, triflic acid, and trifluoroacetic acid to protonate the amine in situ, and 
observed products corresponding to terminal C–H functionalization. However, we chose to 
proceed with H2SO4 for the remainder of the studies shown here due to high solubility and 
good reactivity. 
Changing the terminal oxidant to CuCl2 under otherwise analogous conditions provided 
an increased yield (66%) while maintaining high selectivity for 1 (>10:1; entry 2). Increasing 
the temperature to 150 ºC afforded a similar yield (63%) over 30 h (entry 3). At this 
temperature, the catalyst loading could be dropped to 1 mol % with minimal impact on the 
yield or selectivity, although this required a longer reaction time (48 h; entry 5). Upon moving 
to 5 equiv of the amine H2SO4 salt relative to Cu, the hydroxylated product was obtained in 
97% yield (97 turnovers of Pt) as determined by 1H NMR spectroscopic analysis, with 8:1 
selectivity for 1 over 1a (entry 6). Control reactions demonstrate that no product is formed in 
the absence of Cu or Pt (entries 7 and 8). Furthermore, in the absence of H2SO4, <1% of the 
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C–H hydroxylation product was observed (entry 9). The results from these control reactions 
are consistent with our hypothesis that protonation of the amine is essential for this 
transformation.  
Table 2.1. Optimization of Pt-Catalyzed C‒H Hydroxylation of Protonated Dipropylamine 
 
 
entry equiv of 
amine 
oxidant temp (℃) K2PtCl4 
loading 
(mol%) 
yield of 1 
+ 1a (%)a 
1 :1aa 
1b 2 K2PtCl6 120 10 36 >10:1 
2b 2 CuCl2 120 10 66 >10:1 
3c 2 CuCl2 150 10 63 >10:1 
4c 2 CuCl2 150 1 40 >10:1 
5b 2 CuCl2 150 1 70 8:1 
6c 5 CuCl2 150 1 97 8:1 
7c 5 -- 150 1 nde -- 
8c 5 CuCl2 150 -- nd
e -- 
9c,d 5 CuCl2 150 1 <1 -- 
a Yield and ratio of products determined by 1H NMR. Reactions were conducted in sealed vials under an 
atmosphere of ambient air. Yields are calculated based on the oxidant (K2PtCl4 or CuCl2) as the limiting reagent. 
b 48 h c 30 h d No H2SO4 added. e Products 1 and 1a were not detected. 
 
Probing Site-Selectivity of Platinum Oxidation 
We next examined the Pt-catalyzed C–H hydroxylation of a series of N-alkyl 
pyrrolidine substrates to probe the impact of chain length on site selectivity (Table 2.2). In all 
cases, the major product was derived from C–H hydroxylation at the terminal position. As the 
terminal methyl group is moved closer to the nitrogen atom, selectivity for the 1º C–H bond 
increases sequentially from 2:1 in 5 to >20:1 in 2.19 In all cases, the selectivity was determined 
by 1H NMR spectroscopic analysis of the crude reaction mixture (see the supporting 
information in reference 1 for crude 1H NMR spectra). The amino alcohol products were then 
derivatized with pivaloyl chloride (PivCl) to facilitate product isolation and characterization. 
Using these conditions, the oxygenated amino ester products 3-5 could be isolated in high 
yields.20  
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Table 2.2. Pt-Catalyzed C‒H Functionalization of N-Alkylpyrrolidines 
 
a Crude selectivity determined by 1H NMR spectroscopic analysis prior to treatment with PivCl. 
b Yield determined by spectroscopic analysis 
 
The observed increase in selectivity with shorter chain length correlates with a 
decreased reactivity towards C–H functionalization at sites that are closer to the ammonium 
cation.  For example, the C–H hydroxylation of N-ethyl pyrrolidine to form 2 proceeded in 
modest 25% yield under conditions used to obtain products 3–5. This is consistent with -
C(sp3)–H bonds being significantly less reactive than more remote C–H sites. In addition, a 
competition between N-propyl and N-butyl pyrrolidine afforded a 10 : 7 : 1 : <1 ratio of 
products 4-OH : 3-OH : 4a-OH : 3a-OH (Scheme 2.4). Again, the selectivity for 4-OH over 
3-OH as well as for 4a-OH over 3a-OH is consistent with higher reactivity of C–H sites that 
are further from the protonated nitrogen atom. Overall, these results support our hypothesis 
that quaternization of the amine electronically deactivates the C(sp3)–H sites proximal to 




Scheme 2.4. Competition between N-Propyl- and N-Butylpyrrolidine 
 
Substrate Scope of Remote Oxidation 
Our standard conditions were effective for the C–H hydroxylation of a variety of 2º and 
3º aliphatic amine substrates (Table 2.3). In all cases, the site selectivity was determined by 1H 
NMR spectroscopic analysis of the crude reaction mixtures (see supporting information in 
reference 1 for crude 1H NMR spectra).19 Following C–H hydroxylation, the amino alcohol 
products were derivatized with pivaloyl chloride to facilitate isolation and characterization. 
Notably, the CuCl2 oxidant is the limiting reagent in these transformations. As such, yields 
greater than 100% reflect regeneration of the CuII oxidant, presumably by O2.
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All the examples in Table 2.3 display modest to excellent selectivity for terminal C–H 
functionalization.19 Notably, the derivatization and purification sequence results in an upgrade 
of selectivity for the terminal product in many cases. This is likely attributed to an inefficient 
protection of the secondary alcohol with PivCl and subsequent recovery during purification. 
The terminal selectivity partially reflects the inherent steric preference of Pt for the activation 
of 1º over 2º or 3º C–H bonds.5,7 However, selectivity is highest in the formation of the products 
in entries 1, 4, 5, and 7-10 where the competing 2º C(sp3)–H sites are  or  to the quaternized 
nitrogen atom. Again, these results implicate a significant inductive deactivation by the 
ammonium cation. In addition to linear aliphatic amines, nitrogen heterocycles including 
pyrrolidine, piperidine, and morpholine are compatible with the reaction conditions. Minimal 
C–H oxidation of the 2º C–H bonds of the ring (<5%) is observed in these systems. Although 
terminal -C(sp3)–H sites are electronically deactivated, triethylamine does provide the -C–
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H oxygenation product in high yields under slightly modified reaction conditions with 15 
equivalents of amine over 48 hours (entry 7). Minimal oxidation of tert-butyl groups is 
observed (entry 10) even in the absence of competing 1º C–H bonds (e.g., entries 11, 12). 
Similar observations have been made by Hartwig in Ir-catalyzed alkane borylation3 and can be 
rationalized based on steric deactivation of the tert-butyl C–H bonds. 
Table 2.3. Pt-Catalyzed C‒H Hydroxylation of Secondary and Tertiary Amines 
 
a General conditions: 1 mol % K2PtCl4, 1 equiv CuCl2, 5 equiv of amine, 5.5 equiv H2SO4 (1.1 equiv relative to 
amine), 150 ºC, 24 h. b Entry 6: Amine used as HCl salt, 10 mol % K2PtCl4. c Entry 7: 15 equiv amine, 16.5 
equiv H2SO4, 48 h. d Entry 8: 0.5 mol % K2PtCl4, 15 equiv amine, 16.5 equiv H2SO4. e  Entries 9-11: 5 mol % 
K2PtCl4. f  Entries 11-12: Amine used as HCl salt, 10 mol % K2PtCl4; g Yields estimated by 1H NMR analysis of 
crude reaction mixtures; <5% of C(sp3)–H hydroxylation or C(sp3)–H chlorination products were observed. 
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Comparison to Other State of the Art Methodologies 
We next compared this terminal-selective C–H hydroxylation reaction to Ir-catalyzed 
C–H borylation, which represents the current state-of-the-art method for terminal-selective 
alkane C–H functionalization.3 The Hartwig group published a report on the C(sp3)–H 
borylation of tertiary aliphatic amines in which diethylbutylamine undergoes Ir-catalyzed C–
H borylation to afford the terminal -C(sp3)–H borylation product 18-BPin with 6 : 1 
selectivity relative to the terminal -C(sp3)–H borylation product 19-BPin (Scheme 2.5a).14 
Formation of the 2º C(sp3)–H borylation product 19a-BPin was not observed. In contrast, our 
Pt-catalyzed hydroxylation conditions with diethylbutylamine provide a complete switch in 
site selectivity, affording a >20:1 preference for 19-OH over 18-OH and a 3:1 ratio of 19-OH 
to 19a-OH (Scheme 2.5b). These results highlight the complementarity of the two methods. 
Notably, Pt catalysis has the additional advantages of compatibility with ambient air and 
moisture as well as applicability to 1º, 2º and 3º amine substrates. 
Scheme 2.5. Comparison of Selectivity of Ir-Catalyzed C–H Borylation Versus Pt-Catalyzed 





Mechanistic Insights  
A final set of investigations focused on probing the mechanism of this transformation. 
In particular, we noted that C–H hydroxylation products are formed exclusively at the end of 
24–48 hours under our reaction conditions, despite the presence of a high concentration of 
chloride. In other studies of Shilov-type alkane C–H oxidation, mixtures of C–H chlorination 
and C–H hydroxylation products are often observed under related conditions.6,7,22  




When the Pt-catalyzed C–H oxidation of dipropylamine was monitored by 1H NMR 
spectroscopy, we observed rapid initial formation of an intermediate (A), which then fully 
converted to the C–H hydroxylation product over a 24 h period (Figure 2.1). Intermediate A 
was identified as the terminal C–H chlorination product based on in situ characterization by 1H 
NMR spectroscopy and by the independent synthesis (see experimental section for more details 




























authentic sample of A undergoes quantitative conversion to 1 over 24 h at 150 ºC in H2O, both 
in the presence and in the absence of the Pt catalyst. This suggests that a significant quantity 
of the hydroxylated product 1 is formed from the chlorinated intermediate A via a nucleophilic 
substitution reaction.   
Further Reactivity of Chlorinated Products 
The time study profile in Figure 2.1 suggests the feasibility of selectively accessing 
C(sp3)–H chlorination products. As proof-of-principle, we subjected substrates 20 and 24 to 
our Pt-catalyzed C–H oxidation conditions for short reaction times (2 h). We hypothesized that 
the presence of branching in 20 and 24 could slow the nucleophilic attack of possible 
chlorinated intermediates by H2O. Analysis of the crude reaction mixtures by 
1H NMR 
spectroscopy showed exclusive formation of the C–H chlorination products 21 and 25 (Scheme 
2.7). While 21 and 25 proved challenging to isolate due to their high volatility, work up of these 
reactions with KHCO3 resulted in the formation of the corresponding oxazinones 23 and 26, 
which were isolated in 65% and 55% isolated yield, respectively (Scheme 2.6). In addition, 
the treatment of 21 with phenyl isothiocyanate afforded 22 in 73% yield (Scheme 2.6). 








2.3. Conclusion and Outlook 
In conclusion, Chapter 2 describes the PtII catalyzed, primary selective C(sp3)–H 
oxidation of protonated aliphatic amines utilizing CuII as the terminal oxidant. These reactions 
proceed with low catalyst loadings, high TONs, and high selectivities. Protonation of the amine 
plays three critical roles in this transformation. First, protonation renders the substrates water-
soluble. Second, protonation prevents deactivation of the PtII and CuII via amine binding. 
Finally, the inductive electron-withdrawing ammonium cation electronically deactivates 
proximal C–H bonds, resulting in high selectivity for terminal C(sp3)–H sites remote from the 
nitrogen atom. Preliminary H/D exchange experiments demonstrate higher selectivity 
compared to hydroxylation, suggesting modifications to reaction conditions (oxidant, solvent, 
nucleophile) can potentially impact the site selectivity of the functionalized product (Scheme 
2.8). Current efforts in our laboratory are focused on designing second-generation Pt catalysts 
with water-soluble ligands to enhance selectivity and catalyst longevity, as well as investigating 
the use of organic co-solvents to expand the current substrate scope.   
Scheme 2.8. Deuterium Incorporation Studies with Dipropylamine and Dibutylamine 
 
2.4. Updates Since Publication 
Since our publication on the remote functionalization of protonated aliphatic amines, 
several groups have utilized a similar strategy for transition metal mediated, remote C–H 
oxidation. Both the White group and our group have utilized protonated aliphatic amines as 
substrates for Fe-catalyzed oxidation of remote secondary, tertiary, and benzylic C(sp3)–H 
bonds.23 The Sigman group jointly with the DuBois group recently published a Ru-catalyzed 
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remote tertiary and benzylic C–H oxidation.24 Schulz and co-workers achieved the remote C–
H oxidation of protonated cyclic and linear aliphatic amines via decatungstate photocatalysis.25 
This ongoing work demonstrates the promise of this approach for the selective C–H oxidation 
of important amine scaffolds. 
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2.5. Experimental Procedures and Characterization of Compounds 
2.5.1 General Procedures and Materials and Methods 
General Procedures 
 
NMR spectra were recorded on a Varian vnmrs 700 (700 MHz for 1H; 176 MHz for 13C), 
Varian vnmrs 500 (500 MHz for 1H; 126 MHz for 13C), Varian Inova 500 (500 MHz for 1H), 
or Varian MR400 (400 MHz for 1H; 100 MHz for 13C) with the residual solvent peak (CDCl3; 
1H: δ = 7.26 ppm, 13C: δ = 77.16 ppm) as the internal reference unless otherwise noted. 
Chemical shifts are reported in parts per million (ppm) (δ) relative to tetramethylsilane. 
Multiplicities are reported as follows: br (broad signal), s (singlet), d (doublet), t (triplet), q 
(quartet), quin (quintet), sex (sextet), m (multiplet), dd (doublet of doublets), ddd (doublet of 
doublet of doublets), qd (quartet of doublets). Coupling constants (J) are reported in Hz. 
Infrared (IR) spectroscopy was performed on a Perkin-Elmer Spectrum BX Ft-IR spectrometer 
and peaks are reported in cm-1. Melting points were determined with a Thomas Hoover Uni-
Melt 6427-H10 Capillary Melting-Point Apparatus and are uncorrected.  High-resolution mass 
spectra were recorded on a Micromass AutoSpec Ultima Magnetic Sector mass spectrometer. 
Stock solutions were made using volumetric glassware. Liquid reagents were dispensed by 
difference from syringes. All reagents were weighed out under ambient conditions.  
 
Materials and Methods 
 
HPLC grade water, ethyl acetate (EtOAc), hexanes, methanol, and dichloromethane for column 
chromatography were purchased from VWR. Silica gel for flash column chromatography was 
purchased from Dynamic Adsorbents. CDCl3 was purchased from Cambridge Isotope 
Laboratories, Inc. K2PtCl4, K2PtCl6 (Acros), and copper(II) chloride dihydrate (J.T. Baker 
Chemicals) were used as purchased without further purification. Amine substrates were 
purchased from commercial sources (Alfa Aeser, Sigma Aldrich, TCI, and ACROS, Astatech) 
and used without further purification, unless otherwise noted. Thin layer chromatography 
(TLC) was performed on Merck TLC plates pre-coated with silica gel 60 F254. 
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2.5.2 Synthesis and Characterization of Substrates 
 N-(tert-butyl)propan-1-amine: 
 
N-(tert-butyl)propan-1-amine was synthesized from tert-butylamine and 1-iodopropane using 
a literature procedure26 and was purified via distillation.  
HRMS: ESI+ (m/z): [M+H]+ calcd for C7H18N: 116.1434; found: 116.1434 
1H NMR (CDCl3, 500 MHz): δ 2.50 (t, J = 7.5 Hz, 2H), 1.46 (sex, J = 7.5 Hz, 2H), 1.08 (s, 
9H), 0.91 (t, J = 7.5 Hz, 3H), 0.61 (s, 1H, N–H)  




1-propylpyrrolidine was synthesized from pyrrolidine and 1-iodopropane using a literature 
procedure26 and was purified via distillation. 
HRMS: ESI+ (m/z): [M+H]+ calcd for C7H16N: 114.1277; found: 114.1279 
1H NMR (CDCl3, 500 MHz): δ 2.47 (m, 4H), 2.37 (t, J = 7.5 Hz, 2H), 1.76 (m, 4H), 1.52 (sex, 
J = 7.5 Hz, 2H), 0.91 (t, J = 7.5 Hz, 3H)  




1-butylpyrrolidine was synthesized from pyrrolidine and 1-iodobutane using a literature 
procedure26 and was purified via distillation. 
HRMS: ESI+ (m/z): [M+H]+ calcd for C8H18N: 128.1434; found: 128.1433 
1H NMR (CDCl3, 500 MHz): δ 2.48 (m, 4H), 2.42 (t, J = 7.5 Hz, 2H), 1.77 (m, 4H), 1.50 (sex, 
J = 7.5 Hz, 2H), 1.34 (sex, J = 7.5 Hz, 2H), 0.92 (t, J = 7.5 Hz, 3H)  




1-pentylpyrrolidine was synthesized from pyrrolidine and 1-iodopentane using a literature 
procedure26 and was purified via distillation. 
HRMS: ESI+ (m/z): [M+H]+ calcd for C8H20N: 143.1590; found: 143.1590 
1H NMR (CDCl3, 500 MHz): δ 2.48 (m, 4H), 2.40 (t, J = 7.5 Hz, 2H), 1.77 (m, 4H), 1.51 (quin, 
J = 7.5 Hz, 2H), 1.36-1.28 (multiple peaks, 4H), 0.91 (t, J = 7.5 Hz, 3H)  




1-Propylpiperidine was synthesized from piperidine and 1-iodopropane using a literature 
procedure26 and was purified via distillation. 
HRMS: ESI+ (m/z): [M+H]+ calcd for C8H18N: 128.1434; found: 128.1435 
1H NMR (CDCl3, 500 MHz): δ 2.35 (br s, 4H), 2.23 (t, J = 7.5 Hz, 2H), 1.57 (m, 4H), 1.52 (m, 
2H), 1.42 (sex, J = 7.5 Hz, 2H), 0.88 (t, J = 7.5 Hz, 3H)  




4-Propylmorpholine was synthesized from morpholine and 1-iodopropane using a literature 
procedure26 and was purified via distillation. 
HRMS: ESI+ (m/z): [M+H]+ calcd for C7H16N: 130.1226; found: 130.1227 
1H NMR (CDCl3, 500 MHz): δ 3.71 (t, J = 4.5 Hz, 4H), 2.42 (m, 4H), 2.29 (t, J = 7.5 Hz, 2H), 
1.50 (sex, J = 7.5 Hz, 2H), 0.90 (t, J = 7.5 Hz, 3H)   
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13C NMR (CDCl3, 126 MHz): δ 67.2, 61.3, 53.9, 19.9, 12.0   
 
2.5.3 Synthesis and Characterization of Minor Isomers 
1-(pyrrolidin-1-yl)propan-2-ol: 
 
An authentic sample of 1-(pyrrolidin-1-yl)propan-2-ol (for comparison with samples produced 
from Pt catalysis) was synthesized from pyrrolidine and propylene oxide using a literature 
procedure.27   
HRMS: ESI+ (m/z): [M+H]+ calcd for C7H16NO: 130.1226; found: 130.1226  
1H NMR (CDCl3, 500 MHz): δ 3.78 (m, 1H), 3.50 (br s, 1H, O-H) 2.66 (m, 2H), 2.52 (app t, 
J = 12.0 Hz, 1H), 2.43 (m, 2H), 2.23 (dd, J = 12.0 Hz, J = 2.5 Hz, 1H), 1.75 (m, 4H), 1.12 (d, 
J = 6.0 Hz, 3H)  




An authentic sample of 1-(piperidin-1-yl)propan-2-ol (for comparison with samples produced 
from Pt catalysis) was synthesized from piperidine and propylene oxide using a literature 
procedure.27   
HRMS: ESI+ (m/z): [M+H]+ calcd for C8H18NO: 144.1383; found: 144.1383  
1H NMR (CDCl3, 500 MHz): δ 3.79 (m, 1H), 3.69 (br s, 1H, O-H), 2.57 (m, 2H), 2.27 (m, 2H), 
2.24 (dd, J = 12.5 Hz, J = 3.0 Hz, 1H), 2.13 (t, J = 10.5 Hz, 1H), 1.55 (m, 4H), 1.42 (m, 2H), 
1.10 (d, J = 6.0 Hz, 3H)   








An authentic sample of 1-morpholinopropan-2-ol (for comparison with samples produced from 
Pt catalysis) was synthesized from morpholine and propylene oxide using a literature 
procedure.27  
HRMS: ESI+ (m/z): [M+H]+ calcd for C7H16NO2: 146.1175; found: 146.1176 
1H NMR (CDCl3, 700 MHz): δ 3.84 (m, 1H), 3.70 (m, 4H), 3.40 (br s, 1H, O-H), 2.64 (m, 2H), 
2.38 (m, 2H), 2.31 (dd, J = 12.5 Hz, J = 3.0 Hz, 1H), 2.21 (dd, J = 12.5 Hz, J = 10.5 Hz, 1H), 
1.12 (d, J = 6.0 Hz) 




An authentic sample of 1-(propylamino)propan-2-ol (for comparison with samples produced 
from Pt catalysis) was synthesized from n-propylamine and propylene oxide using a literature 
procedure.27   
HRMS: ESI+ (m/z): [M+H]+ calcd for C6H16NO: 118.1226; found: 118.1228  
1H NMR (CDCl3, 500 MHz): δ 3.76 (m, 1H), 2.70 (dd, J = 12.0 Hz, J = 3.5 Hz, 1H), 2.61 (m, 
1H), 2.56 (m, 1H), 2.39 (dd, J = 12.0 Hz, J = 9.0 Hz, 1H), 2.16 (br s, 2H, O-H and N-H), 1.50 
(sex, J = 7.5 Hz, 2H), 1.14 (d, J = 6.0 Hz, 3H), 0.92 (t, J = 7.5 Hz, 3H)  




An authentic sample of 1-(dipropylamino)propan-2-ol (for comparison with samples produced 
from Pt catalysis) was synthesized from dipropylamine and propylene oxide using a literature 
procedure.27   
HRMS: ESI+ (m/z): [M+H]+ calcd for C9H22NO: 160.1696; found: 160.1693  
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1H NMR (CDCl3, 500 MHz): δ 3.70 (multiple peaks, 2H, where 1H from O-H), 2.47 (m, 2H), 
2.38-2.33 (multiple peaks, 3H), 2.21 (dd, J = 10.5 Hz, J = 12.5 Hz, 1H), 1.45 (m, 4H), 1.11 (d, 
J = 6.0 Hz, 3H), 0.88 (t, J = 7.0 Hz, 6H) 




An authentic sample of 5-(N-methylpivalamido)pentan-2-yl pivalate (for comparison with 
samples produced from Pt catalysis) was synthesized from 5-chloro-2-pentanone using a 
literature procedure.28 
HRMS: ESI+ (m/z): [M+H]+ calcd for C16H32NO3: 286.2377; found: 286.2376 
1H NMR (CDCl3, 400 MHz): δ 4.88 (sex, J = 6.8 Hz, 1H), 3.36 (m, 2H), 3.01 (s, 3H), 1.65-
1.45 (multiple peaks, 4H), 1.27 (s, 9H), 1.20 (d, J = 6.8 Hz, 3H), 1.18 (s, 9H) 
13C NMR (CDCl3, 126 MHz): 178.3, 177.4, 70.2, 49.9, 38.9, 38.9, 33.2, 28.5, 27.3, 27.2, 23.5, 
20.0 
 
2.5.4 General Procedures for Reaction Optimization 
General Procedure A: 
 
120 °C Conditions: To a 4 mL scintillation vial containing K2PtCl4 (10 mol %, 2.1 mg), 
CuCl2•2H2O (1 equiv, 0.1 mmol, 17 mg) were added aqueous H2SO4 (2.2 equiv, 0.11 mmol) 
from a stock solution and dipropylamine (2.0 equiv, 0.1 mmol, 14 μL). The reaction vial was 
equipped with a micro stir bar, sealed with a Teflon-lined cap, and placed in an aluminum block 
preheated to 120 °C. The reaction mixture was stirred for 48 h at 120 ºC. The reaction mixture 
was then quenched with NH4OH (28% aqueous solution, 0.5 mL) and saturated NaCl. The 
product was extracted into CDCl3 (2.0 mL) containing mesitylene as an internal standard 
(0.025 mmol). The organic extracts were filtered through a Celite plug and the yield was 
determined via 1H NMR spectroscopic analysis.  
 
150 °C Conditions: To a 10 mL scintillation vial (10 cm tall) containing K2PtCl4 (10 mol %, 
2.1 mg), CuCl2•2H2O (1 equiv, 0.1 mmol, 17 mg) were added aqueous H2SO4 (2.2 or 5.5 equiv, 
0.11 mmol or 0.55 mmol) from a stock solution, and dipropylamine (2.0 or 5.0 equiv, 0.1 mmol 
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or 0.25 mmol, 14 μL or 34 μL). The reaction vial was equipped with a micro stir bar, sealed 
with a Teflon-lined cap and placed in an aluminum block preheated to 150 °C. The reaction 
mixture was stirred for 30–48 h at 120 ºC. The reaction mixture was then cooled to room 
temperature and quenched with NH4OH (28% aqueous solution, 0.5 mL) and saturated NaCl. 
The product was extracted into CDCl3 (2.0 mL) containing mesitylene as an internal standard 
(0.025 mmol). The organic extracts were filtered through a Celite plug and the yield was 
determined via 1H NMR spectroscopic analysis.  Notably, when 1 mol % of Pt was used, the 
K2PtCl4 was added from a stock solution (0.0124 M aqueous stock solution) and was the last 
reagent added. 
 
2.5.5 General Procedures for Isolation of Products and Characterization 
General Procedure B:  
 
To a 10 mL scintillation vial (10 cm tall) containing CuCl2•2H2O (1 equiv) were added aqueous 
H2SO4 (5.5 equiv) from a stock solution, the appropriate amine substrate (5 equiv), and K2PtCl4 
(0.5-1 mol % from a 0.0124 M aqueous stock solution and 5-10 mol % as a solid). The reaction 
vial was equipped with a micro stir bar, sealed with a Teflon-lined cap, and placed in an 
aluminum block preheated to 150 °C. The reaction mixture was stirred for 24 to 48 h at 150 
ºC. Unless otherwise noted, all reactions were run until all C–H chlorination products 
transformed into C–H hydroxylation products for accurate determination of selectivity and for 
ease of isolation. The reaction was cooled to room temperature and quenched with NH4OH 
(28% aqueous solution, 0.5 mL) and saturated NaCl. The product was extracted into CHCl3 (3 
x 3 mL), the organic extracts were filtered through a Celite plug, and the resulting mixture was 
concentrated by rotary evaporation.  
 
General Procedure C: 
Two reactions conducted and worked on the scale of procedure B were combined. To the crude 
reaction mixture from part B was added dichloromethane (3 mL), and then triethylamine (0.7 
mL) and pivaloyl chloride (1 equiv, 61 μL for products 3-5, 11, 14, 15, 19 or 3 equiv, 184 μL 
for products 6-10, 12, 13) were added. The resulting mixture was stirred at room temperature 
for 3 h. The reaction was diluted with dichloromethane (50 mL), and the organic layer was 
washed three times with NaOH (1M aqueous solution, 50 mL). The organic extracts were 
collected and the volatiles were removed by rotary evaporation. The resulting residue was 
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purified by column chromatography. In all cases, the yield is calculated based on CuCl2•2H2O 
as the limiting reagent. Since the copper acts as a 1-electron oxidant, 100% yield = 0.5*(mmol 
CuCl2•2H2O added to the reaction).  
 
2-(pyrrolidin-1-yl)ethan-1-ol (2-OH):  
  
General procedure A was followed using 1-ethylpyrrolidine (0.25 mmol, 30.6 μL, 5 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 5.5 equiv, 
1.1 M stock solution), and K2PtCl4 (0.0025, 1.0 mg, 5 mol %). The reaction was stirred at 150 
°C for 48 h. The reaction was performed side-by-side in duplicate and the reaction was 
quenched and analyzed by 1H NMR as outlined in general procedure A. The identity of the 
product was confirmed by a commerically available authentic sample of 2-(pyrrolidin-1-
yl)ethan-1-ol. 
1H NMR Yield: 25% 
 
3-(pyrrolidin-1-yl)propyl pivalate (3):  
 
General procedure B was followed using 1-propylpyrrolidine (0.25 mmol, 28.3 mg, 5 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 5.5 equiv, 
1.1 M stock solution), and K2PtCl4 (0.0025, 1.0 mg, 5 mol %). The reaction was stirred at 150 
°C for 24 h. The reaction was performed side-by-side in duplicate, the two duplicate runs were 
combined, and the hydroxylated product was protected via general procedure C. The product 
was then purified by silica column chromatography (gradient of 1% to 10%, MeOH in DCM). 
Isolated Yield: 85% (18.2 mg, crude ratio of 3-OH : 3a-OH = 10 : 1; isolated ratio of 3 : 3a = 
>20:1; light yellow oil) 
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Rf: 0.30 (10% MeOH/90% DCM) 
IR (ν, cm-1): 2958, 2791, 1727, 1480, 1459, 1284, 1151, 732 
HRMS: APCI+ (m/z): [M+H]+ calcd for C12H24NO2: 214.1807; found: 214.1802 
1H NMR (CDCl3, 700 MHz): δ 4.11 (t, J = 6.3 Hz, 2H), 2.50 (overlapping m, 6H), 1.85 
(quin, J = 7.0 Hz, 2H), 1.78 (m, 4H), 1.19 (s, 9H)   
13C NMR (CDCl3, 176 MHz): δ 178.7, 63.0, 54.4, 53.2, 38.9, 28.5, 27.3, 23.6 
 
4-(pyrrolidin-1-yl)butyl pivalate (4):  
 
General procedure B was followed using 1-butylpyrrolidine (0.25 mmol, 31.8 mg, 5 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 5.5 equiv, 
1.1 M stock solution), and K2PtCl4 (0.0025, 1.0 mg, 5 mol %). The reaction was stirred at 150 
°C for 24 h. The reaction was performed side-by-side in duplicate, the two duplicate runs were 
combined, and the hydroxylated product was protected via general procedure C. The product 
was then purified by silica column chromatography (gradient of 1% to 10%, MeOH in DCM). 
Isolated Yield: 126% (28.7 mg as a mixture of isomers; crude ratio of 4-OH : 4a-OH = 4 : 1; 
isolated ratio of 4 : 4a = 4 : 1; yellow oil) 
Rf: 0.48 (4), 0.55 (4a) (10% MeOH/90% DCM) 
IR (ν, cm-1) (mixture of isomers): 2966, 1719, 1479, 1459, 1284, 1161, 908, 724 
HRMS:  
4: ESI+ (m/z): [M+H]+ calcd for C13H26NO2: 228.1958; found: 228.1959 
4a: ESI+ (m/z): [M+H]+ calcd for C13H26NO2: 228.1958; found: 228.1959 
4: 1H NMR (CDCl3, 700 MHz): δ 4.07 (t, J = 6.3 Hz, 2H), 2.50 (br s, 4H), 2.47 (t, J = 7.0 Hz, 
2H), 1.78 (br s, 4H), 1.67 (sex, J = 7.0 Hz, 2H), 1.59 (br s, 2H, overlaps with water peak), 1.92 
(s, 9H) 
4: 13C NMR (CDCl3, 176 MHz): δ 178.8, 64.4, 56.3, 54.3, 38.9, 27.4, 27.0, 25.6, 23.6   
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4a: 1H NMR (CDCl3, 700 MHz): δ 4.92 (sex, J = 6.3 Hz, 1H), 2.50 (overlapping peaks, 6H), 
1.78 (overlapping peaks, 6H), 1.22 (d, J = 5.6 Hz, 3H), 1.18 (s, 9H) 
4a: 13C NMR (CDCl3, 176 MHz): δ 178.2, 69.4, 54.4, 52.7, 38.9, 35.5, 27.3, 23.6, 20.2 
 
5-(pyrrolidin-1-yl)pentyl pivalate (5):  
 
General procedure B was followed using 1-pentylpyrrolidine (0.25 mmol, 35.3 mg, 5 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 5.5 equiv, 
1.1 M stock solution), and K2PtCl4 (0.0025, 1.0 mg, 5 mol %). The reaction was stirred at 150 
°C for 24 h. The reaction was performed side-by-side in duplicate, the two duplicate runs were 
combined, and the hydroxylated product was protected via general procedure C. The product 
was then purified by silica column chromatography (gradient of 1% to 10%, MeOH in DCM). 
Isolated Yield: 73% (17.7 mg, crude ratio of 5-OH : 5a-OH = 2:1; isolated ratio of 5 : 5a = 
3:1; light yellow oil) 
Major Rf (5): 0.52 (10% MeOH/90% DCM) 
IR (ν, cm-1) (mixture of 5 and 5a): 2958, 2934, 2872, 2783, 1727, 1480, 1459, 1396, 1284, 
1159 
HRMS (mixture of 5 and 5a): ESI+ (m/z): [M+H]+ calcd for C14H28NO2: 242.2115; found: 
242.2116 
5: 1H NMR (CDCl3, 700 MHz): δ 4.04 (t, J = 6.3 Hz, 2H), 3.16 (br s, 4H), 2.94 (t, J = 7.7 Hz, 
2H), 2.11 (br s, 4H), 1.90 (quin, J = 7.7 Hz, 2H), 1.67 (quin, J = 7.7 Hz, 2H), 1.41 (quin, J = 
7.7 Hz, 2H), 1.18 (s, 9H) 






3-(N-propylpivalamido)propyl pivalate (6):  
 
General procedure B was followed using dipropylamine (0.50 mmol, 68.5 μL, 5 equiv), 
CuCl2·2H2O (0.2 mmol, 34.1 mg, 1 equiv), 0.50 mL of aqueous H2SO4 (0.55 mmol, 5.5 equiv, 
1.1 M stock solution), and K2PtCl4 (0.001 mmol, 80 μL of a 0.0124 M aqueous stock solution, 
1 mol %). The reaction was stirred at 150 °C for 24 h. The reaction was performed side-by-
side in triplicate, the three triplicate runs were combined, and the hydroxylated product was 
protected via general procedure C. The product was then purified by silica column 
chromatography (gradient of 0 to 20%, EtOAc in Hex).  
Isolated Yield: 87% (74.4 mg, crude ratio of 6-OH : 6a-OH = 10:1; isolated ratio of 6 : 6a =  
>20:1; light yellow oil) 
Rf: 0.41 (20% EtOAc/ 80% Hex) 
IR (ν, cm-1): 2964, 1728, 1625, 1481, 1413, 1365, 1283, 1150, 1124  
HRMS: ESI+ (m/z): [M+H]+ calcd for C16H32NO3: 286.2377; found: 286.2377 
1H NMR (CDCl3, 400 MHz): 4.07 (t, J = 6.0 Hz, 2H), 3.39 (poorly resolved triplet, 2H), 3.29 
(t, J = 8.0 Hz, 2H), 1.90 (quin, J = 6.4 Hz, 2H), 1.58 (sex, J = 7.6 Hz, 2H), 1.26 (s, 9H), 1.20 
(s, 9H), 0.89 (t, J = 7.2 Hz, 3H)   
13C NMR (CDCl3, 176 MHz, 50 °C): δ 178.4, 177.3, 62.3, 49.9, 44.9, 41.7, 39.2, 38.9, 28.7, 
27.3. 21.7, 11.2  
Scale-up: The same reaction was carried out on a larger scale using dipropylamine (1.0 mmol, 
137 μL, 5 equiv), CuCl2·2H2O (0.4 mmol, 68.2 mg, 1 equiv), 1.0 mL of aqueous H2SO4 (1.1 
mmol, 5.5 equiv, 1.1 M stock solution), and K2PtCl4 (0.002 mmol, 160 μL of a 0.0124 M 
aqueous stock solution, 1 mol %). The reaction was stirred at 150 °C for 24 h. The reaction 
was performed side-by-side in duplicate, the two duplicate runs were combined, and the 
hydroxylated product was protected via general procedure C. The product was then purified as 






4-(N-butylpivalamido)butyl pivalate (7):  
 
General procedure B was followed using dibutylamine (0.25 mmol, 42 μL, 5 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 5.5 equiv, 
1.1 M stock solution), and K2PtCl4 (0.0005 mmol, 40 μL of a 0.0124 M aqueous stock solution, 
1 mol %). The reaction was stirred at 150 °C for 24 h. The reaction was performed side-by-
side in duplicate, the two duplicate runs were combined, and the hydroxylated product was 
protected via general procedure C. The product was then purified by silica column 
chromatography (gradient of 0 to 30%, EtOAc in Hex). 
Isolated Yield: 76% (23.9 mg, crude ratio of 7-OH : 7a-OH = 5:1; isolated ratio of 7 : 7a = 
7:1; light yellow oil) 
Rf: 0.42 (7), 0.52 (7a) (20% EtOAc/80% Hex)  
IR (ν, cm-1) (mixture of 7 and 7a): 2958, 1726, 1625, 1480, 1458, 1414, 1364, 1283, 1155, 
1126 
HRMS:  
7: ESI+ (m/z): [M+H]+ calcd for C19H36NO3: 314.2690; found: 314.2690 
7a: ESI+ (m/z): [M+H]+ calcd for C19H36NO3: 314.2690; found: 314.2690 
 7: 1H NMR (CDCl3, 700 MHz, 50 °C): δ 4.08 (t, J = 5.6 Hz, 2H), 3.33 (m, 4H), 1.63 (m, 4H), 
1.55 (quin, J = 7.0 Hz, 2H), 1.32 (sex, J = 7.7 Hz, 2H), 1.27 (s, 9H), 1.20 (s, 9H), 0.95 (t, J = 
7.7 Hz, 3H)   
7: 13C NMR (CDCl3, 176 MHz, 50 °C): δ 178.8, 177.4, 64.2, 48.0, 47.6, 39.4, 39.1, 30.9, 29.0, 
27.6, 26.7, 25.1, 20.6, 14.2 
7a: 1H NMR (CDCl3, 700 MHz, 50 °C): δ 4.90 (sex, J = 6.3 Hz, 1H), 3.35 (m, 4H), 1.83 (m, 
2H), 1.54 (m, 2H), 1.32 (sex, J = 7.7 Hz, 2H), 1.27 (s, 9H), 1.24 (d, J = 6.3 Hz, 3H), 1.21 (s, 
9H), 0.95 (t, J = 7.7 Hz, 3H)  
7a: 13C NMR (CDCl3, 176 MHz, 50 °C): δ 178.1, 177.3, 69.1, 48.1, 44.5, 39.2, 39.0, 34.5, 30.7, 




5-(N-methylpivalamido)pentyl pivalate (8): 
 
General procedure B was followed using N-methylpentylamine (0.25 mmol, 34 μL, 5 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 5.5 equiv, 
1.1 M stock solution), and K2PtCl4 (0.0025 mmol, 1.0 mg, 5 mol %). The reaction was stirred 
at 150 °C for 24 h. The 2º C–H chlorination product (~14%) was observed at the end of the 
reaction (24 h). This compound still remained after 48 h. The reaction was performed side-by-
side in duplicate, the two duplicate runs were combined, and the hydroxylated product was 
protected via general procedure C. The product was then purified by silica column 
chromatography (gradient of 0 to 30%, EtOAc in Hex). 
Isolated Yield: 47% (13.5 mg, crude ratio of 8-OH : 8a-OH = 3:1; isolated ratio 8 : 8a = 17:1; 
light yellow oil) 
Rf (8): 0.50 (30% EtOAc/70% Hex)  
IR (ν, cm-1) (isolated mixture of 8 and 8a): 2936, 2871, 1725, 1626, 1480, 1401, 1364, 1283, 
1152, 1077, 1030 
HRMS (isolated mixture of 8 and 8a): EI+ (m/z): M+ calcd for C16H31NO3: 285.2304; found: 
285.2308 
8: 1H NMR (CDCl3, 401 MHz): δ 4.04 (t, J = 6.8 Hz, 2H), 3.35 (dd, J = 7.6 Hz, 2H), 3.03 (s, 
3H), 1.66 (m, 2H), 1.57 (m, 2H), 1.34 (m, 2H), 1.27 (s, 9H), 1.19 (s, 9H) 
8: 13C NMR (CDCl3, 176 MHz, 50 °C): δ 178.7, 177.4, 64.3, 50.2, 39.0, 38.9, 36.4, 28.8, 28.6, 
27.4, 27.3, 23.6  
 
3-(N-isobutylpivalamido)-2-methylpropyl pivalate (9):  
 
General procedure B was followed using diisobutylamine (0.25 mmol, 43 μL, 5 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 5.5 equiv, 
1.1 M stock solution), and K2PtCl4 (0.0005 mmol, 40 μL of a 0.0124 M aqueous stock solution, 
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1 mol %). The reaction was stirred at 150 °C for 48 h. Trace amounts of the aldehyde product 
were observed at the end of the reaction (see spectra for more detail). The reaction was 
performed side-by-side in duplicate, the two duplicate runs were combined, and the 
hydroxylated product was protected via general procedure C. The product was then purified 
by silica column chromatography (gradient of 0 to 30%, EtOAc in Hex). 
Isolated Yield: 54% (16.8 mg, crude ratio of 9-OH : 9a-OH = 8:1; isolated ratio of 9 : 9a =  
>20:1, light orange oil)  
Rf: 0.54 (20% EtOAc/80% Hex) 
IR (ν, cm-1): 2963, 2872, 1729, 1628, 1479, 1411, 1364, 1283, 1200, 1152, 1126 
HRMS: ESI+ (m/z): [M+H]+ calcd for C19H36NO3: 314.2690; found: 314.2689 
1H NMR (CDCl3, 700 MHz, 50 °C): δ 3.99 (dd, J = 11.2 Hz, 4.9 Hz, 1H), 3.89 (dd, J = 10.5 
Hz, 5.6 Hz, 1H), 3.40 (multiplet, 2H), 3.29 (dd, J = 14.0 Hz, 7.7 Hz, 1H), 3.10 (m, 1H), 2.23 
(m, 1H), 1.98 (m, 1H), 1.28 (s, 9H), 1.20 (s, 9H), 0.90 (m, 9H)   
13C NMR (CDCl3, 175.95 MHz, 50 °C): δ 178.4, 178.4, 67.0, 54.2, 48.9, 39.8, 39.1, 31.4, 29.3, 
27.4, 26.8, 20.2, 19.9, 14.9   
 
3-(tert-butylamino)propyl pivalate (10):  
 
General procedure B was followed using N-(tert-butyl)propan-1-amine (0.25 mmol, 28.6 mg, 
5 equiv), CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 
5.5 equiv, 1.1 M stock solution), and K2PtCl4 (0.0005 mmol, 40 μL of a 0.0124 M aqueous 
stock solution, 1 mol %). The reaction was stirred at 150 °C for 24 h. Trace amounts of the 
terminal C(sp3)–H chlorination product were present at the end of the reaction. The reaction 
was performed side-by-side in duplicate, the two duplicate runs were combined, and the 
hydroxylated product was protected via general procedure C. The product was then purified 
by silica column chromatography (gradient of 1 to 8%, MeOH in DCM). 
Isolated Yield: 46% (9.9 mg, >20:1 selectivity, yellow oil) 
Rf: 0.40 (10% MeOH/90% DCM)  
IR (ν, cm-1): 2958, 2924, 2871, 1725, 1480, 1459, 1395, 1363, 1283, 1157 
HRMS: ESI+ (m/z): [M+H]+ calcd for C12H26NO2: 216.1958; found: 216.1956 
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1H NMR (CDCl3, 500 MHz): δ 4.14 (t, J = 6.5 Hz, 2H), 2.63 (t, J = 7.0 Hz, 2H), 1.80 (quin, J 
= 7.0 Hz, 2H), 1.19 (s, 9H), 1.10 (s, 9H)   
13C NMR (CDCl3, 126 MHz): δ 178.7, 62.8, 39.3, 38.9, 30.3, 29.9, 29.1, 27.4   
 
4-(1-pivaloylpiperidin-4-yl)butyl pivalate (11):  
  
General procedure B was followed, using commerically available 4-butylpiperidine 
hydrochloride as the substrate (0.25 mmol, 44.4 mg, 5 equiv), CuCl2•2H2O (0.1 mmol, 17 mg, 
1 equiv), H2O (0.25 mL), and K2PtCl4 (0.005 mmol, 2.1 mg, 10 mol %). The reaction stirred 
at 150 °C for 24 h. The reaction was performed side-by-side in duplicate, the two duplicate 
runs were combined, and the hydroxylated product was protected via general procedure C. 
The product was then purified by silica column chromatography (gradient of 0 to 30%, EtOAc 
in DCM).  
Isolated Yield: 65% (21.1 mg, crude ratio of 11-OH : 11a-OH = 5:1; isolated ratio of 11:11a 
= 17:1; yellow oil) 
Rf (11): 0.24 (20% EtOAc/80% Hex)  
IR (ν, cm-1) (isolated mixture of 11 and 11a): 2924, 2864, 1725, 1695, 1627, 1480, 1419, 1364, 
1283, 1152 
HRMS (isolated mixture of 11 and 11a): ESI+ (m/z): [M+H]+ calcd for C19H36NO3: 326.2690; 
found: 326.2693 
11: 1H NMR (CDCl3, 700 MHz): δ 4.40 (m, 2H), 4.05 (t, J = 6.3 Hz, 2H), 2.73 (m, 2H), 1.70 
(m, 2H), 1.61 (quin, J = 7.0 Hz, 2H), 1.48 (m, 1H), 1.37 (quin, J = 7.0 Hz, 2H), 1.26 
(overlapping s and m, 11 H), 1.89 (s, 9H), 1.08 (qd, J = 3.5 Hz, J = 12.6 Hz, 2H)   
11: 13C NMR (CDCl3, 176 MHz): δ 178.8, 176.2, 64.4, 45.7, 38.9, 38.8, 36.3, 36.2, 32.7, 28.9, 
28.6, 27.4, 23.1 
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2-(diethylamino)ethyl pivalate (12): 
 
General procedure B was followed using triethylamine (0.75 mmol, 104 μL, 15 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.83 mmol, 16.5 equiv, 
3.3 M stock solution), and K2PtCl4 (0.0005 mmol, 40 μL of a 0.0124 M aqueous stock solution, 
1 mol %). The reaction was stirred at 150 °C for 48 h. The reaction stirred at 150 °C for 24 h. 
The reaction was performed side-by-side in duplicate, the two duplicate runs were combined, 
and the hydroxylated product was protected via general procedure C. The product was then 
purified by silica column chromatography (gradient of 1% to 10%, MeOH in DCM). 
Isolated Yield: 88% (17.8 mg, single isomer, orange oil) 
Rf: 0.31 (10% MeOH/ 90% DCM) 
IR (ν, cm-1): 2970, 2818, 1727, 1480, 1460, 1396, 1364, 1282, 1151, 1066, 1036 
HRMS: ESI+ (m/z): [M+H]+ calcd for C11H24NO2: 202.1802; found: 202.1801 
1H NMR (CDCl3, 700 MHz): δ 4.13 (t, J = 6.3 Hz, 2H), 2.70 (t, J = 6.3 Hz, 2H), 2.57 (q, J = 
7.0 Hz, 4H), 1.19 (s, 9H), 1.03 (t, J = 7.0 Hz, 6H) 
13C NMR (CDCl3, 176 MHz): δ 178.7, 63.1, 51.1, 47.9, 38.8, 27.4, 12.3  
 
3-(dipropylamino)propyl pivalate (13):  
  
General procedure B was followed using tripropylamine (0.75 mmol, 142 μL, 15 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.83 mmol, 16.5 equiv, 
3.3 M stock solution), and K2PtCl4 (0.00025 mmol, 20 μL of a 0.0124 M aqueous stock 
solution, 0.5 mol %). The reaction was stirred at 150 °C for 24 h. Trace amounts of the 
dihydroxylated product were observed at the end of the reaction. The reaction was performed 
side-by-side in duplicate, the two duplicate runs were combined, and the hydroxylated product 
was protected via general procedure C. The product was then purified by silica column 
chromatography (gradient of 1% to 10%, MeOH in DCM). 
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Isolated Yield: 102% (24.9 mg, crude ratio of 13-OH to 13a-OH = 7:1; isolated ratio of 13:13a 
= >20:1; yellow oil)  
Rf: 0.50 (10% MeOH/90% DCM) 
IR (ν, cm-1): 2958, 2803, 1728, 1480, 1459, 1283, 1079 
HRMS: ESI+ (m/z): [M+H]+ calcd for C14H30NO2: 244.2272; found: 244.2271  
1H NMR (CDCl3, 400 MHz): δ 4.09 (t, J = 6.4 Hz, 2H), 2.47 (t, J = 7.2 Hz, 2H), 2.34 (t, J = 
7.2 Hz, 4H), 1.73 (quin, J = 6.4 Hz, 2H), 1.42 (sex, J = 7.2 Hz, 4H), 1.19 (s, 9H), 0.86 (t, J = 
7.2 Hz, 6H)  
13C NMR (CDCl3, 176 MHz): δ 178.7, 62.9, 56.3, 50.5, 38.8, 27.3, 26.6, 20.5, 12.1  
 
3-(piperidin-1-yl)propyl pivalate (14):  
 
 
General procedure B was followed using 1-propylpiperidine (0.25 mmol, 31.8 mg, 5 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 5.5 equiv, 
1.1 M stock solution), and K2PtCl4 (0.0025, 1.0 mg, 5 mol %). The reaction was stirred at 150 
°C for 24 h. The reaction was performed side-by-side in duplicate, the two duplicate runs were 
combined, and the hydroxylated product was protected via general procedure C. The product 
was then purified by silica column chromatography (gradient 1% to 10%, MeOH in DCM). 
Isolated Yield: 90% (20.5 mg, crude ratio of 14-OH:14a-OH = 14:1; isolated ratio of 14:14a 
= >20:1; light yellow oil) 
Rf: 0.33 (10% MeOH/90% DCM) 
IR (ν, cm-1): 2935, 2769, 1728, 1672, 1480, 1283, 1152, 1126, 1037 
HRMS: ESI+ (m/z): [M+H]+ calcd for C13H26NO2: 228.1958; found: 228.1956  
1H NMR (CDCl3, 700 MHz): δ 4.09 (t, J = 6.3 Hz, 2H), 2.36 (t, J = 7.7 Hz, 6H), 1.82 (quin, J 
= 6.3 Hz, 2H), 1.58 (quin, J = 5.6 Hz, 4H), 1.43 (br m, 2H), 1.19 (s, 9H) 




3-morpholinopropyl pivalate (15):  
  
General procedure B was followed using 1-propylmorpholine (0.25 mmol, 32.3 mg, 5 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 5.5 equiv, 
1.1 M stock solution), and K2PtCl4 (0.0025, 1.0 mg, 5 mol %). The reaction was stirred at 150 
°C for 24 h. The reaction was performed side-by-side in duplicate, the two duplicate runs were 
combined, and the hydroxylated product was protected via general procedure C. The product 
was then purified by silica column chromatography (gradient of 1% to 10%, MeOH in DCM). 
Isolated Yield: 122% (27.9 mg, crude ratio of 15-OH:15a-OH = 10:1; isolated ratio of 15:15a 
= >20:1; light yellow oil)  
Rf: 0.61 (10% MeOH/90% DCM)  
IR (ν, cm-1): 2964, 2906, 1725, 1485, 1284, 1152, 1117, 1036, 862 
HRMS: ESI+ (m/z): [M+H]+ calcd for C12H24NO3: 230.1752; found: 230.1751 
1H NMR (CDCl3, 400 MHz): δ 4.11 (t, J = 6.4 Hz, 2H), 3.71 (t, J = 4.4 Hz, 4H), 2.43 (multiple 
peaks, 6H), 1.82 (quin, J = 6.4 Hz, 2H), 1.19 (s, 9H)   
13C NMR (CDCl3, 176 MHz): δ 178.7, 67.1, 62.8, 55.6, 53.9, 38.9, 27.3, 26.0 
 
4-(diethylamino)butyl pivalate (19): 
 
General procedure B was followed using diethylbutylamine (0.25 mmol, 43 μL, 5 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 5.5 equiv, 
1.1 M stock solution) and K2PtCl4 (0.0005 mmol, 40 μL of a 0.0124 M aqueous stock solution, 
1 mol %). The reaction was stirred at 150 °C for 24 h. The reaction was performed side-by-
side in duplicate, the two duplicate runs were combined, and the hydroxylated product was 
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protected via general procedure C. The product was then purified by silica column 
chromatography (gradient of 1% to 10%, MeOH in DCM). 
Isolated Yield: 52% (11.9 mg, crude ratio of 19-OH:19a-OH  = 3:1; isolated ratio 19-
OPiv:19a-OPiv = 6:1; yellow oil) 
Rf
 (mixture of isomers): 0.39 (10% MeOH/90% DCM) 
IR (ν, cm-1) (mixture of isomers): 2970, 2804, 1728, 1480, 1368, 1284, 1154, 1072, 910, 731 
19-OPiv: HRMS: ESI+ (m/z): [M+H]+ calcd for C13H28NO2: 230.2115; found: 230.2112 
19a-OPiv: HRMS: ESI+ (m/z): [M+H]+ calcd for C13H28NO2: 230.2115; found: 230.2114 
19-OPiv: 1H NMR (CDCl3, 500 MHz): δ 4.07 (t, J = 6.5 Hz, 2H), 2.52 (q, J = 7.5 Hz, 4H), 
2.44 (t, J = 7.5 Hz, 2H), 1.64 (quin, J = 7.0 Hz, 2H), 1.51 (quin, J = 7.5 Hz, 2H), 1.19 (s, 9H), 
1.01 (t, J = 7.0 Hz, 6H)   
19-OPiv: 13C NMR (CDCl3, 100 MHz): δ 178.8, 64.5, 52.6, 47.0, 38.9, 27.4, 27.0, 23.7, 11.8  
19a-OPiv: 1H NMR (CDCl3, 500 MHz): δ 4.90 (sex, J = 6.5 Hz, 1H), 2.50 (m, 6H), 1.74 (m, 
1H), 1.67 (m, 1H), 1.21 (d, J = 6.5 Hz, 3H), 1.19 (s, 9H), 1.02 (t, J = 7.0 Hz, 6H)   




General procedure B was followed using diisobutylamine (0.25 mmol, 43 μL, 5 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 5.5 equiv, 
1.1 M stock solution), and K2PtCl4 (0.005 mmol, 2.1 mg, 10 mol %), and the reaction was 
stirred at 150 °C for 2 h. The reaction was allowed to cool to room temperature, and the water 
layer was saturated with NaCl.  The reaction mixture was then cooled to room temperature and 
quenched with NH4OH (28% aqueous solution, 0.5 mL) and saturated NaCl. The product was 
extracted into CHCl3 and filtered through a plug of celite. To the CHCl3 extract were added 
triethylamine (0.7 mL) and phenyl isothiocyanate (1.25 mmol, 150 μL, 2.5 equiv). The reaction 
was allowed to stir overnight at room temperature.  The reaction was washed with 1 M NaOH 
(50 mL) and extracted into DCM (2 x 50 mL) and purified by silica column chromatography 
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(gradient 1 to 6% MeOH in DCM) and repurified via preparative TLC (5% MeOH in DCM). 
The product assignment was based on the 13C shift of the imine carbon.  
Isolated Yield: 73% (19.3 mg, yellow oil) 
Rf: 0.53 (10% MeOH/ 90% DCM) 
IR (ν, cm-1): 2959, 1575, 1492, 1463, 1358, 1221, 1154 
HRMS: ESI+ (m/z): [M+H]+ calcd for C15H23N2S: 263.1576; found: 263.1578 
1H NMR (CDCl3, 400 MHz): δ 7.24 (t, J = 7.6 Hz, 2 H), 6.98 (t, J = 7.2 Hz, 1H), 6.81 (d, J = 
7.6 Hz, 2H), 3.43 (dd, J = 7.6 Hz, J = 2.4 Hz, 2H), 3.28 (ddd, J = 6.0 Hz, J = 4.0 Hz, J = 1.2 
Hz, 1H), 3.11 (dd, J = 12.8 Hz, J = 9.6 Hz, 1H), 2.86 (ddd, J = 11.6 Hz, J = 4.4 Hz, J = 1.2 Hz, 
1H), 2.62 (dd, J = 12.0 Hz, J = 9.6 Hz, 1H), 2.30 (m, 1H), 2.13 (sep, J = 6.8 Hz, 1H), 1.08 (d, 
J = 6.8 Hz, 3H), .98 (d, J = 1.2 Hz, 3H), .08 (d, J = 1.6 Hz, 3H) 
13C NMR (CDCl3, 176 MHz): δ 151.5, 150.8, 128.8, 122.7, 122.4, 58.7, 56.2, 34.7, 30.2, 27.2, 




General procedure B was followed using diisobutylamine (0.25 mmol, 43 μL, 5 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.28 mmol, 5.5 equiv, 
1.1 M stock solution), and K2PtCl4 (0.005 mmol, 2.1 mg, 10 mol %), and the reaction was 
stirred at 150 °C for 2 h.  The reaction was allowed to cool to room temperature, and then 
KHCO3
 (1 mL of a saturated aqueous solution) was added. The resulting mixture was stirred 
for 4 h at 50 °C. The reaction was allowed to cool to room temperature, and NH4OH (0.5 mL 
of a 28% aqueous solution) was added. The product was extracted into CHCl3 and purified by 
silica column chromatography (gradient of 1 to 6%, MeOH in DCM).  
Isolated Yield: 65% (11.2 mg, single isomer, yellow oil) 
Rf: 0.77 (10% MeOH/ 90% DCM) 
IR (ν, cm-1): 2959, 2925, 2871, 1681, 1488, 1431, 1251, 1204, 1158, 1112, 1073, 758 
HRMS: ESI+ (m/z): [M+H]+ calcd for C9H18NO2: 172.1332; found: 172.1330 
1H NMR (CDCl3, 700 MHz): δ 4.18 (d, J = 10.5 Hz, 1H), 3.85 (t, J = 10.5 Hz, 1H), 3.25 (ddd, 
J = 11.9 Hz, J = 5.6 Hz, J = 1.4 Hz, 1H), 3.21 (dd, J = 13.3 Hz, J = 7.7 Hz, 1H), 3.06 (dd, J = 
 52 
13.3 Hz, J = 7.0 Hz, 1H), 2.97 (dd, J = 11.2 Hz, J = 9.1 Hz, 1H), 2.25 (m, 1H), 2.00 (sep, J = 
6.3 Hz, 1H), 1.01 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 3.5 Hz, 3H), 0.90 (d, J = 3.5 Hz, 3H). 
13C NMR (CDCl3, 176 MHz): δ 57.0, 52.9, 27.2, 26.5, 20.1, 19.9, 14.1 
 







General procedure B was followed using isobutylamine (0.75 mmol, 74 μL, 15 equiv), 
CuCl2•2H2O (0.1 mmol, 17 mg, 1 equiv), 0.25 mL of aqueous H2SO4 (0.83 mmol, 16.5 equiv, 
3.3 M stock solution), and K2PtCl4 (0.005 mmol, 2.1 mg, 10 mol %). The reaction was heated 
at 150 °C for 2 h. The resulting mixture was allowed to cool to room temperature, after which 
a solution of saturated aqueous KHCO3 (1 mL) was added. The resulting mixture was stirred 
at for 1 h at 100 °C, and then allowed to cool to room temperature. NH4OH (28% aqueous 
solution, 1 mL) was added. The product was extracted into CHCl3 and purified by silica column 
chromatography (gradient of 1 to 5%, MeOH in DCM).  
Isolated Yield: 59% (6.8 mg, singel isomer, white solid) 
Rf: 0.61 (10% MeOH/ 90% DCM) 
IR (ν, cm-1): 1688, 1488, 1272, 1112 
MP: 47-48 °C  
HRMS: ESI+ (m/z): [M+H]+ calcd for C5H10NO2: 116.0706; found: 116.0707 
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1H NMR (CDCl3, 500 MHz): δ 5.32 (br s, 1H), 4.24 (ddd, J = 11.0 Hz, 3.5 Hz, 2.0 Hz, 1H), 
3.92 (dd, J = 11.0 Hz, J = 10.0 Hz, 1H), 3.39 (m, 1H), 3.01 (t, J = 10.0 Hz, 1H), 2.22 (m, 1H), 
1.03 (d, J = 7.0 Hz, 3H)   
13C NMR (CDCl3, 126 MHz): δ 153.9, 72.2, 47.0, 26.3, 13.9  
 






3-(propylamino)propan-1-ol was formed from dipropylamine (General procedure B). The 
volatiles were removed via rotary evaporation. The HCl salt of 3-(propylamino)propan-1-ol 
was generated using 4M HCl in THF and dried to obtain a yellow solid. The salt was 
redissolved in DCM, subjected to excess SOCl2, and allowed to stir at room temperature 
overnight. The volatiles were removed via rotary evaporation. The HCl salt of the chlorinated 
amine was dissolved in CDCl3 and free-based with 1M aqueous NaOH. The 
1H and 13C NMR 
spectra of the authentic product match the 1H and 13C NMR shifts of the intermediate formed 
in the time study, thereby further confirming the identity of terminal chlorinated product as an 
intermediate en route to the hydroxylated product (see NMR spectra for more detail).  
HRMS: ESI+ (m/z): [M+H]+ calcd for C6H15ClN: 136.0888; found: 136.0888 
1H NMR (CDCl3, 700 MHz): δ 3.59 (t, J = 7.0 Hz, 2H), 2.73 (t, J = 7.0 Hz, 2H), 2.54 (t, J = 
7.0 Hz, 2H), 1.92 (quin, J = 7.0 Hz, 2H), 1.47 (sex, J = 7.0 Hz, 2H), 0.89 (t, J = 7.0 Hz, 3H) 




2.5.6 General Procedure for Time Study Reaction Profile 
General Procedure D: 
Reactions were set up using general procedure A at 150 °C and were individually quenched at 
the appropriate time points. The reactions were worked up using general procedure A and the 
product yields and ratios were determined via 1H NMR spectroscopic analysis.   
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Chapter 3 focuses on the remote secondary and tertiary C(sp3)–H oxygenation of 
protonated aliphatic amines. Aliphatic amines appear in a wide variety of pharmaceuticals and 
agrochemicals.2 As such, methods for the selective C–H functionalization of aliphatic amines 
would be valuable for the synthesis and late-stage modification of biologically active 
molecules.3 A variety of methods have been developed for the functionalization of the weak 
C(sp3)–H bonds  to a nitrogen atom .3b,4  
In contrast, at the time of our investigation, very few protocols addressed the challenge 
of selectively functionalizing less activated C(sp3)–H bonds remote from nitrogen.3a,c,d,5,6 The 
incorporation of various nitrogen protecting groups including carbamates,7 amides,7b,8 
imides,3a,9 and sulfonamides4f,10 is one of the main strategies organic chemists have utilized to 
deactivate the -C–H bonds and enable C(sp3)–H functionalization at alternate sites (Scheme 
3.1a). Similarly, directing groups can be installed on the nitrogen to enforce selective C(sp3)–
H functionalization at remote sites (Scheme 3.1b).3c,11 However, both strategies require 
additional steps of protecting group installation and subsequent removal. Furthermore, these 




Scheme 3.1. Remote C(sp3)–H Functionalization of Protected Aliphatic Amines 9b,11a 
 
An alternative approach involves the strategy we introduced in Chapter 2 – the in situ 
protonation of unprotected aliphatic amines.3a,3d,12 Protonation of the nitrogen reversibly 
converts it into a strong electron-withdrawing group,13 thereby deactivating the -C–H 
bonds.14 Our lab3d,12b and others3a,12a have utilized this strategy to achieve several different 
types of amine C(sp3)–H functionalization reactions. However, the existing methods have some 
limitations. For example, the earliest reported example of this approach examined a narrow 
substrate scope and required the use of an impractical oxidant, 
methyl(trifluoromethyl)dioxirane (TFDO) (Scheme 3.2).12a,15 More recent approaches have 
utilized transition metal catalysts such as Pd and Fe,3a,d,12b which can be expensive and/or 
difficult to separate from the functionalized amine products. Finally, in most reported 
examples, the scope is largely restricted to the oxygenation of remote primary (Chapter 2),12b 
tertiary,3a or benzylic3d C(sp3)–H bonds.  
Scheme 3.2. TFDO Mediated Oxidation of Protonated Aliphatic Amines 
 
This chapter addresses these limitations via the development of an operationally simple, 
remote C(sp3)–H hydroxylation of protonated amines that is applicable to a broad range of 
aliphatic amine substrates. This method uses aqueous solutions of the inexpensive oxidant 
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K2S2O8 to achieve this transformation. The method is effective for the oxygenation of tertiary 
and benzylic C(sp3)–H bonds as well as secondary C(sp3)–H sites. Additionally, by controlling 
the amount of oxidant in the reaction, both alcohol and ketone products can be accessed from 
the latter. We further demonstrate that this method can be applied to the C–H oxidation of 
unprotected amino acids and to the amine-containing drug memantine (Alzheimer’s).   
3.2. Results and Discussion 
Protonation Strategy and Reaction Optimization 
Our initial studies focused on the hydroxylation of the remote, tertiary C–H bond in 4-
methyl piperidine (1) using commercially available and inexpensive K2S2O8 as the oxidant, 
which has been demonstrated to facilitate C‒H functionalization of 2º and 3º C‒H bonds (Table 
1).9d,16 Water was selected as the ideal solvent for two main reasons. First, unlike most organic 
solvents, water lacks C–H bonds that could undergo competitive oxidation. Second, both 
K2S2O8 and most protonated amine substrates are soluble in water, while the free amine is less 
soluble. As such, these conditions were expected to enable selective oxidation at the remote C–
H.17  
The combination of 1 equiv of 1 and 1.1 equiv of D2SO4 at room temperature, followed 
by the addition of 1 equiv of K2S2O8 and heating at 80 ºC for 2 h afforded the 3º alcohol product 
2 in 47% yield as determined by 1H NMR spectroscopy. A significant quantity of starting 
material (25%) remained under these conditions. Increasing the reaction time to 4 h did not 
lead to further conversion of 1 (entry 2), implying that potassium persulfate is fully consumed 
within 2 h and additional oxidant is necessary to increase the conversion/yield. Indeed, the use 
of 2 equiv of K2S2O8 in conjunction with 2.2 equiv of D2SO4 under otherwise identical 
conditions resulted in complete consumption of the starting material 1 and the formation of the 
product 2 in 75% yield (entry 4). Increasing to 3.3 equiv of D2SO4 did not lead to further 
improvement in the yield of 2 (entry 5). Most importantly, the protonation of 1 is crucial for 
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accessing product 2. As shown in entry 6, in the absence of added D2SO4, <5% of the 3º 
hydroxylation product 2 was detected.  










yield 2 (%)a 
1 1 1.1 2 75 47 
2 1 1.1 4 76 51 
3 2 1.1 2 >99 53 
4 2 2.2 2 >99 75 
5 2 3.3 2 >99 75 
6 2 none 2 50 <5 
aYields and conversions determined by 1H NMR spectroscopy 
 
Comparison to Platinum Catalyzed Remote Oxidation 
This method represents an inexpensive and operationally simple approach for the 
selective C–H hydroxylation of 1. Furthermore, the observed site selectivity is highly 
complementary to that of the method described in Chapter 2 for the Pt-catalyzed oxidation of 
protonated amines.12b For example, as shown in Scheme 3.3, the Pt-catalyzed reaction of 1 
leads to selective functionalization at the least hindered primary C(sp3)–H bond to form the 
chlorinated product 3, while the method described in this chapter affords tertiary C(sp3)–H 
hydroxylation with high selectivity. The observed oxidation of the weaker tertiary C–H bond 




Scheme 3.3. Complementary Reactivity of Protonated Aliphatic Amines 
 
Substrate Scope of Remote Oxidation for Remote Tertiary Oxidation 
We next applied this method to the hydroxylation of tertiary C–H bonds in a variety of 
secondary and primary amine substrates to form products 4-12. The amino alcohol products 
derived from primary and secondary amine substrates were subsequently converted to amides 
to facilitate isolation (Scheme 3.4). In all cases, we observed selective hydroxylation at a 
remote tertiary C–H site. However, the yield and selectivity vary as a function of substrate. In 
general, the highest yields and selectivities are obtained when the tertiary C–H bond is two or 
three carbons from the protonated nitrogen (e.g., forming products 4, 5, 8–10). The modest 
yields of 6 and 7 were due to incomplete conversion of starting material, and conducting the 
reaction of 6 under more forcing conditions (i.e., at 100 ºC) led to the formation of side 
products.19 In systems with longer alkyl chains between the protonated nitrogen and the tertiary 
C–H site (e.g., 11, 12), side products most likely derived from oxidation of secondary C–H 
bonds were detected by crude 1H NMR spectroscopy. Conducting these reactions at a 65 ºC led 
to more selective functionalization, albeit in modest isolated yields (11, 12).  
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Scheme 3.4. C(sp3)–H Hydroxylation of Secondary and Primary Aliphatic Amines  
 
a2.2 equiv H2SO4, 2 equiv K2S2O8, 80 °C, followed by protection with BzCl. b1.1 equiv H2SO4, 2 equiv 
K2S2O8, 65 °C, followed by protection with BzCl. 
 
These conditions were also applied in the context of cyclic tertiary amine substrates to 
form products 13–17 (Scheme 3.5). Similar to the results in Scheme 3.4, good yields and 
selectivities were obtained when the tertiary C–H bond is three carbons from the protonated 
nitrogen atom (e.g., forming products 14–16). In ring systems where the tertiary C–H bond is 
located two carbons from the protonated nitrogen, lower reactivity is observed, and side 
products derived ring oxidation become more prominent. Similar side products were 
problematic in larger ring systems such as 17. Thus, the reactions were conducted at 65 ºC to 
minimize ring oxidation. Small quantities of related ring oxidation side products were also 
observed in 13–16.  
Scheme 3.5. C(sp3)–H Hydroxylation of Tertiary Aliphatic Amines  
 
a 2.2 equiv H2SO4, 2 equiv K2S2O8, 80 °C. b 1.1 equiv H2SO4, 2 equiv K2S2O8, 65 °C. 
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The yields and selectivities in Scheme 3.3 and Scheme 3.4 are consistent with 
protonation of the nitrogen deactivating proximal C–H bonds. As the alkyl chain length 
increases, a decrease in selectivity is observed due to a decrease in electronic differentiation 
between the remote C–H bonds. This effect is best demonstrated in a competition study 
between isobutylamine and isopentylamine, wherein a 1 : 5 ratio of 8-OH : 9-OH was observed 
by 1H NMR spectroscopy, favoring hydroxylation at the more remote 3º C–H bond (Scheme 
3.6).   
Scheme 3.6. Competition between Isobutylamine and Isopentylamine  
 
Substrate Scope of Remote Oxidation for Remote Secondary Oxidation 
We next probed secondary C(sp3)–H oxidation in the absence of competing tertiary C–
H bonds. Initial studies investigated the use of aliphatic amines containing secondary benzylic 
C–H bonds (Scheme 3.7). Under our standard reaction conditions these substrates afforded 
mixtures of alcohol and ketone products. For example, 4-ethyl benzylamine reacted to form a 
0.94 : 1 mixture of alcohol 18-OH to ketone 18-O (61% overall yield of C–H oxygenated 
products). By using 1 equiv of K2S2O8 under otherwise identical conditions, the ratio could be 
shifted to favor the alcohol affording a 1 : 0.48 ratio of 18-OH : 18-O (55% yield). The alcohol 
product was also favored when the benzylic C–H bonds were closer to the protonated amine. 
This is demonstrated for phenethylamine, which afforded benzylic alcohol 19-OH as the major 
product (19-OH : 19-O = 1 : 0.28) under our standard conditions with 2 equiv of K2S2O8. 
Unactivated secondary C–H sites in butylamine also afforded secondary alcohol products. 
Under the standard conditions with excess amine, butylamine reacted to form a 1 : 0.29 ratio 
of the -hydroxylated products (23-OH-a : 23-OH-b) in moderate 32% isolated yield.  
 
 64 
Scheme 3.7. Substrate Scope Containing Amines with Remote Secondary C(sp3)–H Bonds 
 
The product selectivity in Scheme 3.7 shows several differences compared to reported 
systems for the remote C(sp3)–H oxygenation of protonated amines. For example, the Pt/Cu 
system described in Chapter 2 affords primary C(sp3)–H hydroxylation products with 
dibutylamine (analogous to butylamine in Scheme 3.7).12b The White group’s Fe(PDP)/H2O2 
system provided ketone products selectively, and was only effective for oxygenation of C(sp3)–
H bonds that were ≥3 carbons from the protonated nitrogen.3a Meanwhile, our group’s 
FeCl3/TBHP system only oxidizes benzylic C–H bonds to form ketone products selectively.
3d 
Furthermore, no reactivity was observed when the benzylic C–H sites were < 3 carbons from 
the amine. Overall, these comparisons highlight the complementarity of the method described 
here to those reported in the literature at the time of our investigations. 
Oxidation of Bioactive Molecules 
A final set of studies focused on applying this transformation to amine-containing 
biologically active molecules. As shown in Scheme 3.8, under our standard conditions the 
Alzheimer’s drug memantine was converted to the corresponding 3º alcohol 24 in moderate 
yield. Similarly, the amino acid leucine underwent C(sp3)–H oxygenation to afford lactone 25 
 65 
in 47% isolated yield and 90% ee, after protection of the product and isolation. Pregabalin 
(epilepsy drug) underwent selective oxygenation at the remote, tertiary C(sp3)–H site to afford 
lactone 26 in 40% yield after protection and isolation.20  
Scheme 3.8. Substrate Scope Containing Bioactive Amines 
 
 
3.3. Conclusion and Outlook 
In summary, the work in Chapter 3 demonstrates an operationally straightforward 
method for the remote C(sp3)–H oxygenation of protonated amines. This method uses an 
inexpensive and bench stable oxidant (potassium persulfate) and proceeds in water under mild 
conditions. We demonstrate that this transformation is complementary to several recently 
reported C–H oxidation reactions of protonated amines and that it is applicable to bioactive 
substrates, including unprotected amino acids. We anticipate that this method will prove useful 
in early stage discovery chemistry efforts, for the elaboration of small molecules, and for the 
late-stage derivatization of amine-containing bioactive targets.  
Current work in our laboratory is focused on expanding the breadth C(sp3)–H 
functionalization, and investigations into the feasibility of accessing C–F and C–N bond 
forming reactions are underway. Additionally, we are interested in developing and applying 
complementary C–H functionalization methods in the context of complex, bioactive molecules 
and scaffolds to rapidly access multiple products.  
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3.4. Experimental Procedures and Characterization of Compounds 
3.4.1 General Procedures and Materials and Methods 
General Procedures 
NMR spectra were recorded on a Varian vnmrs 700 (700 MHz for 1H; 176 MHz for 13C), 
Varian vnmrs 500 (500 MHz for 1H; 126 MHz for 13C), or Varian MR400 (400 MHz for 1H; 
100 MHz for 13C) with the residual solvent peak (CDCl3; 
1H: δ = 7.26 ppm, 13C: δ = 77.16 
ppm; C6D5CD3; 
1H: δ = 2.09 ppm, 13C: δ = 20.40 ppm; CD3OD; 
1H: δ = 3.30 ppm, 13C: δ = 
49.00 ppm; D2O; 
1H: δ = 4.79 ppm) as the internal reference unless otherwise noted. NMR 
spectra were recorded at room temperature unless otherwise noted. Chemical shifts are reported 
in parts per million (ppm) (δ) relative to tetramethylsilane. Multiplicities are reported as 
follows: br (broad signal), s (singlet), d (doublet), t (triplet), q (quartet), quin (quintet), sex 
(sextet), sep (septet), m (multiplet), dd (doublet of doublets), ddd (doublet of doublet of 
doublets), td (triplet of doublets). Coupling constants (J) are reported in Hz. Infrared (IR) 
spectroscopy was performed on a Perkin-Elmer Spectrum BX Ft-IR spectrometer and peaks 
are reported in cm-1. Melting points were determined with a OptiMelt (Stanford Research 
Systems) and are uncorrected.  High-resolution mass spectra were recorded on a Micromass 
AutoSpec Ultima Magnetic Sector mass spectrometer. Stock solutions were made using 
volumetric glassware. The enatiomeric excess for compound 23 was determined using chiral 
HPLC analysis with a Daicel Chiralpak OD-H chiral stationary phase column. Liquid reagents 
were dispensed by difference from syringes. All reagents were weighed out under ambient 
conditions. 
 
Materials and Methods 
HPLC grade water, ethyl acetate (EtOAc), hexanes (Hex), methanol (MeOH), and 
dichloromethane (DCM) for column chromatography were purchased from VWR. Basic 
aluminum oxide (Brockmann 1) for flash column chromatography was purchased from Acros. 
Biotage® SNAP Ultra column cartridges were used for flash column chromatography. CDCl3, 
C6D5CD3, CD3OD, and D2O were purchased from Cambridge Isotope Laboratories, Inc. 
K2S2O8 was purchased from Acros and used without further purification. Amine substrates 
were purchased from commercial sources (Alfa Aeser, Sigma Aldrich, TCI, Acros, Astatech, 
Ark Pharm, Enamine, and Matrix Scientific) and used without further purification. Thin layer 
chromatography (TLC) was performed on Macherey-Nagel SIL G-25 TLC plates pre-coated 
with silica gel UV254 or Merck TLC plates pre-coated with basic aluminum oxide 60 F254. 
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3.4.2 Synthesis and Characterization of Substrates 
1-isobutylpyrrolidine: 
 
1-isobutylpyrrolidine was synthesized from pyrrolidine and 1-iodo-2-methylpropane using a 
literature procedure21 and was purified via distillation. 
HRMS: ESI+ (m/z): [M+H+] calcd for C8H18N: 128.1434; found: 128.1434. 
1H NMR (CDCl3, 700 MHz): δ 2.47 (m, 4H), 2.23 (d, J = 7.0 Hz, 2H), 1.77 (multiple peaks, 
5H), 0.93 (t, J = 6.3 Hz, 6H). 




1-isopentylpyrrolidine was synthesized from pyrrolidine and 1-bromo-3-methylbutane using a 
literature procedure21 and was purified via distillation.  
HRMS: ESI+ (m/z): [M+H+] calcd for C9H20N: 142.1590; found: 142.1589. 
1H NMR (CDCl3, 500 MHz): δ 2.45 (m, 4H), 2.40 (dd, J = 8.0 Hz, 6.0 Hz, 2H), 1.75 (m, 4H), 
1.57 (app sep, J = 6.5 Hz, 1H), 1.39 (m, 2H), 0.88 (d, J = 6.5 Hz, 6H).  




1-isopentylpyrrolidine was synthesized from piperidine and 1-bromo-3-methylbutane using a 
literature procedure21 and was purified via distillation.  
HRMS: ESI+ (m/z): [M+H+] calcd for C10H22N: 156.1747; found: 156.1754. 
1H NMR (CDCl3, 500 MHz): δ 2.35 (br s, 4H), 2.28 (dd, J = 7.5 Hz, 5.0 Hz, 2H), 1.57 (quin, 
J = 5.5 Hz, 4H), 1.54 (app sep, J = 6.5 Hz, 1H), 1.40 (multiple peaks, 4H), 0.88 (d, J = 6.5 Hz, 
6H).   






1-isopentylmorpholine was synthesized from morpholine and 1-bromo-3-methylbutane using 
a literature procedure21 and was purified via distillation.  
HRMS: ESI+ (m/z): [M+H+] calcd for C9H20NO: 158.1539; found: 158.1539.  
1H NMR (CDCl3, 700 MHz): δ 3.72 (br s, 4H), 2.44 (br s, 4H), 2.34 (t, J = 7.0 Hz, 2H), 1.58 
(overlapping with water peak, 1H), 1.38 (q, J = 7.0 Hz, 2H), 0.90 (d, J = 3.2 Hz, 6H). 




1-isopentylazepane was synthesized from azepane and 1-bromo-3-methylbutane using a 
literature procedure21 and was purified via distillation.  
HRMS: ESI+ (m/z): [M+H+] calcd for C11H24N: 170.1903; found: 170.1901.  
1H NMR (CDCl3, 500 MHz): δ 2.61 (dd, J = 5.0 Hz, 4.0 Hz, 4H), 2.46 (dd, J = 7.5 Hz, 5.5 Hz, 
2H), 1.61 (multiple peaks, 8H), 1.55 (app sep, J = 7.0 Hz, 1H), 1.35 (m, 2H), 0.89 (d, J = 7.0 
Hz, 6H).  
13C NMR (CDCl3, 126 MHz): δ 56.81, 55.8, 36.7, 28.2, 27.1, 26.9, 23.0.  
 
3.4.3 General Procedures for Reaction Optimization and Crude 1H NMR 
Analysis 
General Procedure A: 
 
To a 4 mL scintillation vial containing K2S2O8, D2SO4 (1.1 M aqueous solution), and D2O 
(combined volume 1 mL) was added 4-methylpiperidine (1.0 equiv, 0.25 mmol, 24.8 mg). The 
reaction vial was equipped with a micro stir bar, sealed with a Teflon-lined cap, and placed in 
an aluminum block preheated to 80 ºC and stirred for 2 h at 80 ºC. To the crude reaction, 
nitromethane (10 μL, 0.186 mmol) was added and the crude yield was determined via 1H NMR 
spectroscopic analysis.  
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3.4.4 General Procedures for Isolation of Products and Characterization 
General Procedure B:  
 
To a 4 mL (0.25 mmol substrate) or 20 mL (0.75 mmol substrate) scintillation vial containing 
K2S2O8, H2SO4 (aqueous) and H2O was added the amine substrate. The reaction vial was 
equipped with a micro magnetic stir bar, sealed with a Teflon-lined cap, placed in an aluminum 
block preheated to 65 or 80 ºC, and stirred for 2–4 h at 65 or 80 ºC. 
 
General Procedure C:  
 
The crude reaction mixture was quenched with Na2SO3 and was then stirred at room 
temperature until a peroxide test strip was negative. The aqueous solution was acidified with 
concentrated H2SO4 to pH ~2 before the water was removed as an azeotrope with toluene via 
rotary evaporation at ~65 ºC. To the resulting solid was added Na2CO3 (159 mg for 0.25 mmol 
reactions and 954 mg for 1.5 mmol reactions), and then the product was purified via 
chromatography on basic alumina.  
 
General Procedure D:  
 
The crude reaction mixture was quenched with Na2SO3 and was then stirred at room 
temperature until a peroxide test strip was negative. The aqueous solution was acidified with 
concentrated H2SO4 to a pH ~2 before the water was removed as an azeotrope with toluene via 
rotary evaporation at 65–70 ºC. To the resulting solid was added MeCN, triethylamine, and 
benzoyl chloride. The mixture was allowed to stir at room temperature for 1–12 h. The 
acetonitrile was removed by rotary evaporation, the product was dissolved in dichloromethane 
(150 mL), and the organic layer was washed with NaOH (1M, 1x100 mL). The aqueous layer 
was extracted a second time with dichloromethane (150 mL). The organic extracts were 
combined, washed with brine (100 mL), and dried over sodium sulfate. The volatiles were 
removed via rotary evaporation and purified via flash column chromatography on silica.  
 
General Procedure E: 
The crude reaction mixture was quenched with Na2SO3 and was then stirred at room 
temperature until a peroxide test strip was negative. To the crude reaction was added THF (20 
mL), NaOH (6.0 mL of a 2 M aqueous solution), and CbzCl (0.32 mL) at 0 ºC.4 The reaction 
was allowed to warm to room temperature and was then stirred at room temperature for 36 h. 
The aqueous layer was extracted with diethyl ether and the organic layer was set aside. The 
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aqueous layer was acidified with 1 M HCl to a pH ~2 and extracted with ethyl acetate (3x150 
mL). The organic extracts were combined and dried over sodium sulfate after which the 
volatiles were removed via rotary evaporation and the product was purified via flash column 




To a solution of CuCl2•2H2O (0.10 mmol, 17 mg, 1 equiv) and K2PtCl4 (0.005 mmol, 2.1 mg, 
10 mol %) in aqueous H2SO4 (0.55 mmol, 0.25 mL 11 equiv, 2.2 M stock solution) was added 
4-methylpiperidine (0.50 mmol, 50 mg, 10 equiv) in a 10 mL scintillation vial. The reaction 
was stirred at 150 ºC for 12 h. The reaction was performed side-by-side in duplicate. The two 
duplicate runs were combined and the product was protected via a reported procedure.12b The 
product was then purified by flash column chromatography on silica (gradient of 12% to 100%, 
EtOAc in hexanes) and isolated as a colorless oil. 
Isolated Yield: 84% (20.0 mg) 
Rf: 0.42 (1:1 EtOAc : Hex) 
IR (ν, cm-1): 2940, 2856, 1716, 1624, 1576, 1432, 1322, 1279, 1108, 966, 786, 708.  
HRMS: ESI+ (m/z): [M+H+] calcd for C13H17ClNO: 238.0993; found: 238.0990. 
1H NMR (C6D5CD3, 700 MHz, 90 ºC): δ 7.27 (m, 2H), 7.08 (multiple peaks, 3H), 4.03 (br s, 
2H), 2.91 (m, 2H), 2.41 (t, J = 12.6 Hz, 2H), 1.31 (multiple peaks, 3H), 0.87 (m, 2H).  
13C NMR (C6D5CD3, 176 MHz, 90 ºC): δ 169.8, 129.4, 128.4, 127.6, 49.2, 44.7, 39.2, 30.3 (1 
aromatic peak overlaps with C6D5CD3). 
13C NMR (CDCl3, 176 MHz, room temperature): δ 170.5, 136.4, 128.6, 127.0, 49.4, 47.6, 42.0, 






(4-hydroxy-4-methylpiperidin-1-yl)(phenyl)methanone (4):  
 
General procedure B was followed using 4-methylpiperidine (1.50 mmol, 149 mg, 1 equiv), 
K2S2O8 (3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (3.3 mmol, 2.2 equiv, 3.0 mL of a 1.1 
M stock solution), and water (3.0 mL). The reaction was stirred at 80 ºC for 4 h. The product 
was protected via general procedure D, using MeCN (100 mL), triethylamine (2.09 mL, 15.0 
mmol), and benzoyl chloride (552 μL, 4.5 mmol). The product was then purified by flash 
column chromatography on silica (gradient of 2% to 10%, MeOH in dichloromethane) and 
isolated as a light yellow solid. 
Isolated Yield: 64% (208.9 mg) 
Rf: 0.65 (1:9 MeOH : dichloromethane) 
IR (ν, cm-1): 3382, 2926, 1607, 1443, 1373, 1256, 1178, 1117, 969, 708.  
mp: 91–93 ºC 
HRMS: ESI+ (m/z): [M+H+] calcd for C13H18NO2: 220.1332; found: 220.1330. 
1H NMR (C6D5CD3, 700 MHz, 90 ºC): δ 7.29 (m, 2H), 7.07 (multiple peaks, 3H), 3.71 (br s, 
2H), 3.19 (m, 2H), 1.23 (m, 2H), 1.17 (m, 2H), 0.89 (s, 3H), 0.78 (br s, 1H). 
13C NMR (C6D5CD3, 176 MHz, 90 ºC): δ 169.9, 137.9, 129.3, 128.4, 127.6, 67.6, 41.7, 39.3, 
30.1.  
13C NMR (CDCl3, 176 MHz, room temperature): δ 170.5, 136.4, 129.6, 127.0, 68.3, 44.2, 39.3, 





General procedure B was followed using 3-methylpiperidine (1.50 mmol, 149 mg, 1 equiv), 
K2S2O8 (3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (3.3 mmol, 2.2 equiv, 3.0 mL of a 1.1 
M stock solution), and water (3.0 mL). The reaction was stirred at 80 ºC for 4 h. The product 
was protected via general procedure D with MeCN (100 mL), ethyldiisopropylamine (3.37 
mL, 15.0 mmol), and benzoyl chloride (552 μL, 4.5 mmol). The product was then purified by 
flash column chromatography on silica (gradient of 2% to 10%, MeOH in dichloromethane) 
and isolated as a light brown oil. 
Isolated Yield: 44% (143.5 mg) 
Rf: 0.66 (1:9 MeOH : dichloromethane) 
IR (ν, cm-1): 3393, 2928, 1608, 1439, 1280, 1131, 930, 788, 700.  
HRMS: ESI+ (m/z): [M+H+] calcd for C13H18O2: 220.1332; found: 220.1329. 
1H NMR (C6D5CD3, 700 MHz, 80 ºC): δ 7.38 (m, 2H), 7.09 (m, 3H), 3.73 (br s, 1H), 3.63 (br 
s, 1H), 2.79 (m, 2H), 2.54 (br s, 1H), 1.67 (m, 1H), 1.49 (m, 1H), 1.18 (m, 1H), 1.13 (m, 1H), 
0.98 (s, 3H).  
13C NMR (C6D5CD3, 176 MHz, 80 ºC): δ 171.2, 137.5, 129.4, 128.4, 127.9 (overlaps with peak 
from C6D5CD3), 69.1, 55.8, 45.8, 38.0, 27.2, 22.4. 
 
(4-hydroxy-4-phenylpiperidin-1-yl)(phenyl)methanone (6):  
 
General procedure B was followed using 4-phenlylpiperidine (0.25 mmol, 40 mg, 1 equiv), 
K2S2O8 (0.50 mmol, 135 mg, 2 equiv), aqueous H2SO4 (0.55 mmol, 2.2 equiv, 0.5 mL of a 1.1 
M stock solution), and water (0.5 mL). The reaction was stirred at 80 ºC for 2 h. The product 
was protected via general procedure D with MeCN (10 mL), triethylamine (348 μL, 2.5 
mmol), and benzoyl chloride (89 μL, 0.75 mmol). The product was then purified by flash 
column chromatography on silica (gradient of 12% to 100%, EtOAc in hexanes) and isolated 
as a light yellow oil. 
Isolated Yield: 31% (21.9 mg) 
Rf: 0.27 (1:1 EtOAc : hexanes) 
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IR (ν, cm-1): 3363, 3059, 2923, 1598, 1444, 1283, 1254, 1111, 1004, 697. 
HRMS: ESI+ (m/z): [M+H+] calcd for C18H20NO2: 282.1489; found: 282.1488. 
1H NMR (C6D5CD3, 700 MHz, 100 ºC): δ 7.32 (m, 2H), 7.21 (m, 2H), 7.13 (m, 2H), 7.07 
(multiple peaks, 4H), 4.02 (br s, 2H), 3.22 (t, J = 12.6 Hz, 2H), 1.74 (m, 2H), 1.39 (d, J = 12.6 
Hz, 2H), 1.31 (br s, 1H).  
13C NMR (C6D5CD3, 176 MHz, 100 ºC): δ 170.0, 148.2, (some aromatic peaks overlap with 
C6D5CD3), 71.6, 41.4, 39.0.  
13C NMR (CD3OD, 176 MHz, room temperature): δ 172.5, 149.5, 137.2, 131.0, 129.7, 129.3, 
127.9, 127.8, 125.7, 72.0, 45.4, 39.7, 38.8. Rotamers present at room temperature 
 
(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)(phenyl)methanone (7):  
 
General procedure B was followed using 4-(4-chlorophenyl)piperidine (0.25 mmol, 49 mg, 
1 equiv), K2S2O8 (0.50 mmol, 135 mg, 2 equiv), aqueous H2SO4 (0.55 mmol, 2.2 equiv, 0.5 
mL of a 1.1 M stock solution), and water (0.5 mL). The reaction was stirred at 80 ºC for 2 h. 
The product was protected via general procedure D with MeCN (10 mL), triethylamine (348 
μL, 2.5 mmol), and benzoyl chloride (89 μL, 0.75 mmol). The product was then purified by 
flash column chromatography on silica (gradient of 12% to 100%, EtOAc in hexanes) and 
isolated as an off-white solid. 
Isolated Yield: 32% (25.2 mg) 
Rf: 0.24 (1:1 EtOAc : hexanes) 
IR (ν, cm-1): 3370, 2924, 1600, 1444, 1281, 1094, 1002, 826, 709. 
mp: 154–156 ºC 
HRMS: ESI+ (m/z): [M+H+] calcd for C18H19ClNO2: 316.1099; found: 316.1097.  
1H NMR (C6D5CD3, 700 MHz, 100 ºC): δ 7.32 (m, 2H), 7.10 (m, 4H), 7.06 (br s, 1H), 7.00 (m, 
2H), 3.99 (br s, 2H), 3.14 (t, J = 12.6 Hz, 2H), 1.63 (t, J = 12.6 Hz, 2H), 1.28 (d, J = 12.6 Hz, 
2H), 1.16 (s, 1H).  
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13C NMR (C6D5CD3, 176 MHz, 100 ºC): δ 170.1, 147.2, 133.6, 129.6, 128.5, 126.5 (some 
aromatic peaks overlap with C6D5CD3), 71.4, 41.3, 38.8.  
13C NMR (CD3OD, 176 MHz, room temperature): δ 172.5, 148.5, 137.2, 133.7, 131.0, 129.3, 
127.6, 71.8, 45.3, 39.6, 39.6, 38.6. Rotamers present at room temperature 
 
N-(2-hydroxy-2-methylpropyl)benzamide (8):  
 
General procedure B was followed using isobutylamine (1.50 mmol, 110 mg, 1 equiv), 
K2S2O8 (3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (3.3 mmol, 2.2 equiv, 3.0 mL of a 1.1 
M stock solution), and water (3.0 mL). The reaction was stirred at 80 ºC for 4 h. The product 
was protected via general procedure D with MeCN (100 mL), triethylamine (2.09 mL, 15.0 
mmol), and benzoyl chloride (552 μL, 4.5 mmol). The product was then then purified by flash 
column chromatography on silica (gradient of 2% to 10%, MeOH in dichloromethane) and 
isolated as a white solid. 
Isolated Yield: 51% (147.8 mg) 
Rf: 0.40 (1:9 MeOH : dichloromethane) 
IR (ν, cm-1): 3326, 2974, 1636, 1540, 1489, 1385, 1306, 1177, 925, 709.  
mp: 101–103 ºC 
HRMS: ESI+ (m/z): [M+H+] calcd for C11H16NO2: 194.1176; found: 194.1170. 
1H NMR (CDCl3, 401 MHz): δ 7.79 (d, J = 7.2 Hz, 2H), 7.50 (t, J = 7.2 Hz, 1H), 7.42 (t, J = 
7.2, 2H), 6.69 (br s, 1H), 3.47 (d, J = 6.0 Hz, 2H), 2.56 (s, 1H), 1.28 (s, 6H).  




General procedure B was followed using isoamylamine (1.50 mmol, 131 mg, 1 equiv), 
K2S2O8 (3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (3.3 mmol, 2.2 equiv, 3.0 mL of a 1.1 
M stock solution), and water (3.0 mL). The reaction was stirred at 80 ºC for 4 h. The product 
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was protected via general procedure D with MeCN (100 mL), ethyldiisopropylamine (3.37 
mL, 15.0 mmol), and benzoyl chloride (552 μL, 4.5 mmol). The product was then purified by 
flash column chromatography on silica (gradient of 2% to 10%, MeOH in dichloromethane) 
and isolated as a light yellow solid. 
Isolated Yield: 60% (187.8 mg) 
Rf: 0.62 (1:9 MeOH : dichloromethane) 
IR (ν, cm-1): 3258, 2969, 1631, 1540, 1492, 1378, 1312, 1159, 912, 688.  
mp: 101–102 ºC 
HRMS: ESI+ (m/z): [M+H+] calcd for C12H18NO2: 208.1332; found: 208.1329. 
1H NMR (CDCl3, 700 MHz): δ 7.76 (d, J = 7.7 Hz, 2H), 7.46 (t, J = 7.7 Hz, 1H), 7.39 (t, J = 
7.7 Hz, 2H), 7.31 (br s, 1H), 3.62 (q, J = 5.6 Hz, 2H), 1.98 (br s, 1H), 1.79 (t, J = 5.6 Hz, 2H), 
1.32 (s, 6H).  




General procedure B was followed using 4-methylpentan-2-amine (1.50 mmol, 152 mg, 1 
equiv), K2S2O8 (3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (3.3 mmol, 2.2 equiv, 3.0 mL 
of a 1.1 M stock solution), and water (3.0 mL). The reaction was stirred at 80 ºC for 4 h. The 
product was protected via general procedure D with MeCN (100 mL), triethylamine (2.09 
mL, 15.0 mmol), and benzoyl chloride (552 μL, 4.5 mmol). The product was then purified by 
flash column chromatography on silica (gradient of 2% to 10%, MeOH in dichloromethane) 
and isolated as a light brown oil. 
Isolated Yield: 50% (166.0 mg) 
Rf: 0.62 (1:9 MeOH : dichloromethane) 
IR (ν, cm-1): 3322, 2970,1635, 1539, 1489, 1354, 1311, 1169, 908, 729. 
HRMS: ESI+ (m/z): [M+H+] calcd for C13H20NO2: 222.1489; found: 222.1488. 
1H NMR (CDCl3, 500 MHz): δ 7.76 (d, J = 7.5 Hz, 2H), 7.43 (t, J = 7.5 Hz, 1H), 7.35 (t, J = 
7.5 Hz, 2H), 7.23 (br s, 1H), 4.23 (m, 1H), 3.06 (br s, 1H), 1.76 (dd, J = 15.0, 10.0 Hz, 1H), 
1.65 (dd, J = 15.0, 4.0 Hz, 1H), 1.29 (d, J = 6.5 Hz, 3H), 1.25 (s, 3H), 1.25 (s, 3H). 
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General procedure B was followed using 3-methylbutan-1-amine (0.25 mmol, 25 mg, 1 
equiv), K2S2O8 (0.50 mmol, 135 mg, 2 equiv), aqueous H2SO4 (0.28 mmol, 1.1 equiv, 0.25 mL 
of a 1.1 M stock solution), and water (0.75 mL). The reaction was stirred at 65 ºC for 2 h. The 
product was protected via general procedure D with MeCN (10 mL), triethylamine (348 μL, 
2.5 mmol), and benzoyl chloride (89 μL, 0.75 mmol). The product was then purified by flash 
column chromatography on silica (gradient of 2% to 10%, MeOH in dichloromethane) and 
isolated as a white solid.  
Isolated Yield: 39% (21.8 mg) 
Rf: 0.46 (1:9 MeOH : dichloromethane) 
IR (ν, cm-1): 3326, 2968, 1636, 1540, 1374, 1308, 1157, 1075, 905, 694.  
mp: 84–87 ºC  
HRMS: ESI+ (m/z): [M+H+] calcd for C13H20NO2: 222.1489; found: 222.1485. 
1H NMR (CDCl3, 401 MHz): δ 7.76 (d, J = 7.2 Hz, 2H), 7.47 (t, J = 7.2 Hz, 1H), 7.40 (t, J = 
7.2 Hz, 2H), 6.62 (br s, 1H), 3.47 (q, J = 7.0 Hz, 2H), 1.88 (br s, 1H), 1.72 (quin, J = 7.0 Hz, 
2H), 1.55 (m, 2H), 1.23 (s, 6H).  
13C NMR (CDCl3, 176 MHz): δ 167.7, 134.9, 131.5, 128.7, 127.0, 71.0, 40.7, 40.5, 29.7, 24.7.  
 
N-(6-hydroxy-6-methylheptan-2-yl)benzamide (12):  
 
General procedure B was followed using 2-amino-6-methylheptane (1.50 mmol, 194 mg, 1 
equiv), K2S2O8 (3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (1.65 mmol, 1.1 equiv, 1.5 mL 
of a 1.1 M stock solution), and water (4.5 mL). The reaction was stirred at 65 ºC for 4 h. The 
product was protected via general procedure D with MeCN (100 mL), triethylamine (2.09 
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mL, 15.0 mmol), and benzoyl chloride (552 μL, 4.5 mmol). The product was then purified by 
flash column chromatography on silica (gradient of 10% to 100%, EtOAc in hexanes) and 
isolated as a light yellow solid. 
Isolated Yield: 32% (119.2 mg) 
Rf: 0.50 (1: 9 MeOH : dichloromethane) 
IR (ν, cm-1): 3326, 2968, 2936, 1635, 1540, 1490, 1457, 1351, 1300, 1166, 934, 801, 695.  
mp: 101–103 ºC 
HRMS: ESI+ (m/z): [M+H+] calcd for C15H24NO2: 250.1802; found: 250.1799. 
1H NMR (CDCl3, 500 MHz): δ 7.74 (d, J = 7.5 Hz, 2H), 7.47 (t, J = 7.5 Hz, 1H), 7.41 (t, J = 
7.5 Hz, 2H), 5.97 (d, J = 7.0 Hz, 1H), 4.23 (app sep, J = 7.0 Hz, 1H), 1.66 (br s, 1H), 1.54 
(multiple peaks, 3H), 1.46 (multiple peaks, 3H), 1.24 (d, J = 7.0 Hz, 3H), 1.20 (s, 3H), 1.19 (s, 
3H).  
13C NMR (CDCl3, 126 MHz): δ 167.1, 135.1, 131.4, 128.7, 127.0, 70.9, 45.6, 43.5, 37.6, 29.7, 




General procedure B was followed using 1-isobutylpyrrolidine (0.25 mmol, 32 mg, 1 equiv), 
K2S2O8 (0.50 mmol, 135 mg, 2 equiv), aqueous H2SO4 (0.55 mmol, 2.2 equiv, 0.5 mL of a 1.1 
M stock solution), and water (0.5 mL). The reaction was stirred at 80 ºC for 2 h. The reaction 
was quenched following general procedure C and the product was purified by column 
chromatography on basic alumina (gradient of 1% to 10%, MeOH in dichloromethane) and 
isolated as a colorless oil.  
Isolated Yield: 24% (8.5 mg) 
Rf: 0.83 (1:9 MeOH : dichloromethane) 
IR (ν, cm-1): 3392, 2966, 2807, 1658, 1460, 1293, 1382, 1137, 909.  
HRMS: ESI+ (m/z): [M+H+] calcd for C8H18NO: 144.1383; found: 144.1381.  
1H NMR (CDCl3, 700 MHz): δ 2.69 (m, 4H), 2.48 (s, 2H), 1.76 (s, 4H), 1.18 (s, 6H). OH peak 
not observed 
13C NMR (CDCl3, 176 MHz): δ 69.4, 67.3, 56.8, 28.5, 24.3.  
2-methyl-4-(pyrrolidin-1-yl)butan-2-ol (14):  
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General procedure B was followed using 1-isopentylpyrrolidine (1.50 mmol, 212 mg, 1 
equiv), K2S2O8 (3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (3.3 mmol, 2.2 equiv, 3.0 mL 
of a 1.1 M stock solution), and water (3.0 mL). The reaction was stirred at 80 ºC for 4 h. The 
reaction was quenched following general procedure C, and the product was purified by 
column chromatography on basic alumina (gradient of 1% to 10%, MeOH in dichloromethane) 
and isolated as a light yellow oil.  
Isolated Yield: 67% (158.2 mg) 
Rf: 0.80 (1:9 MeOH : dichloromethane) 
IR (ν, cm-1): 3360, 2967, 2925, 2803, 1700, 1652, 1558, 1457, 1376, 1203, 1162.  
HRMS: ESI+ (m/z): [M+H+] calcd for C9H20NO: 158.1539; found: 158.1538. 
1H NMR (CDCl3, 700 MHz): δ 7.26 (br s, 1H), 2.75 (m, 2H), 2.55 (br s, 4H), 1.74 (br s, 4H), 
1.60 (m, 2H), 1.21 (s, 6H). 




General procedure B was followed using 1-isopentylpiperidine (1.50 mmol, 233 mg, 1 equiv), 
K2S2O8 (3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (3.3 mmol, 2.2 equiv, 3.0 mL of a 1.1 
M stock solution), and water (3.0 mL). The reaction was stirred at 80 ºC for 4 h. The reaction 
was quenched following general procedure C and the product was purified by column 
chromatography on basic alumina (gradient of 1% to 10%, MeOH in dichloromethane) and 
isolated as a light yellow oil.  
Isolated Yield: 51% (132.2 mg) 
Rf: 0.89 (1:9 MeOH : dichloromethane) 
IR (ν, cm-1): 3371, 2931, 2803, 1717, 1652, 1456, 1374, 1156, 1113, 890, 758. 
HRMS: ESI+ (m/z): [M+H+] calcd for C10H22NO: 172.1696; found: 172.1695. 
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1H NMR (D2O/D2SO4, 700 MHz): δ 3.30 (d, J = 12.6 Hz, 2H), 2.95 (m, 2H), 2.69 (td, J = 12.6, 
2.1 Hz, 2H), 1.69 (m, 4H), 1.57 (d, J = 12.6 Hz, 1H), 1.46 (qt, J = 12.6, 3.5 Hz, 2H), 1.23 (qt, 
J = 12.6, 3.5 Hz, 1H), 1.01 (s, 6H). OH peak not observed 




General procedure B was followed using 1-isopentylpiperidine (1.50 mmol, 236 mg, 1 equiv), 
K2S2O8 (3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (3.3 mmol, 2.2 equiv, 3.0 mL of a 1.1 
M stock solution), and water (3.0 mL). The reaction was stirred at 80 ºC for 4 h. The reaction 
was quenched following general procedure C and the product was purified by column 
chromatography on basic alumina (gradient of 1% to 10%, MeOH in dichloromethane) and 
isolated as a light yellow oil.  
Isolated Yield: 43% (111.6 mg) 
Rf: 0.78 (1:9 MeOH : dichloromethane) 
IR (ν, cm-1): 3377, 2965, 2852, 1654, 1458, 1362, 1164, 1114, 1008, 866.  
HRMS: ESI+ (m/z): [M+H+] calcd for C9H20NO2: 174.1489; found: 174.1489.  
1H NMR: (CDCl3, 500 MHz): δ 5.90 (br s, 1H), 3.69 (t, J = 4.5 Hz, 4H), 2.63 (dd, J = 6.0, 4.5 
Hz, 2H), 2.52 (br s, 4H), 1.62 (dd, J = 6.0, 4.5 Hz, 2H), 1.22 (s, 6H). 




General procedure B was followed using 1-isopentylazepane (1.50, 254 mg, 1 equiv), K2S2O8 
(3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (1.65 mmol, 1.1 equiv, 1.5 mL of a 1.1 M stock 
solution), and water (4.5 mL). The reaction was stirred at 65 ºC for 4 h. The reaction was 
quenched following general procedure C and the product was purified by column 
chromatography on basic alumina (gradient of 1% to 10% MeOH in dichloromethane) and 
isolated as a light yellow oil.  
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Isolated Yield: 26% (72.4 mg) 
Rf: 0.52 (1:4 EtOAc : hexanes) 
IR (ν, cm-1): 3383, 2924, 2851, 1456, 1361, 1266, 1185, 1156, 1083, 943, 884.  
HRMS: ESI+ (m/z): [M+H+] calcd for C11H24NO: 186.1852; found: 186.1852.  
1H NMR (CDCl3, 401 MHz): δ 6.86 (br s, 1H), 2.70 (dd, J = 6.0, 4.8 Hz, 2H), 2.62 (dd, J = 
5.2, 3.6 Hz, 4H), 1.63 (m, 4H), 1.54 (multiple peaks, 6H), 1.19 (s, 6H). 
13C NMR (CDCl3, 176 MHz): δ 71.0, 56.2, 55.8, 37.6, 30.0, 28.2, 26.8. 
 
N-(4-(1-hydroxyethyl)benzyl)benzamide (18-OH and 18-O): 
 
General procedure B was followed using (4-ethylphenyl)methanamine (0.25 mmol, 34 mg, 1 
equiv), K2S2O8 (0.25 or 0.50 mmol, 68 or 135 mg, 1 or 2 equiv), aqueous H2SO4 (0.28 mmol, 
1.1 equiv, 0.25 mL of a 1.1 M stock solution), and water (0.75 mL). The reaction was stirred 
at 80 ºC for 2 h.The products were protected via general procedure D with MeCN (10 mL), 
triethylamine (348 μL, 2.5 mmol), and benzoyl chloride (89 μL, 0.75 mmol). The products 
were then then purified by flash column chromatography on silica (gradient of 10% to 100%, 
EtOAc in hexanes). Compound 18-OH was isolated as a light yellow viscous oil and compound 
18-O was isolated as a white solid. For the purposes of obtaining an accurate isolated yield and 
ratio, products 18-OH and 18-O were isolated as a mixture and the isolated ratio was 
determined by 1H NMR spectroscopy. For the purposes of characterizing each compound, 
fractions that only contained 18-OH or 18-O were collected and analyzed. 
Isolated Yield: 1 equiv K2S2O8: 55% (34.8 mg, 18-OH : 18-O = 1:0.48; crude ratio = 1:0.42) 
           2 equiv K2S2O8: 61% (38.6 mg, 18-OH : 18-O = 0.93:1; crude ratio = 0.94:1) 
18-OH Rf: 0.55 (1:1 EtOAc:hexanes) 
18-O Rf: 0.63 (1:1 EtOAc:hexanes) 
18-OH IR (ν, cm-1): 3316, 2692, 1635, 1539, 1292, 1073, 801, 693. 
18-O IR (ν, cm-1): 3312, 1670, 1636, 1532, 1269, 792, 693.  
18-O mp: 106–108 ºC 
18-OH HRMS: ESI+ (m/z): [M+H+] calcd for C16H18NO2: 256.1332; found: 256.1335 
18-O HRMS: ESI+ (m/z): [M+H+] calcd for C16H16NO2: 254.1176; found: 254.1175  
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18-OH 1H NMR (CDCl3, 700 MHz): δ 7.78 (d, J = 7.7 Hz, 2H), 7.50 (t, J = 7.7 Hz, 1H), 7.43 
(t, J = 7.7 Hz, 2H), 7.36 (d, J = 7.0 Hz, 2H), 7.34 (d, J = 7.0 Hz, 2H), 6.42 (br s, 1H), 4.90 (q, 
J = 7.0 Hz, 1H), 4.63 (d, J = 5.6 Hz, 2H), 1.84 (br s, 1H), 1.49 (d, J = 7.0 Hz, 3H).  
18-OH 13C NMR (CDCl3, 176 MHz): δ 167.5, 145.5, 137.5, 134.5, 131.7, 128.8, 128.4, 127.1, 
126.0, 70.2, 44.0, 25.4. 
18-O 1H NMR (CDCl3, 700 MHz): δ 7.93 (d, J = 8.4 Hz, 2H), 7.93 (d, J = 8.4 Hz, 2H), 7.52 
(t, J = 8.4 Hz, 1H), 7.45 (multiple peaks, 4H), 6.55 (br s, 1H), 4.71 (d, J = 5.6 Hz, 2H), 2.59 (s, 
3H).  
18-O 13C NMR (CDCl3, 176 MHz): δ 197.8, 167.6, 143.8, 136.6, 134.2, 131.9, 129.0, 128.8, 
127.9, 127.1, 43.8, 26.8.  
 
N-(2-hydroxy-2-phenylethyl)benzamide (19-OH and 19-O): 
 
General procedure B was followed using 2-phenylethan-1-amine (1.50 mmol, 182 mg, 1 
equiv), K2S2O8 (3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (3.3 mmol, 2.2 equiv, 3.0 mL 
of a 1.1 M stock solution), and water (3.0 mL). The reaction was stirred at 80 ºC for 4 h. The 
product was protected via general procedure D with MeCN (100 mL), triethylamine (2.09 
mL, 15.0 mmol), and benzoyl chloride (552 μL, 4.5 mmol). The products were then purified 
by flash column chromatography on silica (gradient 10% to 100% EtOAc/hexanes). Compound 
19-OH was isolated as a white solid, and compound 19-O was isolated as a light yellow solid.  
Isolated Yield: 2 equiv K2S2O8: 40% total yield (19-OH + 19-O) (116.8 mg 19-OH; 32.6 mg 
19-O; Ratio of 19-OH : 19-O (isolated) = 1:0.28; Ratio of C-OH:C=O (crude) = 1:0.18) 
19-OH Rf: 0.39 (1:1 EtOAc:hexanes) 
19-O Rf : 0.58 (1:1 EtOAc:hexanes) 
19-OH IR (ν, cm-1) 3402, 3298, 1617, 1541, 1315, 1230, 1062, 923, 817, 692. 
19-O IR (ν, cm-1) 3356, 1691, 1634, 1520, 1484, 1442, 1362, 1222, 999, 756, 686. 
19-OH mp: 144–146 ºC 
19-O mp: 117–119 ºC 
19-OH HRMS: ESI+ (m/z): [M+H+] calcd for C15H16NO2: 242.1176; found: 242.1176. 
19-O HRMS: ESI+ (m/z): [M+H+] calcd for C15H14NO2: 240.1019; found: 240.1017.  
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19-OH 1H NMR (CDCl3, 500 MHz): δ 7.76 (d, J = 7.5 Hz, 2H), 7.51 (t, J = 7.5 Hz, 1H), 7.43 
(multiple peaks, 4H), 7.38 (t, J = 7.5 Hz, 2H), 7.31 (t, J = 7.5 Hz, 1H), 6.59 (br s, 1H), 4.97 
(dd, J = 7.5, 3.5 Hz, 1H), 3.93 (ddd, J = 14.0, 7.0, 3.5 Hz, 1H), 3.54 (ddd, J = 14.0, 7.5, 4.5 Hz, 
1H). OH peak not observed 
19-OH 13C NMR (CDCl3, 126 MHz): δ 168.8, 141.9, 134.2, 131.9, 128.8, 128.8, 128.1, 127.1, 
126.0, 74.0, 48.0. 
19-O 1H NMR (CDCl3, 500 MHz): δ 8.04 (d, J = 7.5 Hz, 2H), 7.89 (d, J = 7.5 Hz, 2H), 7.65 
(t, J = 7.5 Hz, 1H), 7.53 (multiple peaks, 3H), 7.47 (t, J = 7.5 Hz, 2H), 7.31 (br s, 1H), 4.97 (d, 
J = 4.0 Hz, 2H).  
19-O 13C NMR (CDCl3, 126 MHz): δ 194.4, 167.5, 134.5, 134.4, 134.1, 131.9. 129.1, 128.8, 




General procedure B was followed using N,N-dimethyl-3-phenylpropan-1-amine (0.25 
mmol, 41 mg, 1 equiv), K2S2O8 (1.00 mmol, 270 mg, 4 equiv), aqueous H2SO4 (0.28 mmol, 
1.1 equiv, 0.25 mL of a 1.1 M stock solution), and water (0.75 mL). The reaction was stirred 
at 80 ºC for 2 h. The reaction was quenched following general procedure C, evaporated to 
dryness, and purified by column chromatography on basic alumina (0.5–5% MeOH/DCM). 
The product was isolated as a light yellow oil. The 1H and 13C NMR spectra matched literature 
values.4 
Isolated Yield: 57% (25.1 mg) 
HRMS: ESI+ (m/z): [M+H+] calcd for C11H16NO: 178.1226; found: 178.1225.  
1H NMR (CDCl3, 700 MHz): δ 7.97 (d, J = 7.7 Hz, 2H), 7.56 (t, J = 7.7 Hz, 1H), 7.47 (t, J = 
7.7 Hz, 2H), 3.17 (t, J = 7.0 Hz, 2H), 2.77 (t, J = 7.0 Hz, 2H), 2.30 (s, 6H).  







(4-(hydroxy(phenyl)methyl)piperidin-1-yl)(phenyl)methanone (21-OH and 21-O):  
 
General procedure B was followed using (4-ethylphenyl)methanamine (1.50 mmol, 263 mg, 
1 equiv), K2S2O8 (3.00 mmol, 811 mg, 1 equiv), aqueous H2SO4 (3.3 mmol, 2.2 equiv, 3.0 mL 
of a 1.1 M stock solution), and water (3.0 mL). The reaction was stirred at 80 ºC for 4 h. The 
reaction was quenched with sodium sulfite, evaporated to dryness, and protected via general 
procedure D with MeCN (100 mL), triethylamine (2.09 mL, 15.0 mmol), and benzoyl chloride 
(552 μL, 4.5 mmol). The product was then purified by flash column chromatography on silica 
(gradient of 10% to 100%, EtOAc in hexanes). Compound 21-OH was isolated as a light 
yellow, viscous oil, and compound 21-O was isolated as a light yellow solid.   
Isolated Yield: 2 equiv oxidant: 40% total (32.6 mg of 21-OH,144.0 mg of 21-O; Ratio of 21-
OH:21-O (isolated) = 1:0.23) 
21-OH Rf: 0.34 (1:1 EtOAc:hexanes) 
21-O Rf: 0.56 (1:1 EtOAc:hexanes) 
21-OH IR (ν, cm-1): 3401, 2859, 1610, 1447, 1282, 1026, 909, 728, 700. 
21-O IR (ν, cm-1): 2947, 1681, 1624, 1446, 1285, 1212, 970, 700. 
21-O mp: 100–102 ºC 
21-OH HRMS: ESI+ (m/z): [M+H+] calcd for C19H22NO2: 296.1645; found: 296.1648. 
21-O HRMS: ESI+ (m/z): [M+H+] calcd for C19H20NO2: 294.1489; found: 294.1494.  
21-OH 1H NMR (C6D5CD3, 700 MHz, 90 ºC): δ 7.25 (m, 2H), 7.12 (multiple peaks, 4H), 7.06 
(multiple peaks, 4H), 4.09 (br s, 2H), 4.07 (d, J = 7.0 Hz, 1H), 2.48 (td, J = 12.6, 2.8 Hz, 1H), 
2.41 (m, 1H), 1.99 (br s, 1H), 1.68 (d, J = 12.6 Hz, 1H), 1.55 (m, 1H), 1.19 (qd, J = 12.6, 4.2 
Hz, 1H), 1.10 (multiple peaks, 2H). 
21-OH 13C NMR (C6D5CD3, 176 MHz, 90 ºC): δ 169.9, 144.3, 129.3, 128.4, 127.6, 126.9 
(some aromatic peaks overlap with C6D5CD3), 45.4, 44.4, 29.4, 20.7.  
21-OH 13C NMR (CDCl3, 176 MHz, room temperature): 170.4, 143.0, 137.6, 136.3, 129.5, 
128.5, 127.8, 126.9, 126.6, 78.2, 47.9, 43.7, 42.3, 29.2, 29.0, 28.4, 28.1. Rotamers present at 
room temperature. 
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21-O 1H NMR (C6D5CD3, 700 MHz, 90 ºC): δ 7.71 (d, J = 7.7 Hz, 2H), 7.29 (m, 2H), 7.17 (t, 
J = 7.7 Hz, 1H), 7.11 (t, J = 7.7 Hz, 2H), 7.08 (m, 3H), 4.03 (br s, 2H), 2.99 (m, 1H), 2.75 (t, J 
= 12.6 Hz, 2H), 1.60 (q, J = 12.6 Hz, 2H), 1.48 (d, J = 12.6 Hz, 2H). 
21-O 13C NMR (C6D5CD3, 176 MHz, 90 ºC): δ 200.5, 169.9, 137.0, 132.7, 129.4, 128.5, 127.6, 
(some aromatic peaks overlap with C6D5CD3), 44.5, 43.7, 29.0. 
21-O 13C NMR (CDCl3, 176 MHz, room temperature): 201.8, 170.6, 136.1, 135.8, 133.4, 




General procedure B was followed using N,N-dimethyl-4-phenylbutan-1-amine (0.25 mmol, 
44 mg, 1 equiv), K2S2O8 (1.00 mmol, 270 mg, 4 equiv), aqueous H2SO4 (0.28 mmol, 1.1 equiv, 
0.25 mL of a 1.1 M stock solution), and water (0.75 mL). The reaction was stirred at 80 ºC for 
2 h. The reaction was quenched following general procedure C, evaporated to dryness, and 
purified by column chromatography on basic alumina (0.5–5% MeOH/dichloromethane). The 
product was isolated as a light yellow oil. The 1H and 13C NMR spectra matched literature 
values.4 
Isolated Yield: 40% (19.0 mg) 
HRMS: ESI+ (m/z): [M+H+] calcd for C12H18NO: 192.1383; found: 192.1381. 
1H NMR (CDCl3, 700 MHz): δ 7.97 (d, J = 7.7 Hz, 2H), 7.54 (t, J = 7.7 Hz, 1H), 7.45 (t, J = 
7.7 Hz, 2H), 3.02 (t, J = 7.0 Hz, 2H), 2.36 (t, J = 7.0 Hz, 2H), 2.23 (s, 6H), 1.92 (quin, J = 7.0 
Hz, 2H). 
13C NMR (CDCl3, 176 MHz): δ 200.2, 137.2, 133.0, 128.7, 128.2, 59.1, 45.5. 36.4, 22.2. 
 
N-(3-hydroxybutyl)benzamide (23-OH-a and 23-OH-b):  
 
General procedure B was followed using 1-butylamine (6.00 mmol, 439 mg, 2 equiv), K2S2O8 
(3.00 mmol, 811 mg, 1 equiv), and aqueous H2SO4 (13.2 mmol, 2.2 equiv, 6.0 mL of a 2.2 M 
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stock solution). The reaction was stirred at 80 ºC for 2 h. The product was protected via general 
procedure D with MeCN (100 mL), triethylamine (8.36 mL, 60.0 mmol), and benzoyl chloride 
(2.09 mL, 18.0 mmol). The product was then purified by flash column chromatography on 
silica (gradient of 2% to 10%, MeOH in dichloromethane). Compound 23-OH-a was isolated 
as a light yellow oil, and compound 23-OH-b was isolated as a white solid. 
Isolated Yield: 32% total (143.6 mg of 23-OH-a, 41.6 mg of 23-OH-b; Ratio of 23-OH-a:23-
OH-b (isolated) = 1:0.29; Ratio of 23-OH-a:23-OH-b (crude) = 1:0.39) 
23-OH-a Rf: 0.38 (1:9 MeOH:dichloromethane) 
23-OH-b Rf: 0.38 (1:9 MeOH:dichloromethane); this compound elutes after 23-OH-a with the 
gradient used for purification  
23-OH-a IR (ν, cm-1): 3312, 2967, 1635, 1540, 1489, 1449, 1310, 1134, 1002, 909, 694.  
23-OH-b IR (ν, cm-1): 3356, 3310, 2932, 1631, 1540, 1373, 1257, 1128, 909, 696.  
23-OH-b mp: 93-96 ºC 
23-OH-a HRMS: ESI+ (m/z): [M+H+] calcd for C11H16NO2: 194.1176; found: 194.1176. 
23-OH-b HRMS: ESI+ (m/z): [M+H+] calcd for C11H16NO2: 194.1176; found: 194.1175. 
23-OH-a 1H NMR (CDCl3, 400 MHz): δ 7.77 (d, J = 7.6 Hz, 2H), 7.50 (t, J = 7.6 Hz, 1H), 7.42 
(t, J = 7.6 Hz, 2H), 6.83 (br s, 1H), 3.91 (m, 2H), 3.35 (dq, J = 14.0 Hz, 5.2 Hz, 1H), 3.14 (br 
s, 1H), 1.69 (multiple peaks, 2H), 1.34 (d, J = 6.4 Hz, 3H). 
23-OH-a 13C NMR (CDCl3, 101 MHz): δ 168.4, 134.4, 131.7, 128.7, 127.0, 65.9, 38.7, 37.5, 
23.5. 
23-OH-b 1H NMR (CDCl3, 700 MHz): δ 7.78 (d, J = 7.7 Hz, 2H), 7.49 (t, J = 7.7 Hz, 1H), 
7.42 (t, J = 7.7 Hz, 2H), 6.71 (br s, 1H), 3.75 (m, 1H), 3.70 (ddd, J = 14.0, 6.3, 2.8 Hz, 1H), 
3.32 (ddd, J = 14.0, 7.7, 4.9 Hz, 1H), 2.32 (br s, 1H), 1.55 (multiple peaks, 2H), 0.99 (t, J = 7.0 
Hz, 3H). 






General procedure B was followed using (1r,3R,5S,7r)-3,5-dimethyladamantan-1-amine 
(0.75 mmol, 134 mg, 1 equiv), K2S2O8 (0.75 mmol, 202 mg, 1 equiv), aqueous H2SO4 (1.65 
mmol, 2.2 equiv, 1.5 mL of a 1.1 M stock solution), and water (1.5 mL). The reaction was 
stirred at 80 ºC for 2 h. The product was protected via general procedure D with MeCN (100 
mL), triethylamine (2.09 mL, 15.0 mmol), and benzoyl chloride (552 μL, 4.5 mmol). The 
product was then purified by flash column chromatography on silica (gradient of 12% to 100%, 
EtOAc/hexanes) and isolated as a white solid. 
Isolated Yield: 27% (61.4 mg) 
Rf: 0.30 (1:1 EtOAc:hexanes) 
IR (ν, cm-1): 3326, 2946, 2851, 1641, 1531, 1335, 1201, 1063,  910, 731. 
mp: 163–164 ºC 
HRMS: ESI+ (m/z): [M+H+] calcd for C19H26NO2: 300.1958; found: 300.1967. 
1H NMR (CDCl3, 700 MHz): δ 7.69 (d, J = 7.7 Hz, 2H), 7.46 (t, J = 7.7 Hz, 1H), 7.40 (t, J = 
7.7 Hz, 2H), 5.92 (br s, 1H), 2.01 (s, 2H), 1.77 (d, J = 11.9 Hz, 2H), 1.71 (d, J = 11.9 Hz, 2H), 
1.46 (d, J = 11.9 Hz, 2H), 1.38 (d, J = 11.9 Hz, 2H), 1.18 (d, J = 12.6 Hz, 1H), 1.13 (d, J = 
12.6 Hz, 1H), 0.96 (s, 6H). OH peak not observed 
13C NMR (CDCl3, 176 MHz): δ 167.0, 135.7, 131.4, 128.6, 126.8, 70.5, 55.6. 50.5, 49.6, 47.8, 
46.7, 34.4, 29.3.  
 
benzyl (S)-(5,5-dimethyl-2-oxotetrahydrofuran-3-yl)carbamate (25): 
 
 
General procedure B was followed using L-leucine (1.50 mmol, 197 mg, 1 equiv), K2S2O8 
(3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (3.3 mmol, 2.2 equiv, 3.0 mL of a 1.1 M stock 
solution), and water (3.0 mL). The reaction was stirred at 80 ºC for 4 h. The product was 
protected via general procedure E, purified by flash column chromatography on silica 
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(gradient of 20% to 75%, EtOAc in hexanes), and isolated as a white solid. The product was 
recrystallized from hot hexanes with a few drops of dichloromethane to obtain an X-ray crystal 
structure, which shows retention of stereochemistry (see supporting information from reference 
1).1  
Isolated Yield: 47% (187.1 mg) 
Rf: 0.52 (1:1 EtOAc:hexanes) 
IR (ν, cm-1): 3325, 3058, 2979, 1753, 1708, 1534, 1242, 1179, 1109, 925, 739, 702.  
mp: 103–104 ºC 
HRMS: ESI+ (m/z): [M+Na+] calcd for NaC14H17NO4: 287.1101; found: 287.1109. 
1H NMR (CD3OD, 700 MHz): δ 7.32 (multiple peaks, 5H), 5.10 (s, 2H), 4.84 (s, 1H), 4.62 (t, 
J = 10. 5 Hz, 1H), 2.46 (t, J = 10.5 Hz, 1H), 2.12 (t, J = 11.9 Hz, 1H), 1.47 (s, 3H), 1.40 (s, 
3H).  
13C NMR (CD3OD, 176 MHz): δ 176.7, 158.2, 138.0, 129.5, 129.0, 128.9, 83.3, 67.8, 52.6, 
41.4, 29.1, 27.1. 





HPLC trace of isolated compound 25: OD-H column 30% isopropanol/ 70% hexanes, 210.2 





3-[(benzyloxy)carbonyl(aminomethyl)]-5-hydroxy-5-methylhexanoic acid (26): 
 
General procedure B was followed using (S)-3-(ammoniomethyl)-5-methylhexanoate (1.50 
mmol, 239 mg, 1 equiv), K2S2O8 (3.00 mmol, 811 mg, 2 equiv), aqueous H2SO4 (3.3 mmol, 
2.2 equiv, 3.0 mL of a 1.1 M stock solution), and water (3.0 mL). The reaction was stirred at 
80 ºC for 4 h. The product was protected via general procedure E, purified by flash column 
chromatography on silica (gradient 2% to 10%, MeOH/dichloromethane), and isolated as a 
light pink oil. 
Isolated Yield: 40% (175.6 mg) 
Rf: 0.63 (1:9 MeOH:dichloromethane) 
IR (ν, cm-1): 3325, 2978, 1699, 1522, 1456, 1374, 1242, 1108, 981, 734, 697. 
HRMS: ESI+ (m/z): [M+Na+] calcd for NaC16H21NO4: 314.1363; found: 314.1463. 
1H NMR (CDCl3, 700 MHz): δ 7.35 (multiple peaks, 5H), 5.09 (s, 2H), 5.01 (s, 1H), 3.15 (m, 
2H), 2.64 (dd, J = 18.2, 4.9 Hz, 1H), 2.26 (m, 1H), 2.02 (dd, J = 18.2, 11.9 Hz, 1H), 1.84 (d, J 
= 13.3 Hz, 1H), 1.43 (s, 3H), 1.40 (t, J = 13.3 Hz, 1H), 1.35 (s, 3H). 
13C NMR (CDCl3, 176 MHz): δ 170.6, 156.7, 136.3, 128.7, 128.4, 128.3, 82.0, 67.1, 45.8, 38.3, 
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Palladium-Catalyzed, Transannular C(sp3)‒H Arylation of Cyclic 
Amines: Application to Fragment Based Drug Discovery1
 
4.1. Introduction 
This Chapter focuses on the work that was completed in collaboration with AbbVie 
Pharmaceuticals in the Fragment Based Drug Discovery Group in North Chicago. Recently, 
our group demonstrated a Pd-catalyzed remote C‒H arylation of a variety of alicyclic amines 
(Scheme 4.1).2 This proved effective for the selective functionalization of complex molecules 
and could thus be used in late-stage modification of drug candidates. Another potential 
application of this work is in the synthesis of small molecules for fragment based drug 
discovery (FBDD). In recent years, FBDD has become an increasingly important approach for 
the identification of lead compounds in the pharmaceutical industry.3 However, one key 
limitation of current fragment libraries is that they predominantly consist of sp2-rich, planar 
compounds.4 To cover a wider chemical space, there is increasing demand for fragments 
containing three-dimensional character, and alicyclic amine-based fragments could be 
particularly desirable in this context.5 
Scheme 4.1. Pd-Catalyzed C(sp3)–H Arylation of Alicyclic Amines 2 
 
As such, we sought to leverage recent work from our group on the Pd-catalyzed remote 
C(sp3)‒H arylation of alicyclic amines to assemble 3D fragments for FBDD.2 In order to 
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rapidly access the amine-containing fragments, we needed to address several key challenges 
associated with the existing method. First, the reaction times must be as short as possible to 
accelerate drug discovery efforts. To assemble a diverse fragment library, the conditions should 
must be compatible with a variety of coupling partners, particularly those containing 
heteroatoms and halogenated functional groups. Finally, the directing group required for the 
functionalization step must be easily removed to access the desired fragments.   
Figure 4.1. 3-azabicylco[3.1.0]hexane Containing Bioactive Molecules 6 
 
Our efforts in this area focused on the C(sp3)–H functionalization of the 3-
azabicylco[3.1.0]hexane core to generate C-4-arylated derivatives. Under the originally 
reported conditions, arylation of 3-azabicylco[3.1.0]hexane occurred with excellent yield and 
good functional group compatibility. As such, this reaction provided a good starting point for 
fragment generation.2  Notably, 3-azabicylco[3.1.0]hexane serves as the core structure of a 
variety of bioactive molecules (Figure 4.1).6 C-4-arylated derivatives of this core possess 
three-dimensional character and are rule-of-three compliant (MW < 300; ClogP < 3; hydrogen 
bond donors/acceptors < 3; rotatable bonds < 3).7 Traditionally, the assembly of 3-
azabicylco[3.1.0]hexane derivatives with functionalization at the C-4 position has required 
long synthetic sequences.6a-c However our Pd-catalyzed transannular C–H arylation method 
enables selective functionalization of this core in just three steps: (1) directing group 
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installation, (2) transannular C(sp3)–H arylation, and (3) directing group removal (Scheme 
4.2). 
Scheme 4.2. Pd-Catalyzed C(sp3)–H Arylation for Fragment Generation 
 
We focused on assembling 3-azabicylco[3.1.0]hexane fragments for FBDD, while 
addressing the challenges of shortening the reaction times to increase reaction throughput, 
optimizing and developing new conditions for directing group removal, and preparing 
derivatives relevant to FBDD. The resulting structures are then analyzed and compared to ideal 
fragment properties.  
4.2. Results and Discussion 
Results from Microwave Conditions 
Our original conditions for the C–H arylation of 3-azabicyclo[3.1.0]hexanes required a 
glovebox set up and reaction times of 18 h at 130 °C to achieve high yields.2 We first sought 
to develop conditions to accelerate these reactions as well as to eliminate the need for a 
glovebox. Microwave technology is often used to accelerate the reaction rates and thus reduce 
reaction times.8 As shown in Scheme 4.3, we found that Pd-catalyzed C–H arylation to afford 
1 proceeds in under 1 h at 180 °C under microwave heating, without the use of a glovebox. 
These reactions were set up in a microwave tube on the bench-top and purged with N2. At 0.52 
mmol scale, the arylated product 1 was obtained in 68% yield, which is comparable to the 
previously reported 74% yield from the 18 h reactions.2 Furthermore, when the new conditions 
were scaled to 1.04 mmol, a comparable 83% yield of 1 was obtained (Scheme 4.3).  
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Scheme 4.3. Revised Microwave Conditions for Pd-Catalyzed C‒H Arylation 
 
With these microwave conditions in hand, we next explored the scope of aryl and 
heteroaryl iodide coupling partners for this reaction (Figure 4.2). A wide variety of aryl iodides 
were compatible with the modified conditions, affording 4-aryl-3-azabicyclo[3.1.0]hexanes 
products 2-9 in moderate to good yields. Aryl iodides containing halogen, ether, and 
unprotected phenol functional groups were generally well-tolerated without any modification 
of the standard microwave conditions. Notably, a low yield of 12% was obtained for product 
8. As a result, this reaction was not carried forward to the next step of directing group removal. 
A variety of substituted pyridyl and quinolinyl iodides also reacted under the standard 
conditions to afford modest to good yields of the transannular C(sp3)–H arylation products 10-
16. We did observe that para-substituted phenol and pyridyl groups resulted in low yields of 














Figure 4.2. Synthesis of Arylated Products with Microwave Conditions 
 
a Reaction conditions with 0.52 mmol of S-1b Reaction conditions with 1.04 mmol S-1. Isolated yields. See 
details in experimental section. 
 
Strategies for Directing Group Cleavage 
A key remaining challenge for the application of this directed C‒H arylation in FBDD 
is the development of practical methods for removing the directing group from the product. 
Our previously reported conditions involved reduction of the fluoroimide directing group with 
SmI2, protection of the resulting 2° amine product with pivaloyl chloride, and finally isolation 
of the amide.2 One concern with these conditions in the context of FBDD is the use of 
hexamethylphosphoramide (HMPA) activator, which has been shown to be toxic.9 In addition, 
the original process yielded higher molecular weight amide products rather than the free 2° 
amines, which are lower molecular weight and can be further derivatized.  
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Scheme 4.4. Removal of Directing Group with Model Substrate S-2  
 
We first explored alternative activators for SmI2 and identified tripyrrolidinophosphoric 
acid triamide (TPPA) as a viable replacement.10 S-2 was selected as an ideal substrate for 
optimization because the starting material, 4-phenyl piperidine, was commercially available. 
Upon replacing HMPA with TPPA, the complete cleavage of the directing group was observed 
within 3 h (Scheme 4.4). Under these revised conditions, the directing group cleavage 
proceeded within 3 h at room temperature, compared to 24 h under previous conditions. Further 
studies revealed that the 2° amine product could be isolated directly by changing the work-up 
procedure. Rather than protection with pivaloyl chloride at the end of the SmI2 reaction, we 
subjected the crude reaction mixture to an aqueous work-up and then purified the resulting 
product by reverse phase HPLC. This procedure enabled direct isolation a variety of 2° amine 
fragments in yields ranging from 34-51% (Table 4.1). Notably, a slightly modified procedure 
involving a Boc-protection step was required for efficient isolation of the polar secondary 
amine 9-A.  
A key limitation of the SmI2-mediated directing group cleavage process is that it is 
incompatible with substrates containing aryl halide functional groups (Cl, Br, and I) that are 
easily reduced.11 In addition, pyridine derivatives such as 11-A undergo competing heteroarene 
reduction in the presence of SmI2 (entry 9, Table 4.1).
12 These limitations highlight the need 
to develop a complementary procedure to remove the directing group from these substrates. 




Table 4.1. Reductive Cleavage of Directing Group with SmI2  
 
entry product yielda 
1 4-Ph (1-A) 34% 
2 4-F-Ph (2-A) 48% 
3 4-CF3-Ph (3-A) 44% 
5 4-Me-Ph (5-A) 49% 
6 4-Et-Ph (6-A) 39% 
7 4-MeO-Ph (7-A) 51% 
8 3-OH-Ph (9-A) 38%b 
9 3-Pyr (11-A) 0% 
 a Isolated yields. b Boc protection of intermediate followed by deprotection. See 
details in experimental section. 
 
dealkylation of the fluoroamide directing group.13 However, one challenge for this process is 
that the nitrogen atom is highly sterically hindered, and, as such, acylation might require more 
forcing reaction conditions. Temperature, reaction time, and the use of Lewis acids was 
investigated. However, the use of Lewis acid additives was inconclusive, leading to NMR 
spectra that were difficult to interpret due to peak broadening and shifting. We found that the 
treatment of 1 with neat acetyl chloride with microwave heating at 150 °C for 3 h led to 
reproducible formation of amide product 1-B in 35% yield as determined by 1H NMR 
spectroscopic analysis of the crude reaction mixture. Furthermore, the product was isolated in 
25% yield from this procedure (Table 4.2, entry 6 and Table 4.3, entry 1). Similar optimization 
studies were carried out with 11 resulting in a 23% yield of 11-B as determined by 1H NMR 
spectroscopy. 
These conditions proved effective to cleave the directing group from products 1 and 4 
as well as most of the pyridine-containing derivatives, although the isolated yields were 
relatively low (12-25%, Table 4.3). In the case of 10, complete consumption of starting 
material and minimal formation of 10-B was observed. This is most likely due to the 
 98 
Table 4.2. Optimization Conditions for Acylative Dealkylation 
 
entry temp (℃) time (h) yielda 
1 100 5 trace 
2 100b 5 trace 
3 125 5 32% 
4 150 1.5 12% 
5 150 2.5 29% 
6 150 3 35% 
  a NMR Yields. See details in experimental section. b hot plate 
decomposition of the starting material under these conditions, as the neat acetyl chloride 
solution turned dark even prior to heating. Notably, the aryl-Cl bonds of 4-B, 14-B, and 15-B 
were compatible with these conditions (Table 4.3).  In contrast, product 13-B was not isolable 
due to competing nucleophilic aromatic substitution at the C–F bond to generate the 2-chloro 
product 13-B. 
Table 4.3. Acylative Dealkylation of Directing Group with Acetyl Chloride 
 
entry product yielda 
1 4-Ph (1-B) 25% 
2 4-Cl-Ph (4-B) 25% 
3 4-Pyr (10-B) 0% 
4 3-Pyr (11-B) 19% 
5 2-Pyr (12-B) 19% 
6 2-F-5-Pyr (13-B) 0% 
7 2-Cl-5-Pyr (14-B) 19% 
8 2-Cl-3-Pyr (15-B) 12% 
9 6-quinoline (16-B) 23% 
  a Isolated yields. See details in experimental section. 
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Relating Products to Fragment Properties 
Finally, the physicochemical properties of the fragments synthesized via C–H 
functionalization were assessed.14  The calculated values show that nearly all of the prepared 
arylated amines and amides fall within the ideal range as defined by the restrictions set by the 
Rule of 3 and guidelines by Astex Pharmaceuticals (Table 4.4).7 The fragments in this study 
have a low mean molecular weight (204), while maintaining high levels of Fsp3 (Fraction 
aromatic = 0.48). The Principal Moments of Inertia (PMI), which describes whether a molecule 
is rod-, disk-, or sphere-like, demonstrate that most of the fragments possess rod- and sphere-
like characteristics.15 The Plane of Best Fit (PBF) is another topographic descriptor that 
describes the average distance (Å) from the plane, and is a measure of molecular complexity. 
The average PBF score for the 14 fragments is 0.69.16   
Table 4.4. Physicochemical Properties of Synthesized Fragments 
 
Propertya Ideal7 This Work 
ClogP 0-2 0.92 
MW 140-230 204 
PSA ≤60 22.8 
HBA ≤3 1.5 
HBD ≤3 0.57 
RBC -- 1.2 
Fraction Aromatic -- 0.48 
a cLogP = partition coefficient, MW = molecular weight, PSA = polar surface area, HBA = hydrogen bond 
acceptor, HBD = hydrogen bond donor, RBC = rotatable bond count 
 
Preliminary Efforts in Expanding Fragment Synthesis  
To further explore the utility of C–H functionalization in the synthesis of fragments, 
the C(α)–H arylation of the 3-azabicyclo[3.1.0]hexane core was conducted using modified 
conditions developed by the Yu laboratory.17 Preliminary results indicate that C(α)–H arylation 
can be achieved, albeit in low yields. The isolated mixture of diastereomers were analyzed by 
1H NMR spectroscopy via integration of the newly formed benzylic proton. With the use of 
either phenyl or p-tolylboronic acid, a slight excess of the trans diastereomer is observed. To 
provide useful quantities of the final amine fragment, further optimization and subsequent 
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removal of the thioamide directing group will be necessary. Accessing these regio- and 
stereoisomeric products would be attractive, as they would further broaden current fragment 
libraries.   
Scheme 4.5. Preliminary Results on C(α)–H Arylation Reactions 
 
4.3. Conclusion and Outlook 
In conclusion, we have shown that C–H functionalization is a viable method for the 
generation of amine fragments from the 3-azabicylco[3.1.0]hexane core. With the use of 
microwave technology, we rapidly generated a library of molecules bearing aryl substituents 
at remote C‒H bonds. In the process, we addressed several key challenges associated with 
removal of the directing group. Cleavage of the directing group was accomplished while 
maintaining the integrity of the newly installed functional groups. Analysis of the final amines 
demonstrate that they possess desirable physicochemical properties, and that they can be added 















4.4. Experimental Procedures and Characterization of Compounds 
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4.4.1 Materials and Methods 
Materials and Methods 
 
HPLC grade water, ethyl acetate (EtOAc), heptanes (Hep), methanol (MeOH), 
dichloromethane (DCM), and acetonitrile (MeCN) for column chromatography were 
purchased from Aldrich. Deuterated solvents for NMR spectroscopy were purchased from 
Sigma Aldrich. Reagents were purchased from commercial sources (Sigma Aldrich, Alfa 
Aeser, Ark Pharm, and ACROS) and used without further purification, unless otherwise noted. 
Microwave reactions were carried out with Biotage® Initiator+. Thin layer chromatography 
(TLC) was performed on Merck TLC plates pre-coated with silica gel 60 F254. NMR spectra 
were recorded on Bruker Avance 500 NMR Spectrometer (500 MHz for 1H; 126 MHz for 13C) 
and a Varian 400-MR NMR Spectrometer (400 MHz for 1H; 101 MHz for 13C; 376 MHz for 
19F) with the residual solvent peak (CDCl3; 
1H: δ = 7.26 ppm, 13C: δ = 77.16 ppm), (CDCN; 
1H: δ = 1.94 ppm, 13C: δ = 1.32 ppm), and (DMSO-d6; 
1H: δ = 2.50 ppm, 13C: δ = 39.52 ppm) 
as the internal reference unless otherwise noted. Chemical shifts are reported in parts per 
million (ppm) (δ) relative to tetramethylsilane. Multiplicities are reported as follows: br (broad 
signal), s (singlet), d (doublet), t (triplet), q (quartet), quin (quintet), sex (sextet), m (multiplet), 
dd (doublet of doublets), ddd (doublet of doublet of doublets), qd (quartet of doublets). 
Coupling constants (J) are reported in Hz. Liquid chromatography mass spectra were recorded 
on a high performance liquid chromatography with mass spectrometer (LC: Agilent 1200 
Series, MS: Thermo Electron Corporation Finnigan Surveyor MSQ Plus). Liquid reagents were 
dispensed by difference from syringes. All reagents were weighed out under ambient 
conditions.  
 
4.4.2 Synthesis and Characterization of Substrates  
Compound (S-1): 
 
Compound S-1 was synthesized based on a modified literature procedure1 with the addition of 




An authentic sample of compound S-2 was synthesized using 4-phenyl piperidine based on a 
modified literature procedure1 with the addition of 0.5 equiv NaI. 1H and 19F NMR of the 
isolated product was consistent with literature values.2 
Compound (S-3):  
 
Compound S-3 was synthesized based on literature a procedure in 75% yield after two 
purifications.2  
LC-MS: APCI+ (m/z): [M+H]+ calcd for C10H18NS: 184.116 ; found: 184.229.  
1H NMR (CDCl3, 400 MHz): δ 4.50 (d, J = 12.8 Hz, 1H), 4.27 (J = 10.0 Hz, 1H), (m, 2H), 
1.71 (br s, 1H), 1.5 (br s, 1H), 1.38 (s, 9H), 0.74 (m, 1H), 0.14 (q, J = 10.0 Hz, 1H). 
13C NMR (CDCl3, 126 MHz): δ 211.4, 59.7, 54.2, 43.9, 30.5, 16.8, 13.0, 9.2.  
 
4.4.3 General Procedures for the Isolation of C‒H Arylation Products and 
Characterization 
General Procedure A for Small Scale Microwave Reactions: 
To a medium biotage microwave tube (biotage, 2-5 mL) equipped with a stir bar was added 
Pd(OAc)2 (11.7 mg, 0.052 mmol, 10 mol %), S-1 (200 mg, 0.52 mmol, 1 equiv), cesium 
pivalate (365 mg, 1.56 mmol, 3 equiv), aryl iodide (2-3 equiv) and 4.8 mL anhydrous tert-amyl 
alcohol. The cap was crimped and the vessel was flushed with nitrogen. The microwave tube 
was heated with following parameters: 1 min pre-stirring, followed by a ramp (Normal) to 180 
°C and held at temperature for 40 min. To the reaction was added 250 μL hydrazine (35% 
aqueous) and allowed to stir at 60°C for 1 hr. The tert-amyl alcohol was removed and the 
remaining residue was dissolved with EtOAc and filtered through a plug of celite and 
concentrated en vacuo. The crude reaction was purified via flash column chromatography with 
EtOAc/Heptanes. 
General Procedure B for Large Scale Microwave Reactions: 
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To a large biotage microwave tube (biotage, 10-20 mL) equipped with a stir bar was added 
Pd(OAc)2 (23.4 mg, 0.10 mmol, 10 mol %), S-1 (400 mg, 1.04 mmol, 1 equiv), cesium pivalate 
(731 mg, 3.12 mmol, 3 equiv), aryl iodide (2-3 equiv) and 9.6 mL anhydrous tert-amyl alcohol. 
The cap was crimped and the vessel was flushed with nitrogen. The microwave tube was heated 
with following parameters: 1 min pre-stirring, followed by a ramp (Normal) to 180 °C and held 
at temperature for 40 to 50 min. To the reaction was added 500 μL hydrazine (35% aqueous) 
and allowed to stir at 60°C for 1 hr or at room temperature overnight. The tert-amyl alcohol 
was removed en vacuo and the remaining residue dissolved with EtOAc and filtered through a 
plug of celite and concentrated en vacuo. The crude reaction was purified via flash column 




General procedures A and B were followed using 3 equiv iodobenzene for 40 min (small 
scale) and 3 equiv iodobenzene for 30 min (large scale). 1H and 19F NMR of the isolated 
product was consistent with literature values.2 
Isolated Yield (small scale 0.13 mmol): 68% (40.7 mg)  




General procedures A and B were followed using 3 equiv 4-fluoroiodobenzene for 40 min 
(small and large scale) and isolated as an off-white solid.  
Isolated Yield (small scale 0.52 mmol): 50% (125.0 mg)  
Isolated Yield (large scale 1.04 mmol): 42% (210.2 mg)  
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Rf: 0.38 (20% EtOAc/80% Hex) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C22H19F8N2O: 479.129; found: 479.119. 
1H NMR (CDCl3, 500 MHz): δ 7.27 (m, 2H), 6.78 (t, J = 8.5 Hz, 2H), 6.48 (br s, 1H), 2.94 (d, 
J = 9.0 Hz, 2H), 2.89 (ddd, J = 9.0 Hz, J = 2.0 Hz, J = 1.0 Hz, 2H), 2.04 (t, J = 8.0 Hz, 1H), 
1.87 (m, 2H), 1.14 (s, 6 H). 
13C NMR (CDCl3, 126 MHz): δ 175.7, 161.1 (d, JC-F = 246 Hz), 133.7, 129.6 (d, JC-F = 7.6 Hz) 
Hz), 61.1, 45.1, 22.2, 20.9. 20.1. The carbon resonances of the directing group (perfluoroarene, 
C7F7) appear as complex multiplets and are not listed. 
19F NMR and LC-MS were used to 
confirm characterization of structure.   
19F NMR (CDCl3, 376 MHz): δ -56.1 (t, J = 21.8 Hz, 3F), -116.4 (m, 1F), -141.4 (m, 2F), -
143.1 (m, 2F). 
 
Compound (3):  
 
General procedures A and B were followed using 3 equiv 4-iodobenzotrifluoride for 40 min 
(small scale) and 3 equiv 4-iodobenzotrifluoride for 30 min (large scale) and isolated as a light 
yellow solid.  
Isolated Yield (small scale 0.52 mmol): 64% (175.3 mg)  
Isolated Yield (large scale 1.04 mmol): 59% (254 mg)  
Rf: 0.26 (20% EtOAc/80% Hex) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C23H19F10N2O: 529.134; found: 529.071. 
1H NMR (CDCl3, 500 MHz): δ 7.46 (d, J = 8.0 Hz, 2H), 7.38 (d, J = 8.0 Hz, 2H), 6.31 (br s, 
1H), 3.98 (d, J = 9.0 Hz, 2H), 2.90 (d, J = 9.0 Hz, 2H), 2.11 (t, J = 8.0 Hz, 1H), 1.94 (d, J = 
8.0 Hz, 2H), 1.14 (s, 6 H). 
13C NMR (CDCl3, 126 MHz): 175.7, 142.4, 128.6, 128.3 (q, JC-F = 32.8 Hz), 125.1 (q, JC-F = 
3.0 Hz), 123.8 (q, JC-F = 272 Hz), 61.2, 46.1, 22.8, 21.0, 20.2. The carbon resonances of the 
directing group (perfluoroarene, C7F7) appear as complex multiplets and are not listed. 
19F 
NMR and LC-MS were used to confirm characterization of structure.   
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19F NMR (CDCl3, 376 MHz): δ -56.3 (t, J = 22.2 Hz, 3F), -63.3 (s, 3F), -141.3 (m, 2F), -143.5 
(m, 2F). 
 
Compound (4):  
 
General procedure B was followed using 3 equiv 1-chloro-4-iodobenzene for 40 min (large 
scale) and isolated as a light yellow solid.  
Isolated Yield (large scale 1.04 mmol): 34% (183.1 mg)  
Rf: 0.44 (20% EtOAc/80% Hex) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C22H19ClF7N2O: 495.107; found: 495.167.  
1H NMR (CDCl3, 400 MHz): δ 7.25 (d, J = 8.4 Hz, 2H), 7.05 (d, J = 8.4 Hz, 2H), 6.41 (br s, 
1H), 2.90 (multiple peaks, 4H), 2.03 (t, J = 8.0 Hz, 1H), 1.87 (m, 2H), 1.15 (s, 6 H). 
13C NMR (CDCl3, 101 MHz): δ 175.9, 136.5, 132.0, 129.5, 128.3, 61.1, 45.1, 22.3, 21.0.    The 
carbon resonances of the directing group (perfluoroarene, C7F7) appear as complex multiplets 
and are not listed. 19F NMR and LC-MS were used to confirm characterization of structure.   
19F NMR (CDCl3, 376 MHz): δ -56.2 (t, J = 21.8 Hz, 3F), -141.2 (m, 2F), -143.1 (m, 2F). 
 
Compound (5):  
 
General procedures A and B were followed using 3 equiv 4-iodotoluene for 40 min (small 
scale) and 3 equiv 4-iodotoluene for 30 min (large scale) and isolated as a light yellow solid.  
Isolated Yield (small scale 0.52 mmol): 53% (130.0 mg)  
Isolated Yield (large scale 1.04 mmol): 79% (388.0 mg)  
Rf: 0.50 (20% EtOAc/80% Hex) 
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LC-MS: APCI+ (m/z): [M+H]+ calcd for C23H22F7N2O: 475.162; found: 475.131.  
1H NMR (CDCl3, 400 MHz): δ 7.18 (d, J = 8.0 Hz, 2H), 6.87 (d, J = 8.0 Hz, 2H), 6.44 (br s, 
1H), 2.97 (d, J = 9.2 Hz, 2H), 2.86 (dd, J = 9.2 Hz,  J = 2.0 Hz, J = 1.2 Hz, 2H), 2.02 (t, J = 
8.0 Hz, 1H), 1.99 (s, 3H), 1.83 (m, 2H), 1.13 (s, 6 H). 
13C NMR (CDCl3, 101 MHz): δ 176.2, 135.5, 134.9, 128.8, 128.0, 61.0, 45.1, 22.4, 20.9, 20.5, 
20.0. The carbon resonances of the directing group (perfluoroarene, C7F7) appear as complex 
multiplets and are not listed. 19F NMR and LC-MS were used to confirm characterization of 
structure.   
19F NMR (CDCl3, 376 MHz): δ -56.2 (t, J = 21.8 Hz, 3F), -141.8 (m, 2F), -142.7 (m, 2F). 
 
Compound (6):  
 
General procedure B was followed using 3 equiv 4-ethyliodobenzene for 30 min (large scale) 
and isolated as a light brown oil.  
Isolated Yield (large scale 1.04 mmol): 71% (360.0 mg)  
Rf: 0.52 (20% EtOAc/80% Hex) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C24H24F7N2O2: 489.178 ; found: 489.113.  
1H NMR (CDCl3, 400 MHz): δ 7.22 (d, J = 8.0 Hz, 2H), 6.91 (d, J = 8.0 Hz, 2H), 6.51 (br s, 
1H), 2.98 (d, J = 9.2 Hz, 2H), 2.85 (m, 2H), 2.27 (q, J = 7.6 Hz, 2H), 2.02 (t, J = 8.0 Hz, 1H), 
1.83 (m, 2H), 1.12 (s, 6 H), 0.95 (t, J = 7.6 Hz, 3H).  
13C NMR (CDCl3, 101 MHz): δ 176.3, 141.9, 135.3, 128.2, 127.6, 61.0, 45.2, 28.0, 22.5, 20.9, 
20.0, 14.9. The carbon resonances of the directing group (perfluoroarene, C7F7) appear as 
complex multiplets and are not listed. 19F NMR and LC-MS were used to confirm 
characterization of structure.   





Compound (7):  
 
General procedures A and B were followed using 3 equiv 4-iodoanisole for 40 min (small 
scale) and and 3 equiv 4-iodoanisole for 30 min (large scale). 1H and 19F NMR of the isolated 
product was consistent with literature values.2 
Isolated Yield (small scale 0.52 mmol): 60% (32.7 mg)  
Isolated Yield (large scale 1.04 mmol): 72% (365.4 mg)  
 
Compound (8):  
 
General procedure A was followed using 3 equiv 4-iodophenol for 40 min (small scale) and 
isolated as an off-white solid.  
Isolated Yield (small scale 0.52 mmol): 12% (30.5 mg)  
Rf: 0.66 (50% EtOAc/50% Hex) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C22H20F7N2O2: 477.141; found: 477.141.  
1H NMR (DMSO-d6, 400 MHz): δ 8.97 (s, 1H), 7.06 (d, J = 8.4 Hz, 2H), 6.56 (br s, 1H), 6.44 
(d, J = 8.4 Hz, 2H), 2.84 (m, 4H), 1.92 (t, J = 7.6 Hz, 1H), 1.79 (d, J = 7.6 Hz, 2H), 1.04 (s, 6 
H). 
13C NMR (DMSO-d6, 101 MHz): δ 175.4, 155.5, 128.8, 127.5, 114.7, 60.3, 44.6, 21.5, 20.8, 
19.6. The carbon resonances of the directing group (perfluoroarene, C7F7) appear as complex 
multiplets and are not listed. 19F NMR and LC-MS were used to confirm characterization of 
structure.   
19F NMR (CDCl3, 376 MHz): δ -55.3 (t, J = 21.4 Hz, 3F), -142.7 (m, 2F), -143.6 (m, 2F). 
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Compound (9):  
 
General procedures A and B were followed using 3 equiv 3-iodophenol for 40 min (small 
scale) and 2 equiv 3-iodophenol for 30 min (large scale). 1H and 19F NMR of the isolated 
product was consistent with literature values.2 
Isolated Yield (small scale 0.52 mmol): 62% (153.1 mg)  
Isolated Yield (large scale 1.04 mmol): 56% (278.0 mg)  
 
Compound (10):  
 
General procedures A and B were followed using 3 equiv 4-iodopyridine for 40 min (small 
scale) and 2 equiv 4-iodopyridine for 1 h 40 min (1 equiv at 0 min, then 1 equiv at 50 min, 
large scale) and isolated as a white solid.  
Isolated Yield (small scale 0.52 mmol): 18% (43.5 mg)  
Isolated Yield (large scale 1.04 mmol): 16% (76.9 mg), recovered 37% SM (144.7 mg)  
Rf: 0.40 (50% EtOAc/50% Hex) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C21H19F7N3O: 462.142; found: 462.123.  
1H NMR (CDCl3, 400 MHz): δ 8.36 (d, J = 5.2 Hz, 2H), 7.28 (d, J = 5.2 Hz, 2H), 6.34 (br s, 
1H), 2.98 (d, J = 9.2 Hz, 2H), 2.88 (d, J = 9.2 Hz, 2H), 2.07 (t, J = 4.4 Hz, 1H), 1.96 (m, 2H), 
1.14 (s, 6 H). 
13C NMR (CDCl3, 101 MHz): δ 175.3, 149.6, 147.2, 123.6, 61.2, 45.1, 22.2, 20.9, 20.0. The 
carbon resonances of the directing group (perfluoroarene, C7F7) appear as complex multiplets 
and are not listed. 19F NMR and LC-MS were used to confirm characterization of structure.   
19F NMR (CDCl3, 376 MHz): δ -56.1 (t, J = 21.8 Hz, 3F), -141.0 (m, 2F), -142.9 (m, 2F). 
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Compound (11):  
 
General procedures A and B were followed using 3 equiv 3-iodopyridine for small scale (40 
min) and 2 equiv 3-iodopyridine for 50 min (large scale) and isolated as an off-white solid. 
Isolated Yield (small scale 0.52 mmol): 58% (139.0 mg)  
Isolated Yield (large scale 1.04 mmol): 49% (234.8 mg)  
Rf: 0.39 (50% EtOAc/50% Hex) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C21H19F7N3O: 462.142; found: 462.130.  
1H NMR (CDCl3, 400 MHz): δ 8.58 (m, 1H), 8.28 (d, J = 4.4 Hz, 1H), 7.67 (d, J = 8.4 Hz, 1H),  
7.14 (dd, J =  7.6 Hz, J = 4.8 Hz, 1H), 6.31 (br s, 1H), 2.95 (d, J = 9.2 Hz, 2H), 2.90 (m,  2H), 
2.06 (t, J = 8.0 Hz, 1H), 1.95 (m, 2H), 1.12 (s, 6 H). 
13C NMR (CDCl3, 101 MHz): δ 175.1, 149.5, 147.5, 135.7, 133.7, 123.1, 61.2, 45.1, 20.8, 20.4, 
19.9. The carbon resonances of the directing group (perfluoroarene, C7F7) appear as complex 
multiplets and are not listed. 19F NMR and LC-MS were used to confirm characterization of 
structure.   
19F NMR (CDCl3, 376 MHz): δ -56.1 (t, J = 21.8 Hz, 3F), -141.2 (m, 2F), -142.8 (m, 2F). 
 
Compound (12):  
 
General procedures A and B were was followed using 2 equiv 2-iodopyridine for 40 min 
(small scale) and 2 equiv 2-iodopyridine for 1 h 40 min (1 equiv at 0 min, then 1 equiv at 50 
min, large scale) and isolated as an off-white solid.  
Isolated Yield (small scale 0.52 mmol): 28% (66.6 mg)  
Isolated Yield (large scale 1.04 mmol): 45% (217.4 mg)  
Rf: 0.16 (50% EtOAc/50% Hex) 
 110 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C21H19F7N3O: 462.142; found: 462.124.  
1H NMR (CDCl3, 400 MHz): δ 8.36 (dd, J = 4.8 Hz, J = 0.8 Hz, 1), 7.47 (dd, J = 7.6 Hz, J = 
1.6 Hz, 1H), 7.31 (dd, J = 7.6 Hz, J = 0.8 Hz, 1H), 6.98 (dd, J = 7.6 Hz, J = 4.8 Hz, 1H), 6.76 
(br s, 1H), 3.11 (d, J = 9.2 Hz, 2H), 2.87 (dd, J = 8.8 Hz, J = 1.6 Hz, 2H), 2.20 (t, J = 8.0 Hz, 
1H), 1.98 (m, 2H), 1.12 (s, 6 H). 
13C NMR (CDCl3, 126 MHz): δ 175.4, 158.6, 149.1, 135.9, 123.3, 121.2, 61.3, 45.3, 24.5, 20.8, 
20.5. The carbon resonances of the directing group (perfluoroarene, C7F7) appear as complex 
multiplets and are not listed. 19F NMR and LC-MS were used to confirm characterization of 
structure.   
19F NMR (CDCl3, 376 MHz): δ -56.1 (t, J = 21.8 Hz, 3F), -141.1 (m, 2F), -142.3 (m, 2F). 
 
Compound (13):  
 
General procedures A and B were followed using 2 equiv 2-fluoro-5-iodopyridine for 40 min 
(small scale) and 2 equiv 2-fluoro-5-iodopyridine for 50 min (large scale) and isolated as an 
off-white solid. 
Isolated Yield (small scale 0.52 mmol): 49% (123.0 mg)  
Isolated Yield (large scale 1.04 mmol): 42% (211.8 mg)  
Rf: 0.51 (50% EtOAc/50% Hex) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C21H18F8N3O: 480.132; found: 480.069.  
1H NMR (CDCl3, 400 MHz): δ 8.14 (m, 1H), 7.76 (td, J = 8.0 Hz, J = 2.4 Hz, 1H), 6.80 (dd, J 
= 8.4 Hz, J = 2.8 Hz, 1H), 6.49 (br s, 1H), 2.93 (s, 4H), 1.99 (multiple peaks, 3H), 1.15 (s, 6 
H). 
13C NMR (CDCl3, 101 MHz): δ 174.9, 162.3 (d, JC-F = 240 Hz), 146.7 (d, JC-F = 13.9 Hz), 
140.9 (d, JC-F = 7.4 Hz), 131.2 (d, JC-F = 4.6 Hz), 109.1 (d, JC-F = 37.3 Hz), 61.3, 45.2, 20.9, 
20.2, 19.6. The carbon resonances of the directing group (perfluoroarene, C7F7) appear as 
complex multiplets and are not listed. 19F NMR and LC-MS were used to confirm 
characterization of structure.   
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19F NMR (CDCl3, 376 MHz): δ -56.1 (t, J = 21.8 Hz, 3F), -70.6 (d, J = 7.5 Hz, 1F), -141.1 (m, 




General procedure B was followed using 2 equiv 2-chloro-5-iodopyridine for 50 min (large 
scale) and isolated as a yellow solid.  
Isolated Yield (large scale 1.04 mmol): 40% (206.6 mg)  
Rf: 0.46 (50% EtOAc/50% Hex) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C21H18 Cl1F7N3O: 496.103 ; found: 496.160.  
1H NMR (CDCl3, 500 MHz): δ 8.33 (m, 1H), 7.63 (ddd, J = 8.5 Hz, J = 2.5 Hz, J = 1.0 Hz, 
1H), 7.17 (d, J = 8.5 Hz, 1H), 6.41 (br s, 1H), 2.93 (m, 4H), 1.97 (multiple peaks, 3H), 1.16 (s, 
6 H). 
13C NMR (CDCl3, 126 MHz): δ 175.1, 149.5, 149.2, 138.5, 132.5, 123.8, 61.3, 45.1, 20.9, 20.0, 
19.7. The carbon resonances of the directing group (perfluoroarene, C7F7) appear as complex 
multiplets and are not listed. 19F NMR and LC-MS were used to confirm characterization of 
structure.   




General procedures A and B were followed using 2 equiv 2-chloro-3-iodopyridine for 40 min 
(small scale) and 2 equiv 2-chloro-3-iodopyridine for 50 min (large scale) and isolated as a 
white solid.  
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Isolated Yield (small scale 0.52 mmol): 25% (63.6 mg)  
Isolated Yield (large scale 1.04 mmol): 24% (124.0 mg)  
Rf: 0.59 (50% EtOAc/50% Hex) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C21H18 Cl1F7N3O: 496.103 ; found: 496.081.  
1H NMR (CDCl3, 500 MHz): δ 8.11 (dd, J = 4.5 Hz, J = 1.5 Hz, 1H), 7.76 (ddd, J = 7.5 Hz, J 
= 2.0 Hz, J = 1.0 Hz, 1H), 7.13 (dd, J = 7.5 Hz, J = 4.5 Hz, 1H), 6.46 (br s, 1H), 3.05 (d, J = 
9.5 Hz, 2H), 2.88 (m, 2H), 2.06 (multiple peaks, 3H), 1.14 (s, 6 H). 
13C NMR (CDCl3, 126 MHz): δ 175.0, 152.4, 147.6, 138.4, 133.4, 121.8, 61.3, 45.8, 21.6, 21.3, 
20.7. The carbon resonances of the directing group (perfluoroarene, C7F7) appear as complex 
multiplets and are not listed. 19F NMR and LC-MS were used to confirm characterization of 
structure.   




General procedures A and B were followed using 2 equiv 6-iodoquinoline for 40 min (small 
and large scale) and isolated as an off-white solid.  
Isolated Yield (small scale 0.52 mmol): 65% (174.0 mg)  
Isolated Yield (large scale 1.04 mmol): 31% (164.9 mg)  
Rf: 0.54 (50% EtOAc/50% Hex) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C25H21F7N3O: 512.157 ; found: 512.098.  
1H NMR (CDCl3, 400 MHz): δ 8.66 (dd, J = 4.0 Hz, J = 1.6 Hz, 1H), 7.97 (d, J = 8.8 Hz, 1H), 
7.86 (dd, J = 8.4 Hz, J = 0.8 Hz, 1H), 7.74 (dd, J = 8.8 Hz, J = 1.6 Hz, 1H), 7.68 (m, 1H), 7.09 
(dd, J = 8.0 Hz, J = 4.0 Hz, 1H), 5.98 (br s, 1H), 3.05 (d, J = 9.2 Hz, 2H), 2.93 (dd, J = 9.6 Hz, 
J = 1.2 Hz, 2H), 2.26 (t, J = 8.0 Hz, 1H), 1.99 (m, 2H), 1.12 (s, 6 H).  
13C NMR (CDCl3, 101 MHz): δ 175.7, 149.8, 146.7, 136.6, 134.7, 129.5, 127.7, 125.8, 120.8, 
60.9, 45.2, 22.7, 21.0, 20.3. The carbon resonances of the directing group (perfluoroarene, 
C7F7) appear as complex multiplets and are not listed. 
19F NMR and LC-MS were used to 
confirm characterization of structure.   
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19F NMR (CDCl3, 376 MHz): δ -56.3 (t, J = 21.8 Hz, 3F), -141.5 (m, 2F), -143.3 (m, 2F). 
 
4.4.4 General Procedure for Isolation of Amine and Amide Products after 
Directing Group Removal and Characterization 
General Procedure C for Removal of Directing Group: 
To a round bottom flask under a flow of nitrogen equipped with a stir bar was added the 
arylated product (1 equiv), 0.1 M SmI2 (12 equiv), anhydrous triethylamine (80 equiv), 
anhydrous methanol (40 equiv), and tris(N,N-tetramethylene)phosphoricacid triamide (5.5 
equiv) and allowed to stir at room temperature for 3 h. The reaction vessel was then exposed 
to atmosphere and formation of a white precipitate is observed within 30 minutes. The reaction 
was quenched with 1 N HCl. To the mixture was added ethyl acetate and the product was 
extracted into the aqueous acidic layer. The organic layer was set aside and the aqueous layer 
was basified with solid NaOH until a pH of 11-12. The aqueous layer was extracted with ethyl 
acetate (3x 100 mL) and dried over sodium sulfate. After volatiles were removed a viscous 
yellow oil remained that was purified by reverse-phase HPLC [Waters XBridge™ C-18 
column, 5 μm, 30×100 mm, flow rate 40 mL/minute, 5-100% gradient of acetonitrile in buffer 
(0.025 M aqueous ammonium bicarbonate, adjusted to pH 10 with ammonium hydroxide) (or 
0.1% TFA)]. 
 
General Procedure D for Removal of Directing Group via Boc Protection:  
To a round bottom flask under a flow of nitrogen equipped with a stir bar was added the 
arylated product (1 equiv), 0.1 M SmI2 (12 equiv), anhydrous triethylamine (80 equiv), 
anhydrous methanol (40 equiv), and tris(N,N-tetramethylene)phosphoricacid triamide (5.5 
equiv) and allowed to stir at room temperature for 3 h. The reaction vessel was then exposed 
to atmosphere and formation of a white precipitate is observed within 30 minutes. To the 
reaction at 0 ºC was added additional trimethylamine (140 equiv) and Boc2O (81 equiv) and 
allowed to stir overnight. To the reaction solution was added 1 M citric acid until pH 3-4. The 
reaction is extracted with DCM (3x, 50 mL). The organic layers were combined, washed with 
brine and dried over sodium sulfate. The volatiles were removed and the product was purified 
via flash column chromatography with EtOAc/Heptanes. To the isolated Boc protected amine 
was added HCl (dioxane, 4 M, 20 equiv) and allowed to stir overnight at room temperature. 
The product was purified by reverse-phase HPLC. 
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General Procedure E for Optimization of Removal of Directing Group via Acetylation: 
To a microwave tube (biotage, 0.2-0.5 mL vial) equipped with a stir bar was added the 1 (10 
mg, 0.022 mmol) and acetyl chloride (neat, 0.3 mL). The reaction was heated to 110 to 150 ºC 
for 1.5 to 10 hours in the microwave. The acetyl chloride was removed under reduced pressure 
and diluted with 0.5 mL of chloroform containing 0.011 mmol of trimethoxybenzene (from a 
stock solution of 18.5 mg in 5 mL chloroform) was added. The crude yield was obtained by 
quantitative 1H NMR spectroscopy in CDCl3.  
 
General Procedure F for Removal of Directing Group via Acetylation: 
To a microwave tube (biotage, 2-5 mL vial) equipped with a stir bar was added the arylated 
product (0.217 mmol, 1 equiv) and acetyl chloride (neat, 3.0 mL). The reaction was heated to 
150 ºC for 3 hours. The acetyl chloride was removed under reduced pressure and the product, 
diluted in DCM (10 mL) and added 1 M NaOH (10 mL). The product was extracted with DCM 
(2 x 10 mL). The volatiles were removed en vacuo and the product was purified by reverse-
phase HPLC. 
 
Compound (17):  
 
General procedure C was followed using 17 (0.216 mmol, 100 mg) and isolated by reverse-
phase HPLC as the TFA amine salt (off-white solid). 
Isolated Yield: 93% yield (55.3 mg) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C11H15N: 162.120; found: 162.108.  
1H NMR (CDCl3, 500 MHz): δ 9.55 (br s, 1H), 9.11 (br s, 1H), 7.33 (t, J = 7.5 Hz, 2H), 7.25 
(m, 1H), 7.21 (d, J = 7.5 Hz, 2H), 3.53 (d, J = 12.5 Hz, 2H), 3.02 (d, J = 11.0 Hz, 2H), 2.76 
(m, 1H), 2.04 (m, 4H). 








General procedure C was followed using 1 (0.272 mmol, 125 mg) and isolated by reverse-
phase HPLC as the TFA amine salt (off-white solid). 
Isolated Yield: 34% yield (25.4 mg) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C11H14N: 160.113 ; found: 160.069. 
1H NMR (CDCl3, 400 MHz): δ 12.48 (br s, 1H), 7.42 (t, J = 8.0 Hz, 2H), 7.36 (t, J = 8.0 Hz, 
1H), 7.24 (d, J = 8.0 Hz, 2H), 4.73 (br s, 1H), 3.64 (d, J = 12.4 Hz, 2H), 3.32 (d, J = 12.4 Hz, 
2H), 2.46 (t, J = 8.0 Hz, 1H), 2.22 (m, 2H).  




General procedure C was followed using 2 (0.408 mmol, 195 mg) and isolated by reverse-
phase HPLC as the TFA amine salt (off-white solid). 
Isolated Yield: 49% yield (57.9 mg) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C11H13FN: 178.103 ; found: 178.069.  
1H NMR (CDCl3, 400 MHz): δ 10.85 (br s, 1H), 7.19 (t, J = 8.4 Hz, 2H), 7.08 (t, J = 8.4 Hz, 
2H), 5.94 (br s, 1H), 3.58 (d, J = 11.2 Hz, 2H), 3.30 (d, J = 11.2 Hz, 2H), 2.39 (t, J = 8.0 Hz, 
1H), 2.22 (m, 2H). 
13C NMR (CDCl3, 101 MHz): δ 162.6 (d, JC-F = 249 Hz), 131.2 (d, JC-F = 8.1 Hz), 127.2 (d, JC-
F = 3.0 Hz), 116.9 (d, JC-F = 22.2 Hz), 45.0, 23.3. 22.0. 





Compound (3-A):  
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General procedure C was followed using 3 (0.848 mmol, 448 mg) and isolated by reverse-
phase HPLC as the TFA amine salt (off-white solid). 
Isolated Yield: 44% (128.4 mg) 
LC-MS: APCI+ (m/z): [M+H]+ calcd for C12H13F3N: 228.100 ; found: 227.994 
1H NMR (CDCl3, 500 MHz): δ 11.07 (br s, 1H), 7.66 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 
2H), 6.26 (br s, 1H), 3.58 (d, J = 12.5 Hz, 2H), 3.29 (d, J = 12.5 Hz, 2H), 2.48 (t, J = 8.5 Hz, 
1H), 2.28 (m, 2H). 
13C NMR (CDCl3, 126 MHz): δ 135.8, 130.6 (d, JC-F = 32.8 Hz), 130.1, 126.7 (d, JC-F = 3.7 
Hz) Hz), 123.9 (d, JC-F = 273 Hz), 44.8, 24.2, 22.2.  
19F NMR (CDCl3, 376 MHz): -63.0 (s, 3F), -75.9 (s, 3F).  
 
Compound (5-A):  
 
General procedure C was followed using 5 (0.769 mmol, 365 mg) and isolated by reverse-
phase HPLC as the TFA amine salt (light brown solid).  
Isolated Yield: 49% (109.0 mg)  
LC-MS: APCI+ (m/z): [M+H]+ calcd for C12H16N: 174.128 ; found: 174.194.  
1H NMR (CDCl3, 400 MHz): δ 12.35 (br s, 1H), 7.22 (d, J = 7.6 Hz, 2H), 7.12 (d, J = 8.0 Hz, 
2H), 4.52 (br s, 1H), 3.63 (m, 2H), 3.32 (dd, J = 12.0 Hz, J = 3.2 Hz, 2H), 2.41 (t, J = 8.4 Hz, 
1H), 2.35 (s, 3H), 2.20 (m, 2H). 





Compound (6-A):  
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General procedure C was followed using 6 (0.588 mmol, 287 mg) and isolated by reverse-
phase HPLC as the TFA amine salt (off-white solid). 
Isolated Yield: 39% (69.0 mg)  
LC-MS: APCI+ (m/z): [M+H]+ calcd for C13H18N: 188.144 ; found: 188.312.  
1H NMR (CDCl3, 400 MHz): δ 11.47 (br s, 1H), 7.23 (d, J = 8.0 Hz, 2H), 7.14 (d, J = 8.0 Hz, 
2H), 5.02 (br s, 1H), 3.60 (m, 2H), 3.32 (dd, J = 12.0 Hz, J = 4.4 Hz, 2H), 2.64 (q, J = 7.6 Hz, 
2H), 2.41 (t, J = 8.4 Hz, 1H), 2.20 (m, 2H), 1.22 (t, J = 7.6 Hz, 3H). 
13C NMR (CDCl3, 101 MHz): δ 144.7, 129.4, 129.2, 128.8, 45.4, 28.4, 23.1, 21.5, 15.2.  
 
Compound (7-A):  
 
General procedure C was followed using 7 (0.367 mmol, 180 mg) and isolated by reverse-
phase HPLC as the TFA amine salt (off-white solid). 
Isolated Yield: 51% yield (56.7 mg)  
LC-MS: APCI+ (m/z): [M+H]+ calcd for C12H16NO: 190.123 ; found: 190.153.  
1H NMR (CDCl3, 400 MHz): δ 10.85 (br s, 1H), 7.13 (d, J = 8.4 H, 2H), 6.91 (d, J = 8.4 Hz, 
2H), 5.38 (br s, 1H), 3.78 (s, 3H), 3.56 (m, 2H), 3.32 (dd, J = 11.6 Hz, J = 3.6 Hz, 2H), 2.36 (t, 
J = 8.4 Hz, 1H), 2.17 (m, 2H). 






Compound (9-A):  
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General procedure D was followed using 9 (0.301 mmol, 143 mg) and isolated by reverse-
phase HPLC as the free amine (light brown solid). 
Isolated Yield: 38% over two steps (20.1 mg)  
LC-MS: APCI+ (m/z): [M+H]+ calcd for C11H14NO: 176.108 ; found: 176.304.  
1H NMR (CDCl3, 500 MHz): δ 7.12 (t, J = 8.0 Hz, 1H), 6.71 (d, J = 8.0 Hz, 1H), 6.56 (multiple 
peaks, 2H), 2.99 (s, 4H), 2.05 (t, J = 8.5 Hz, 1H), 1.82 (d, J = 8.5 Hz, 2H). NH and OH peak 
not present 
13C NMR (CDCl3, 126 MHz): δ 157.6, 137.6, 130.0, 119.5, 115.6, 114.3, 46.7, 22.6, 22.0. 
 
Compound (1-B):  
 
General procedure F was followed using 1 (0.217 mmol, 100 mg) and isolated by reverse-
phase HPLC as a light brown oil.  
Isolated Yield: 25% yield (11 mg)  
LC-MS: APCI+ (m/z): [M+H]+ calcd for C13H16NO: 202.123 ; found: 202.153.  
1H NMR (CDCl3, 400 MHz): δ 7.30 (t, J = 7.6 Hz, 2H), 7.21 (multiple peaks, 3H), 4.92 (d, J 
= 12.4 Hz, 1H), 3.59 (dd, J = 11.0, 4.0 Hz, 1H), 3.32 (d, J = 11.0 Hz, 1H), 3.39 (dd, J = 12.4, 
4.0 Hz Hz, 1H), 2.23 (t, J = 8.0 Hz, 1H), 1.97 (m, 2H), 1.47 (s, 3H). Hindered rotation of acetyl 
group breaks symmetry of molecule 





Compound (4-B):  
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General procedure F was followed using 4 (0.217 mmol, 107 mg) and isolated by reverse-
phase HPLC as a light yellow oil.  
Isolated Yield: 26% yield (13.2 mg)  
LC-MS: APCI+ (m/z): [M+H]+ calcd for C13H15ClNO: 236.084 ; found: 236.162.  
1H NMR (CDCl3, 400 MHz): δ 7.28 (d, J = 8.0 Hz, 2H), 7.14 (d, J = 8.0 Hz, 2H), 3.89 (d, J = 
12.4 Hz, 1H), 3.62 (dd, J = 11.0, 4.0 Hz, 1H), 3.45 (d, J = 11.0 Hz, 1H), 3.42 (dd, J = 12.4, 4.0 
Hz Hz, 1H), 2.17 (t, J = 8.0 Hz, 1H), 1.99 (m, 2H), 1.55 (s, 3H). Hindered rotation of acetyl 
group breaks symmetry of molecule 
13C NMR (CDCl3, 101 MHz): δ 169.3, 132.8, 132.2, 130.1, 128.7, 46.7, 44.7, 21.9, 21.6, 20.7, 
20.1. 
 
Compound (10-B):  
 
General procedure F was followed using 10 (0.217 mmol, 100 mg) and yield was below 
threshhold for collection.   
 
Compound (11-B):  
 
General procedure F was followed using 11 (0.217 mmol, 100 mg) and isolated by reverse-
phase HPLC as the free pyridine (yellow oil).  
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Isolated Yield: 19% yield (8.4 mg)  
LC-MS: APCI+ (m/z): [M+H]+ calcd for C12H15N2O: 203.118 ; found: 203.334. 
1H NMR (CDCl3, 400 MHz): δ 8.51 (s, 1H), 8.46 (d, J = 4.8 Hz, 1H), 7.54 (d, J = 7.6, 1H), 
7.24 (dd, J = 7.6,  4.8 Hz, 1H), 3.84 (d, J = 12.4 Hz, 1H), 3.63 (dd, J = 11.2, 4.0 Hz, 1H), 3.47 
(d, J = 11.2 Hz, 1H), 3.41 (dd, J = 12.4, 4.0 Hz, 1H), 2.18 (t, J = 8.0 Hz, 1H), 2.03 (multiple 
peaks, 2H), 1.50 (s, 3H). Hindered rotation of acetyl group breaks symmetry of molecule 
13C NMR (CDCl3, 101 MHz): δ 168.3, 150.1, 148.1, 136.4, 129.9, 123.5, 46.6, 44.3, 22.0, 20.7, 
19.9, 19.7.  
 
Compound (12-B):  
 
General procedure F was followed using 12 (0.217 mmol, 100 mg) and isolated by reverse-
phase HPLC as the pyridine TFA salt (colorless oil). 
Isolated Yield: 22% yield (15.1 mg)  
LC-MS: APCI+ (m/z): [M+H]+ calcd for C12H15N2O: 203.118 ; found: 203.219. 
1H NMR (CD3CN, 500 MHz): δ  8.75 (dd, J = 5.5, 0.5 Hz, 1H), 8.32 (td, J = 8.0, 1.5 Hz, 1H), 
7.75 (multiple peaks, 2H), 3.81 (d, J = 12.5 Hz, 1H), 3.64 (multiple peaks, 2H), 3.27 (dd, J = 
12.5, 4.0 Hz, 1H), 2.48 (t, J = 8.0 Hz, 1H), 2.20 (m, 1H), 2.15 (m, 1H), 1.44 (s, 3H). Hindered 
rotation of acetyl group breaks symmetry of molecule 
13C NMR (CD3CN, 126 MHz): δ 169.2, 152.5, 145.8, 143.5, 128.1, 125.7, 46.9, 44.6, 22.9, 








Compound (13-B):  
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General procedure F was followed using 13 (0.217 mmol, 104 mg) and SNAr was observed 
on the pyridine. Unable to isolate each product cleanly.   
 
Compound (14-B):  
 
General procedure F was followed using 14 (0.217 mmol, 108 mg) and isolated by reverse-
phase HPLC as the pyridine TFA salt (light yellow oil).  
Isolated Yield: 16% yield (11.8 mg)  
LC-MS: APCI+ (m/z): [M+H]+ calcd for C12H14ClN2O: 237.079 ; found: 237.103.  
1H NMR (CDCl3, 500 MHz): δ 8.29 (d, J = 1.0 Hz, 1H), 7.52 (ddd, J = 8.0, 2.5, 1.0 Hz, 1H), 
7.29 (d, J = 8.0 Hz, 1H), 3.81 (d, J = 12.5 Hz, 1H), 3.67 (dd, J = 11.0, 4.5 Hz, 1H), 3.46 (d, J 
= 11.0 Hz, 1H), 3.45 (dd, J = 12.5, 4.5 Hz, 1H), 2.15 (t, J = 8.0, 1H), 2.09 (m, 1H), 2.05 (m, 
1H), 1.59 (s, 3H). Hindered rotation of acetyl group breaks symmetry of molecule 
13C NMR (CDCl3, 126 MHz): δ 169.0, 149.9, 149.7, 139.3, 128.9, 124.4, 46.6, 44.4, 21.9, 20.8, 
19.8, 19.3.  
 
Compound (15-B):  
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General procedure F was followed using 15 (0.217 mmol, 108 mg) and isolated by reverse-
phase HPLC as the pyridine TFA salt (colorless oil).  
Isolated Yield: 12% yield (9.0 mg)  
LC-MS: APCI+ (m/z): [M+H]+ calcd for C12H14ClN2O: 237.079 ; found: 236.918. 
1H NMR (CDCl3, 400 MHz): δ 8.29 (d, J = 4.8 Hz, 1H), 7.61 (d, J = 7.2 Hz, 1H), 7.19 (dd, J 
= 7.6, 4.8 Hz, 2H), 4.05 (d, J = 13.2 Hz, 1H), 3.61 (dd, J = 11.2, 4.4 Hz, 1H), 3.44 (m, 2H) 
2.15 (multiple peaks, 3H), 1.52 (s, 3H). Hindered rotation of acetyl group breaks symmetry of 
molecule 





General procedure F was followed using 16 (0.217 mmol, 111 mg) and isolated by reverse-
phase HPLC as the pyridine TFA salt (colorless oil).  
Isolated Yield: 23% yield (18.1 mg)  
LC-MS: APCI+ (m/z): [M+H]+ calcd for C16H17N2O: 253.134 ; found: 253.137.  
1H NMR (CDCl3, 500 MHz): δ 9.18 (d, J = 5.0 Hz, 1H), 8.73 (d, J = 8.0 Hz, 1H), 8.53 (d, J = 
9.0 Hz, 1H), 7.93 (m, 1H), 7.91 (d, J = 9.0 Hz, 1H), 8.83 (dd, J = 8.0, 5.0 Hz 1H), 4.03 (d, J = 
12.4 Hz, 1H), 3.71 (dd, J = 11.5, 4.5 Hz, 1H), 3.50 (multiple peaks, 2H), 2.46 (m, 1H), 2.20 
(m, 1H), 1.40 (s, 3H). Hindered rotation of acetyl group breaks symmetry of molecule 
13C NMR (CDCl3, 126 MHz): δ 169.2, 144.5, 144.1, 138.7, 136.9, 135.6, 129.0, 127.6, 122.8, 
121.6, 46.7, 44.5, 22.5, 21.7, 21.3, 20.4. 
 
4.4.5 Synthesis and Characterization of Products of C(α)–H Arylation  
General Procedure C for Microwave Reactions for C(α)-H Arylation17: 
Using modified conditions from reference 17, to a large biotage microwave tube (biotage, 10-
20 mL) equipped with a stir bar was added Pd(TFA)2 (43.5 mg, 0.13 mmol, 10 mol %), 
potassium bicarbonate (262 mg, 2.62 mmol, 2 equiv), aryl boronic acid (2.62 mmol, 2 equiv), 
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benzoquinone (283 mg, 2.62 mmol, 2 equiv), S-3 (240 mg, 1.31 mmol, 1 equiv), and 9.0 mL 
of wet tert-amyl alcohol. The microwave tube was heated with following parameters: 1 min 
pre-stirring, followed by a ramp (Normal) to 200 °C and held at temperature for 60 min. The 
tert-amyl alcohol was removed en vacuo and the remaining residue dissolved with EtOAc and 
filtered through a plug of celite and concentrated en vacuo. The crude reaction was product 
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Ligand Effects on Palladium-Catalyzed, Remote C(sp3)‒H 
Arylation of Cyclic Amines1
 
5.1. Introduction 
Cyclic and bicyclic amines appear in a variety of natural products and bioactive 
molecules. Over 59% of FDA approved pharmaceuticals contain a nitrogen heterocycle.2 More 
importantly, over 20% of the top 200 pharmaceuticals contain an alicyclic amine.3 These drugs 
include those utilized for the treatment of depression, pain, nicotine addiction, and Parkinson’s 
disease, as well as many other illnesses (Figure 5.1). As such, methods for the C‒H 
functionalization of such heterocyclic cores are highly desired in order to facilitate SAR 
studies. While many strategies exist for C(α)‒H functionalization4, far fewer methods exist for 
the remote C‒H functionalization of aliphatic amines (see Chapter 1 for more detail).5,6,7,8,9 We 
viewed this as an opportunity to develop methods to access the distal C‒H bonds in cyclic 
amine scaffolds. 
Figure 5.1. Cyclic Amines in Natural Products and Bioactive Molecules 
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Recent work from our laboratory demonstrated the Pd-catalyzed remote C‒H arylation 
of a variety of alicyclic amines (Scheme 5.1).10 In this system, coordination of Pd to the amine 
nitrogen and the perfluoroamide directing group enables transannular C‒H arylation. 
Reactivity was first demonstrated on a model system containing the conformationally rigid 3-
azabicylco[3.1.0]hexane (explored for fragment synthesis in Chapter 4). High yields of remote 
C‒H arylation products were achieved with catalytic Pd(OAc)2, aryl iodide, and cesium 
pivalate. Under analogous conditions with excess aryl iodide (neat conditions), the arylation of 
piperidine and variety of bicyclic amine cores was achieved (Scheme 5.1). 
 
Scheme 5.1. First Generation Pd-Catalyzed C(sp3)–H Arylation of Alicyclic Amines 
 
 
In addition to demonstrating practical applications of the C‒H arylation methodology 
(Chapter 4), we also sought to address key limitations of the first-generation protocol by 
increasing yields (many of the bicyclic substrates provided arylated products in <50% yield) 
and expanding the substrate scope to include less reactive classes of bioactive 
azabicycloalkanes such as the tropane, 7-azanorbornane, and homotropane cores (Figure 
5.1). Furthermore, we were also interested in incorporating additional functional groups at 
remote C‒H sites by varying nucleophiles and/or oxidants.  
At the onset of our studies in Chapter 5, we hypothesized that the low to modest yields 
with the first-generation system might be due to one or more of the following: (1) high 
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activation barriers for C‒H activation, (2) formation of inactive Pd species via reversible (e.g., 
product inhibition) and/or (3) irreversible off-cycle pathways (e.g., palladium black). Thus, we 
hypothesized that the addition of ligands could be used to increase reaction yields and expand 
the substrate scope. Previous work from our group demonstrated that the addition of ligands 
can have dramatic impacts on reaction rates and modulate selectivity in other C–H 
functionalization reactions.11 Additionally, other groups have successfully utilized ligands in 
the context of Pd(II)-catalyzed C‒H functionalization to (1) enable or improve selectivity 
(stereoselectivity, Scheme 5.2a)12 (2) enhance reaction rates (Scheme 5.2b)13 and (3) prevent 
catalyst decomposition (Scheme 5.2c)14 and/or inhibition.15,16  
 




This chapter outlines our use of ligands to address shortcomings associated with our 
first-generation method for the transannular C‒H arylation of alicyclic amines. These efforts 
led to the discovery of important ligand effects with pyridine-carboxylate and quinoline-
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carboxylate ligands that lead to improved yields and substrate scope. To probe the role of the 
ligand, a series of mechanistic experiments were employed to elucidate the role of ligand 
potential involvement in C‒H activation, product inhibition and/or catalyst decomposition. 
Together these investigations strongly suggest the ligand serves to enhance catalyst longevity 
and to restore the activity of deactivated Pd species. Portions of Chapter 5 were completed in 
collaboration with Dr. Pablo Cabrera and Michael Bellas.1,17  
5.2. Results and Discussion 
Ligand Effects and Reaction Optimization 
Our initial studies focused on the benzo-fused 3-azabicyclo[3.2.1.]octane scaffold (S1), 
which is an important bicyclic core present in Pfizer’s smoking cessation drug vareniciline and 
in isotropane alkaloids (explored for cocaine addiction).18 The first generation conditions 
required temperatures of 150 ºC and neat phenyl iodide to achieve product 1a in 46% yield 
(Table 5.1, entry 1). We started by utilizing pyridine-based ligands L1-L5, which have been 
shown previously by our group and others to accelerate the C‒H acetoxylation of arenes (by 
altering catalyst resting state) and to enhance site selectivity in Pd-catalyzed arene C–H 
functionalization.11 While these ligands did not lead to improved yields, we were encouraged 
that their presence did not shut down reactivity (Table 5.1, entries 2-6).  
We next hypothesized that if product inhibition was leading to low yields, the use of 
bidentate ligands could facilitate product dissociation more readily. Gratifyingly, the use of L6 
led to an ~10% increase in yield, and the use of L7-L9 further improved the yield of 1a. The 
pyridine-carboxylate and quinoline-carboxylates L8 and L9 provided the most promising 
improvements (Table 5.1). With 5-10 mol% ligand loading, they provided comparable yields 






Table 5.1. Evaluation of Ligands for the C‒H Arylation of Compound S1 
 
 
entry ligand L (mol %) conversion S-1 yield 1a 
1 -- -- 68% 46% 
2 L1 5 68% 44% 
3 L2 5 73% 47% 
4 L3 5 68% 43% 
5 L4 5 68% 40% 
6 L5 5 75% 46% 
7 L6 5 80% 56% 
8 L7 5 96% 68% 
9 L8 5 >99% 80% 
10 L8 10 >99% 78% 
11 L8 20 26% 24% 
12 L9 5 >99% 77% 
13 L9 10 >99% 77% 
14 L9 20 >99% 85% 
(82%)b 
a Conditions: S1 (0.03 mmol, 1 equiv), Pd(OAc)2 (10 mol %), ligand (5-20 mol%), CsOPiv (3 equiv), PhI (30 
equiv), 150 ºC. Calibrated GC yields for 1a. b Isolated yield of 1a 
 
We conducted further optimization with L9 and found that both temperature and 
equivalents of phenyl iodide could be significantly lowered in the presence of t-amylOH as 
solvent, while still providing high yields of 1a and good mass balance (Table 5.2). This led to 
the optimized conditions shown in entry 8, which were conducted at 100 ºC and with 3 equiv 
of phenyl iodide (Table 5.2). A high yield of 1a was maintained with 5 mol % L8, while a 
control reaction with no ligand under these conditions afforded a significantly lower yield of 
29% (Table 5.2, entry 9 and 10 respectively).  
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Table 5.2. Optimization Table for Compound S1 with L9 
 
 
entry temp. solvent Ph–I (equiv) yield 2a conv. 
1 150 ºC neat 30 77% > 99% 
2 120 ºC neat 30 60% 74% 
3 120 ºC tAmylOH 30 87% > 99% 
4 120 ºC tAmylOH 15 85% > 99% 
5 120 ºC tAmylOH 3 87% > 99% 
6 120 ºC tAmylOH 1 79% 95% 
7 110 ºC tAmylOH 3 86% > 98% 
8 100 ºC tAmylOH 3 84% 95% 
9b 100 ºC tAmylOH 3 85% 96% 
10c 100 ºC tAmylOH 3 29% 42% 
a Conditions: S1 (0.03 mmol, 1 equiv), Pd(OAc)2 (10 mol %), quinaldic acid (5 mol %) CsOPiv (3 equiv), PhI 
(1-30 equiv), 100-150 ºC. Calibrated GC yields for 1a. b Ligand: picolinic acid (5 mol%). c No ligand additive. 
 
Application of Ligand Conditions to the Arylation of Alicyclic Amines 
Encouraged by the ligand-effects observed for the C‒H arylation S1, we examined the 
application of ligands to previously reported substrates, including alicyclic amines that 
provided both good and low yields (Figure 5.2).10 In many cases, we observed that the addition 
of L8 greatly improved the yields of poorly performing substrates such as S2-S6. In the case 
of 2 and 5 an approximate two-fold increase in the yield was observed. While S7 and S8 
performed similarly to ligand-free conditions, it is important to note that the addition of L8 
was not detrimental to the final yield after 18 h. The C–H arylation of the anti-depressant drug, 
amitifidine, led to a 10% increase in the yield of product 9. We were pleased that a simple 
adjustment to our previous protocol could lead to dramatically increased yields. Next, we 





Figure 5.2. Demonstrating Ligand Effects on Previously Reported Substrates10 
 
 
a Reaction conditions in ref. 10 with L8 (5 mol%) b Reported yield in ref. 10 
More specifically, we were interested in tropane and other azabicycloalkaloids 
containing substitution at the carbon adjacent to the nitrogen atom. These scaffolds have shown 
promise as treatments for cocaine addiction, pain, and Parkinson’s disease.19 Under our first-
generation conditions with neat aryl iodide, a significant amount of S10 (>50%) remained after 
18 h, and only trace amounts of arylated product 10a was observed by GC (<5% yield, 
uncalibrated, Scheme 5.3).  
Scheme 5.3. Arylation of Tropane under First Generation Conditions 
 
As such, we conducted optimization studies with S10 and found that the addition of 
ligand L8 led to high conversions of S10 and greatly improved yields of the C-3 arylated 
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product 10a (Table 5.5 in experimental). Attempts to run the reaction with lower equivalents 
of phenyl iodide and solvent led to lower conversion and decreased formation of 10. With these 
conditions in hand, a variety of aryl iodides with heteroatom functionality could be coupled in 
moderate to good yields (Figure 5.3, 10b-10k).  
Figure 5.3. Scope of Aryl Iodide Functionalization of the Tropane Core with Picolinic Acid 
 
 
Reaction conditions: substrate S10 (0.1 mmol, 1 equiv), Pd(OAc)2 (0.01 mmol, 10 mol %), CsOPiv (0.3 mmol, 3 
equiv), L8 (0.005 mmol, 5 mol%), neat Ar–I, 140 ºC, 18 h. Isolated yields. See details in experimental section. 
We did observe that the use of neat aryl iodide led to incompatibilities with the Pd 
catalyst and difficulties with product isolation in some cases. For example, 4-iodobenzonitrile 
afforded poor results, presumably due to competing coordination of the cyano functional group 
present in solvent quantities to Pd. Similarly, poor reactivity was observed with 3-hydroxy 
iodobenzene, as well as 2-iodothiophene, 3-iodopyridine and 2-fluoro-3-iodopyridine. In 
contrast, 4-iodoacetophenone did afford the desired C-3 arylation product, as observed by GC-
MS. However, all attempts to purify this product away from other minor side-products as well 
 134 
as from the aryl iodide by silica gel chromatography were unsuccessful, and thus the product 
was not pursued further. Future studies should focus on efforts to lower the equivalents of aryl 
iodide, which should enable the incorporation of more coordinating functional groups and 
should also facilitate isolation of functionalized products. 
We also synthesized two tropane derivatives, S11 and S12, which underwent arylation 
smoothly, demonstrating tolerance for functionality (desaturation and substitution) (Figure 
5.4). The protected azabicyclo[3.3.1]nonane, led to good yields of 13, while preserving the 
ketal protecting group. In the case of the azabicyclo[2.2.1]heptane, the core of epibatidine, 
monoarylated product 14 was isolated in 42% yield.20  
Figure 5.4. Scope of Azabicycloalkanes with L8 
 
Reaction conditions: substrate S11-S14 (0.1 mmol, 1 equiv), Pd(OAc)2 (0.01 mmol, 10 mol %), CsOPiv (0.3 
mmol, 3 equiv), L8 (0.005 mmol, 5 mol%), neat 4-iodoanisole, 140 ºC, 18 h.  
 
Mechanistic Studies to Probe Ligand Effects 
Following our studies on reaction scope with L8 and L9, we sought to understand the 
role of ligand in improving these reactions. Based on the enhanced yields of arylated product, 
we hypothesized that the ligand could be serving multiple roles within the catalytic cycle. These 
could be divided into two general roles: (1) the ligand could be bound to the Pd catalyst during 
key steps of the catalytic cycle and thus enhance the rate and/or selectivity and/or (2) the ligand 
could bind to the Pd catalyst at points outside of the catalytic cycle to prevent reversible or 
irreversible catalyst deactivation, including pathways such as product inhibition, formation of 
other off-cycle Pd-intermediates, or formation of Pd black. To probe which role(s) the ligand 
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was playing in the reaction, we carried out a series of mechanistic studies to study the C‒H 
activation step, possible product inhibition, and possible catalyst decomposition.  
We began by quantifying the initial rate associated with product formation from S1 with 
and without the presence of L9. Based on the two-fold increase in rate with 5 mol% L9 
(kobs,ligand-free = 6.2x10
-4 M‧s-1 and kobs,L9 = 1.3x10
-3 M‧s-1), we hypothesized that the ligand could 
be lowering the barrier for the rate determining step (RDS) in the reaction (Figure 5.5). 
Unpublished preliminary KIE studies from our laboratory with S7 indicated that C‒H 
activation is likely the RDS. Furthermore, recent DFT calculations from the Zimmerman group 
concluded that C‒H activation is turnover limiting and has the highest relative barrier of all the 
computed steps for the activation and functionalization of S7.21  
Figure 5.5. Initial Rates of S1 with and without L9 
 
Conditions red curve: S1 (0.03 mmol, 1 equiv, 0.12 M), Pd(OAc)2 (0.012 M), CsOPiv (0.36 M), PhI (0.36 M), 
L9 (0.006 M), 0.25 mL tAmylOH, 100 ºC. Conditions blue curve: S1 (0.03 mmol, 1 equiv, 0.12 M), Pd(OAc)2 
(0.012 M), CsOPiv (0.36 M), PhI (0.36 M), 0.25 mL tAmylOH, 100 ºC.  
y = 0.0006x - 0.0016
R² = 0.991























This led us to question whether the ligand was intimately involved in the C‒H activation 
step of S1 under our second-generation conditions. To probe this possibility, we synthesized 
d5-S1 by following a published route by Pfizer Global Research and Development in Groton, 
CT.22 The procedure was modified to include deuteration steps early in the synthesis to arrive 
at the final product d5-S1 (see experimental for more detail). According to Simmons and 
Hartwig, independent rate studies with proteo- and deutero- substrates can provide conclusive 
data on whether C‒H bond cleavage is turnover limiting.2324 First, we obtained the initial rates 
for the formation of 1a and d5-1a from S1 and d5-S1 under standard conditions without ligand 
and observed a primary KIE of 3.3. With the addition of 5 mol % L9, we observed an extremely 
similar primary KIE value of 3.2 (Scheme 5.4). Together, these experiments demonstrate that 
C‒H bond activation is rate limiting both with and without ligand. Furthermore, because the 
value of the primary KIE is essentially the same under both conditions, it also suggests that L9 
does not significantly alter the transition state of the C‒H bond activation step.25  
Scheme 5.4. Kinetic Isotope Effect for S1 and d5-S1 with and without L9 
 
 
Next, we were interested in examining possible catalyst deactivation pathways. To this 
end, we conducted an extended reaction profile of S1 without ligand and observed that the 
reaction stalls after 480 min, reaching a maximum 29% yield of 1a (0.035 M). In contrast, the 
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reaction with 5 mol % L9 displays a higher rate of arylation over the course of the time study 
and does not stall, providing a final yield of 84% (Figure 5.6). Based on these results, we 
hypothesized that the formation of product could be leading to reaction inhibition and that the 
strongly coordinating L9 could be facilitating the exchange of 1a for S1 on the Pd catalyst.  
Figure 5.6. Reaction Profile of S1 with and without L9 
 
Conditions red curve: S1 (0.03 mmol, 1 equiv, 0.12 M), Pd(OAc)2 (0.012 M), CsOPiv (0.36 M), PhI (0.36 M), 
L9 (0.006 M), 0.25 mL tAmylOH, 100 ºC. Conditions blue curve: S1 (0.03 mmol, 1 equiv, 0.12 M), Pd(OAc)2 
(0.012 M), CsOPiv (0.36 M), PhI (0.36 M), 0.25 mL tAmylOH, 100 ºC.  
To probe the possibility of product inhibition, we conducted two sets of experiments 
that involved addition of 1b at the onset of the reaction. This allowed us to differentiate between 
the product 1b added initially and product 1a formed during the reaction. By conducting the 
reaction to low conversions, we could determine whether the presence of 1b impacts the 
formation of 1a.15 As shown in Table 5.3, the addition of 1b (0.1 – 0.75 equiv relative to S1) 
did not impact the yield of 1a at this early time point (45 min). Similarly, with the addition of 
5 mol % L9, the yield of 1a remained unaffected by the presence of 1b. Initial rates studies of 
the reaction of S1 in the presence and absence of added 1b corroborated the data in Table 5.3 


















inhibition is most likely not occurring during the C‒H arylation of S1. However, we still lacked 
a good explanation for the difference in initial rates upon the addition of L9 (Figure 5.5) as 
well as for the higher yields of 1a at early time points (Table 5.3). This warranted further 
investigation into additional catalyst deactivation pathways. 










(5 mol % L9)b 
1 0 0 13% 28% 
2 0.012 0.1 13% 29% 
3 0.03 0.25 13% 30% 
4 0.06 0.50 13% 28% 
5 0.09 0.75 11% 28% 
a Conditions: 1 (0.03 mmol, 1 equiv, 0.12 M), 2b (0, 0.012, 0.03, 0.06 or 0.09 M), Pd(OAc)2 (0.012 M), CsOPiv 
(0.36 M), PhI (0.36 M), 0.25 mL tAmylOH, 100 ºC.b Reaction with L9 (0.006 M). 
If catalyst deactivation were reversible, the addition of L9 at the time when the 
formation of 1a begins to stall should lead to a change in the reaction profile. To test this 
hypothesis, we conducted our standard ligand-free reaction and added L9 after 240 minutes. 
The addition of L9 led to a reaction profile that diverged drastically from the ligand-free profile 
(Figure 5.7). We observed an increase in the yield of 1a leading to a final yield of 58%. While 
this yield is not as high as that in the reaction conducted with L9 at the onset (Figure 5.6), the 
experiment provides preliminary evidence that the ligand plays an important role in “re-
activating” off-cycle Pd catalyst species. This a possible explanation for the increased yields 




Figure 5.7. Catalyst Recovery Experiment with L9a 
 
a Conditions blue curve: S1 (0.03 mmol, 0.12 M), Pd(OAc)2 (0.012 M), CsOPiv (0.36 M), PhI (0.36 M), 0.25 mL 
tAmylOH, 100 ºC, 4 hours. b Conditions red curve: At 240 minutes, add L9 (0.006 M) and heat to 100 ºC. 
To further confirm the formation of deactivated Pd species, visual inspection of the 
reactions with S1 in the absence of ligand revealed the formation of a dark precipitate within 
90 minutes (Scheme 5.5, step 1). ICP-OES analysis of the precipitate showed the presence of 
both Pd and Cs. While 1H NMR and ESI+ mass spectrometry indicated the presence of 1a, the 
exact structure of the Pd-species remained inconclusive. Nevertheless, this observation led us 
to question whether the precipitate contained off-cycle palladium species. To test for this 
possibility, the dark precipitate was resubjected to the reaction conditions with 4-iodoanisole 
in the presence and absence of L9. In the presence of ligand a 47% yield of product 1b was 
obtained, while a significantly lower yield of 10% was observed in the absence of ligand 
(Scheme 5.5, step 2). This suggests that a small amount of active Pd is present in the precipitate, 
and that the addition of L9 plays a role in “re-activating” off-cycle Pd-species from the 




















5 mol % L9
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Scheme 5.5. Precipitate Formation and Catalyst Recovery with Ligand 
 
Conditions: S1 (0.03 mmol), precipitate, CsOPiv (0.09 mmol), with or without L9 (0.0015 mmol), Ar‒I = 4-
OMe(C6H4)I (0.09 mmol), 0.25 mL tAmylOH, 100 ºC, 18 hours 
 
Incorporating Additional Functional Groups 
Another important advancement would be the development of conditions to incorporate 
different functional groups in these transformations. During our above studies on ligand effects 
with S10, trace amounts of byproducts were observed by GC-MS. Although we were unable to 
cleanly isolate the small of amounts of side-products being formed during reactions, we were 
aware that the product distribution could differ depending on the nature of the aliphatic amine. 
Additionally, we hypothesized the pivalate anion from the base could potentially act as a 
nucleophile to provide C‒O bond forming products. 
Scheme 5.6. Incorporation of Multiple Functional Groups  
 
When S15 was subjected to our reaction conditions, we expected to observe diarylation 
and possible formation of similar side-products observed with S10. In addition to the diarylated 
product 15a (formed in 11% yield), we also observed the formation of 15b and 15c (Scheme 
5.6). The product 15b represents a single C‒H arylation, along with a second C‒H 
functionalization event and likely β‒H elimination to yield an alkene on the second ring. 
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Control experiments demonstrate that subjecting 15b to the reaction conditions leads to allylic 
oxidation to form 15c. Follow-up studies should be conducted to probe whether additional 
cyclic amines scaffolds can undergo multiple C‒H bond functionalization transformations.  
Scheme 5.7. Exclusive Formation of a C‒O bond or a C‒C bond in S16 
 
Based on the reactivity of S14, there are two possible C‒H sites that could be 
functionalized on S16. Under our second-generation conditions, functionalization occurred 
exclusively at the remote C‒H adjacent to the oxygen atom to provide 16a and 16b, which 
were isolated in 24% and 6% yield, respectively. In contrast to S15 wherein arylation occurred 
at least once in all the products, S16 led to the selective formation of either a C‒O bond product 
16a or a C‒C bond product 16b (Scheme 5.7). Conditions that lead to 16a should be further 
investigated in the context of additional oxidants and heteroatom nucleophiles (e.g. nitrogen, 
sulfur, and halogen containing nucleophiles). NMR spectroscopy and X-ray crystallography 
were used to determine the identity and conformation of the products from S15 and S16. 
Scheme 5.8. Selective Incorporation of Remote Alkene 
 
 
Reaction conditions: substrate (0.1 mmol, 1 equiv), Pd(OAc)2 (0.01 mmol, 10 mol %), CsOPiv (0.3 mmol, 3 
equiv), L8 (0.005 mmol, 5 mol%), AgOAc (0.3 mmol, 3 equiv), 0.25 mL tAmylOH, 140 ºC, 18 h. Isolated yields. 
See details in experimental section. 
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In addition to the discovery of this C‒O bond forming reaction, we were also interested 
in selective C‒H functionalization that leads to a net desaturation of the azabicycloalkane 
scaffold.26 We hypothesized that the formation of the alkene was occurring through a Pd(II/0) 
catalytic cycle, and that the aryl iodide could be replaced with a different 1 or 2 electron oxidant 
utilized in Pd catalyzed C‒H functionalization reactions.27 Initial studies with S10 and S17 and 
3 equivalents of AgOAc led to the selective formation of 10l and 17, albeit in moderate isolated 
yields (Scheme 5.8). Further investigation showed that other bases (e.g., CsOAc, KOPiv, 
KOAc, and NaOPiv) provided 10l in diminished yields compared to CsOPiv. Replacing t-
amylOH with nitrile solvents, DMSO, and THF also led to a decrease in yield. A range of 
quinone oxidants were investigated, with 2,6-dichloro-1,4-benzoquinone providing a 44% GC 
yield of 10l (Table 5.4, entry 8).17 Further studies are necessary to optimize and probe the 
generality of this protocol in the context of mono- and bicyclic aliphatic amines.  
Table 5.4. Oxidant Screen for Remote Alkene Formation from S10a, 17 
 
entry oxidant (equiv) yield 10lc conv (%) 
1 AgOAc 3 18% 85% 
2 CuCl2 3 6% 87% 
3 Oxone 3 20% 45% 
4 1,4 benzoquinone 3 8% 41% 
5 2,6-Di-tert-butyl-1,4 benzoquinone 1.5 11% 69% 
6 Tetrachloro-1,4 benzoquinone 1.5 4% 15% 
7 2,6-Dichloro-1,4 benzoquinone 1.5 35% 47% 
8b 2,6-Dichloro-1,4 benzoquinone 1.5 44% 51% 
a Conditions: S10 (0.03 mmol, 1 equiv, 0.12 M), Pd(OAc)2 (0.012 M), CsOPiv (0.36 M), Oxidant (0.045 or 
0.09 M), L8 (0.006 M), 0.25 mL tAmylOH, 100 ºC. b Reaction with L9 (0.012 M) c Yields and conversions 









5.3. Conclusion and Future Outlook 
This chapter describes ligand effects on the Pd-catalyzed transannular C‒H arylation of 
alicyclic amines, with a focus on extending the scope of azabicylcoalkane cores to tropanes, 
homotropanes, and 7-azanorbornanes. The addition of catalytic 2-picolinic acid (L8) or 2-
quinalidic acid (L9) led to significant improvements in yields of the arylated products. The 
beneficial role of ligand in these reactions was studied through a series of mechanistic 
investigations. The data suggest that the ligand is most likely not involved in the rate 
determining C‒H activation step; furthermore, it does not appear to be preventing product 
inhibition. Instead, catalyst recovery experiments suggest the ligand serves to regenerate active 
catalyst from insoluble, off-cycle Pd species, thereby improving the overall efficiency of 
arylation. Preliminary studies on the formation of minor side products led us to discover new 
types of bond-forming reactions that generate C‒O bonds and alkenes. Future investigations 
should further pursue these transformations in order to increase the repertoire of remote 
functionalization.  
Additionally, our group and others have a longstanding interest in understanding the 
fundamental mechanistic steps of catalytic cycles in order to inform further developments in 
transition metal catalysis. Ongoing work in our laboratory is focused on understanding the 
mechanism of transannular C‒H functionalization through the synthesis of catalytically 
relevant Pd complexes. Information regarding the different steps within the catalytic cycle is 
expected to lead to the development of milder reactions as well as to new methods for the 
incorporation of additional functional groups. The development of second-generation directing 
groups should focus on scaffolds that are easily installed, enable C‒H functionalization with 
high efficiency, and can be easily cleaved under mild conditions.  
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5.4. Experimental Procedures and Characterization of Compounds 
5.4.1 Materials and Methods 
Materials and Methods 
All reagents were obtained from a commercial vendor (Aldrich, CombiBlocks, Oakwood, 
AstaTech, Synthonix, Enamine, Manchester Organics, Carbosynth, Pressure Chemicals, 
Matrix, SantaCruz Biotech, PharmaBlock, Ark Pharm, or Ontario Chemicals) and were used 
without further purification unless otherwise stated. Reagents were stored under ambient 
conditions unless otherwise stated. The solvent tert-amyl alcohol was stored over activated 
molecular sieves. The manipulation of solid reagents was conducted on the benchtop unless 
otherwise stated. Reactions were conducted under an ambient atmosphere unless otherwise 
stated. Reaction vessels were sealed with either a septum (flask) or a Teflon lined cap (4-mL 
or 20-mL vial). Reactions conducted at elevated temperatures were heated on a hot plate using 
an aluminum block. Temperatures were regulated using an external thermocouple. For 
reactions that were heated in excess of the ambient boiling point of the solvent (i.e. tert-amyl 
alcohol heated to 140 ºC), the cap of the sealed vial was re-tightened after 5 minutes of heating. 
For TLC analysis, Rf values are reported based on normal phase silica plates with fluorescent 
indicator and sample detection was conducted based on quenched fluorescence at 254 nm or 
KMNO4 stain. 
 
Instrumental Information  
NMR spectra were obtained on Varian 400 MHz, Varian 500 MHz, or Varian 700 MHz NMR 
spectrometers. 1H, 2H and 13C NMR chemical shifts are reported in parts per million relative 
to TMS with the residual solvent peak (most commonly CDCl3) used as an internal reference 
(δ 7.26 for 1H, 2H NMR and δ 77.16 for 13C NMR for CDCl3). 
19F NMR spectra were 
referenced to the solvent lock. 1H and 19F multiplicities are reported as follows: singlet (s), 
doublet (d), triplet (t), quartet (q), doublet of doublets (dd), doublet of triplets (dt) and multiplet 
(m). High resolution mass spectra were obtained at the University of Michigan core facility. 
Flash chromatography was conducted on a Biotage Isolera One auto chromatography system 
using preloaded high performance silica gel columns (10 g, 25 g, 50 g, or 100 g as appropriate). 
GC-FID was conducted on a Shimadzu 17A using a Restek Rtx®-5 (Crossbond 5% 
diphenyl/95% dimethyl polysiloxane; 15 m, 0.25 mm ID, 0.25 µm df) column. All stock 
solutions were made using volumetric glassware. Melting points were obtained on an OptiMelt 
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automated melting point system. Ligand additives were weighed on a Sartorius ME36S 
microgram analytical balance unless otherwise stated.  
 
5.4.2 Synthesis and Characterization of Substrates for Ligand Promoted 
Functionalization 
 
General Procedure A: A 20 mL scintillation vial was charged with the corresponding 
hydrochloride salt of the azabicycloalkane (2.5 mmol, 1 equiv), α-bromo methylpropanamide 
E1 (955 mg, 2.50 mmol, 1 equiv), K2CO3 (1.1 g, 8.25 mmol, 3.3 equiv), and NaI (188 mg, 1.25 
mmol, 0.5 equiv). Anhydrous acetonitrile (12 mL, 0.2 M) was added. The vial was equipped 
with a stirbar, sealed with a Teflon-lined screw cap, and heated to 60 ºC for 18 h. The reaction 
was cooled to room temperature, diluted with EtOAc (~5 mL), and filtered through a pad of 
silica gel using 100% EtOAc (~50 mL). The filtrate was concentrated under reduced pressure. 
Final purification via silica gel column chromatography (gradient elution from 0% to 20% 




Compound E1 was synthesized using 2,3,5,6-tetrafluoro-4-(trifluoromethyl)aniline and 2-





Compound S1 was isolated in 85% yield as a white solid following general procedure A. 





A 20-mL scintillation vial was charged with solid 3-oxo-2,3-dihydro-1H-indene-1-carboxylic 
acid (500 mg, 2.83 mmol) and D2O (10 mL). To this solution, dropwise NaOD (30% in D2O) 
was added at 0 ºC to a pH 12-13. The reaction was warmed to room temperature and allowed 
to stir for 3 hours. The reaction was quenched with dropwise addition of D2SO4 at 0 ºC to a pH 
2–3. The reaction mixture was extracted with DCM (3 x 75 mL), dried over Na2SO4, decanted, 
and the volatiles were removed by rotary evaporation, affording compound int-1-d5-S1 in 
>99% yield as an off-white solid that was used without further purification (96% deuterium 
incorporation by 1H NMR). 
Isolated Yield: >99%  
HRMS: ESI- (m/z): [M-H]- calcd for C10H4D3O3: 178.0589; found: 178.0588. 
1H NMR (CDCl3, 700 MHz): δ 7.79 (d, J = 7.7, 1H), 7.76 (d, J = 7.7, 1H), 7.66 (t, J = 7.7, 1H), 
7.48 (t, J = 7.7, 1H). 
2H NMR (CDCl3, 700 MHz): δ 4.34 (br s, 1D), 3.13 (br s, 1D), 2.90 (br s, 1D).  
13C NMR (CDCl3, 176 MHz): δ 204.1, 177.5, 150.5, 136.5, 135.3, 129.2, 126.8, 124.2, 43.1, 
38.7.  
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Note: JC-D were not assigned, the incorporation of deuterium was confirmed by 
2H NMR and 
HRMS.  
  
A 20-mL scintillation vial was charged with solid int-1-d5-S1 (485 mg, 2.69 mmol) and DCM 
(27 mL). Thionyl chloride (0.39 mL, 5.38 mmol) was added dropwise at 0 ºC, followed by d4-
MeOD (1.09 mL, 26.9 mmol), and warmed to room temperature. The reaction was stirred for 
3 hours at room temperature. The volatiles were removed, leading to quantitative conversion 
to compound int-2-d5-S1 as a yellow oil. The intermediate was used without further 
purification (94% deuterium incorporation by 1H NMR). 
HRMS: ESI+ (m/z): [M+H]+ calcd for C11H5D6O3: 197.1079; found: 197.1076. 
1H NMR (CDCl3, 700 MHz): δ 7.78 (d, J = 7.7, 1H), 7.70 (d, J = 7.7, 1H), 7.64 (t, J = 7.7, 1H), 
7.46 (t, J = 7.7, 1H). 
2H NMR (CDCl3, 700 MHz): δ 4.30 (br s, 1D), 3.77 (br s, 3D), 3.13 (br s, 1D), 2.87 (br s, 1D). 
13C NMR (CDCl3, 176 MHz): δ 204.3, 172.4, 151.2, 136.6, 135.1, 129.0, 126.6, 124.1, 52.1, 
43.3, 39.1. 
Note: JC-D were not assigned, the incorporation of deuterium was confirmed by 
2H NMR and 
HRMS.  
 
Compounds int-3-d5-S1 through int-6-d5-S1: Intermediates int-3-d5-1 through int-6-d5-1 
were prepared following a reported literature procedure.22 Note: For the synthesis of int-4-d5-
1 (hydrogenation step), D2 gas (3.6 bar) was employed instead of H2.  
 
 
Compound d5-S1 was isolated as a white solid using general procedure A (90% deuterium 
incorporation by 1H NMR) and purified by column chromatography (silica gel; 0% EtOAc to 
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20% EtOAc in hexanes). Collection of fractions containing product showed minor impurities 
by NMR and the product was further purified by subsequent column chromatography (0% to 
5% THF in hexanes).  
Isolated Yield: 54% yield (over seven steps) 
Rf: 0.24 (5% THF in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C22H15D5F7N2O: 466.1772; found: 466.1758. 
1H NMR (CDCl3, 700 MHz): δ 7.49 (br s, 1H), 7.16 (multiple peaks, 2H), 7.07 (multiple peaks, 
2H), 3.21 (m, 1H), 2.79 (m, 1H), 2.69 (m, 1H), 1.21 (s, 6H). 
2H NMR (CDCl3, 700 MHz): δ 3.21 (br s, 1D), 2.79 (br s, 1D), 2.69 (br s, 1D), 2.30 (br s, 1D), 
1.73 (br s, 1D).  
13C NMR chemical shifts were not assigned due to complex JC-D and JC-F splitting.  
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 












Note: Reaction was heated to 75 ºC for 6 hours. Compound S4 was isolated in 31% yield as a 
white solid following general procedure A. Product characterization matches with previous 


























Compound S10 was isolated as a white solid following general procedure A. 
Rf: 0.23 (10% EtOAc in hexanes) 
Isolated Yield: 69% 
HRMS: ESI+ (m/z): [M+H]+ calcd for C18H20F7N2O: 413.1458; Found: 413.1461. 
1H NMR (CDCl3, 401 MHz): δ 9.86 (s, 1H), 3.45 (m, 2H), 1.89–1.51 (multiple peaks, 10H), 
1.33 (s, 6H). 
13C NMR (CDCl3, 176 MHz): δ 176.40, 63.97, 57.20, 34.87, 29.81, 23.75, 17.27. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 




E2 was prepared by a modified literature procedure.28 In a 100-mL round-bottom flask 2,5-
dimethoxy-2,5-dihydrofuran (mixture of cis and trans) (2.6 g, 2.5 mL, 20 mmol, 1 equiv) was 
added to a 3 M aqueous HCl solution (36 mL). The mixture was stirred overnight (~12 h). The 
solution was neutralized (pH 7–8) with 6 M aqueous NaOH (~18 mL) and stirred for 45 
minutes. During this time, the pH dropped to 5 so dropwise addition of 6 M aq. NaOH was 
used to bring the pH back to 7. This solution was added to a 500-mL round-bottom flask 
containing a solution of NaOAc•3H2O (13.6 g, 100 mmol, 5 equiv), methylamine 
hydrochloride (1.75 g, 26 mmol, 1.3 equiv) and 1,3 acetonedicarboxylic acid (3.8 g, 26 mmol, 
1.3 equiv) in H2O (150 mL). The reaction mixture was stirred at room temperature for 5 days. 
Solid K2CO3 (15 g) and NaCl (15 g) were added to the brown solution and stirred for 30 
minutes. The solution was extracted with CHCl3 (15 × 75 mL) and EtOAc:Acetone (9:1; 4 × 
75 mL). The combined organics were dried over Na2SO4, decanted, and volatiles removed via 
rotary evaporation. The crude product was purified via column chromatography (silica gel; 0% 
to 10% MeOH in DCM) using a Biotage column (50-g column) affording a 36% yield of E2 





E3 was prepared following a modified literature procedure.29 In a 50-mL round bottom flask, 
E2 (0.6 g, 3.87 mmol, 1 equiv) was dissolved in absolute ethanol (8 mL, 0.5 M), followed by 
addition of hydrazine monohydrate (1.9 mL, 38.7 mmol, 10 equiv). The reaction mixture was 
refluxed to 120 ºC for 2 hours. The reflux condenser was replaced with a short-path distillation 
apparatus and the temperature increased to 130 ºC allowing the solvent to gradually distill over 
1 hour. After the solvent was distilled, KOH powder (2 g, 34.8 mmol, 9 equiv) was added to 
the oily residue in one portion. The reflux condenser (no water flowing) was fitted to the flask 
and the mixture was heated to 130 ºC for 1 hour, then at 160 ºC for 2 hours and finally to 190 
ºC for 1.5 hours (Caution: Fumes evolve).  After cooling to room temperature, the residue was 
dissolved in water (20 mL) and extracted with Et2O (5 × 30 mL), DCM (5 × 30 mL) and 
EtOAc:Acetone (9:1; 1 × 30 mL). The combined organic extracts were dried over Na2SO4, 
decanted, and volatiles removed via rotary evaporation. The product was obtained in 56% yield 
as a brown semi-solid and it was utilized without further purification. NMR characterization 




Synthesis of E4. A 50-mL round bottom flask was charged with E3 (298 mg, 2.11 mmol, 1 
equiv), Et3N (0.4 mL, 2.87 mmol, 1.3 equiv), 4-dimethylaminopyridine (27 mg, 0.21 mmol, 
0.1 equiv), p-toluenesulfonyl chloride (0.55 g, 2.87 mmol, 1.3 equiv), and DCM (9.6 mL, 0.23 
M). The mixture was stirred at room temperature for 24 hours. The reaction mixture was diluted 
with water (10 mL) and the product was extracted with DCM (5 × 10 mL). The combined 
organic extracts were dried over Na2SO4, decanted, and volatiles removed via rotary 
evaporation. The crude product was purified via column chromatography (silica gel, 
hexanes:EtOAc:Et3N 3:2:0.5), affording E4 as a yellow oil.   
Isolated Yield: 61% 
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Rf: 0.2 (Hex:EtOAc:Et3N ratio of 3:2:0.5) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C15H22NO3S: 296.1315; Found: 296.1316. 
1H NMR (CDCl3, 500 MHz): δ 7.79 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 4.96 (app. 
dd, J = 7.8, 3.0 Hz, 1H), 3.29 (m, 1H), 3.16 (app. br s, 1H), 2.45 (s, 3H), 2.41 (s, 3H), 2.21 (m, 
1H), 1.98 (m, 1H), 1.77–1.68 (multiple peaks, 2H), 1.50 (m, 1H), 1.37 (m, 1H), 1.26–1.11 
(multiple peaks, 2H). 
13C NMR (CDCl3, 176 MHz): δ 144.80, 134.38, 129.99, 127.89, 86.45, 67.23, 61.99, 40.32, 




A Schlenk flask was charged with compound E4 (0.379 g, 1.28 mmol, 1 equiv) and anhydrous 
1,2-dichloroethane (4.7 mL, 0.4 M) under a N2 atmosphere. To this mixture, 1-chloroethyl 
chloroformate (0.28 mL, 2.57 mmol, 2 equiv) was added dropwise via syringe. The mixture 
was heated to reflux for 5 hours. After cooling to room temperature, the reaction was 
concentrated via rotary evaporation and placed under high vacuum for 1 hour. The remaining 
brown oil was dissolved in methanol (5 mL) and heated to 60 ºC for 3 hours under a N2 
atmosphere. The reaction mixture was transferred to a 20-mL scintillation vial and solvent was 
removed via rotary evaporation. The crude hydrochloride salt of the amine intermediate int-
E5 was dried under high vacuum for 2 hours. Int-E5 was mixed with α-bromo 2-
methylpropanamide E1 (0.489 g, 1.28 mmol, 1 equiv), K2CO3 (0.584 g, 4.22 mmol, 3.3 equiv) 
and NaI (96 mg, 0.64 mmol, 0.5 equiv) in MeCN (6.4 mL, 0.2 M) and heated to 60 ºC. After 
18 h, the reaction was cooled to room temperature, diluted with EtOAc (~5 mL), and filtered 
through a pad of silica gel using 100% EtOAc (~50 mL). The filtrate was concentrated under 
reduced pressure. Final purification via column chromatography (gradient elution from 0% to 
10% EtOAc in hexanes) afforded product E5 as a white solid. 
Isolated Yield: 60% 
Rf: 0.1 (10% EtOAc in Hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C25H26F7N2O4S: 583.1496 ; Found: 583.1503. 
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1H NMR (CDCl3, 700 MHz): δ 9.56 (s, 1H), 7.78 (d, J = 7.8 Hz, 2H), 7.36 (d, J = 7.8 Hz, 2H), 
5.03 (t, J = 5.6 Hz, 1H), 3.75 (app. s, 1H), 3.51 (app. s, 1H), 2.46 (s, 3H), 2.04 (m, 2H), 1.77–
1.61 (multiple peaks, 4H), 1.47–1.35 (multiple peaks, 8H). 
13C NMR (CDCl3, 176 MHz): δ 176.05, 145.23, 133.98, 130.12, 127.79, 85.81, 63.60, 61.35, 
58.26, 38.33, 31.73, 31.49, 26.73, 21.81, 21.61, 17.53. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 




In a N2-filled glove box a 20-mL vial was charged with E5 (0.414 g, 0.71 mmol, 1 equiv), 
tBuOK (0.16 g, 1.4 mmol, 2 equiv) and THF (7 mL, 0.1 M). The reaction mixture was stirred 
at room temperature for 24 hours (Caution: excess tBuOK leads to SNAr in the perfluorinated 
ring). The reaction was mixed with water (1 mL) and stirred for 10 minutes. The solution was 
filtered through a silica gel plug with 100% EtOAc (~10 mL). The volatiles were removed via 
rotary evaporation and the crude product was purified by column chromatography (silica gel, 
0% to 10% EtOAc in Hexanes) affording S11 as a white solid. 
Isolated Yield: 45% (90% yield based on recovered starting material) 
Rf: 0.3 (10% EtOAc in Hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C18H18F7N2O: 411.1302 ; Found: 411.1304. 
1H NMR (CDCl3, 700 MHz): δ 5.94 (s, 2H), 3.73 (s, 2H), 1.76–1.69 (multiple peaks, 2H), 1.61 
(m, 1H), 1.53–1.43 (multiple peaks, 3H), 1.24 (s, 6H). The N–H proton in the amide is not 
observed. 
13C NMR (CDCl3, 176 MHz): δ 175.84, 130.23, 64.13, 61.57, 27.35, 24.03, 16.98. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 
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Steps i and ii: In a N2-filled glovebox, a dry 50-mL round-bottom flask was charged with E3 
(0.6 g, 4.25 mmol, 1 equiv) and THF (15 mL, 0.2 M). The mixture was cooled inside a freezer 
(–35 ºC) for 10 minutes and then NaH (0.11g, 4.5 mmol, 1.05 equiv) was added to the mixture. 
The suspension was brought out of the glovebox and placed under a N2 atmosphere in the fume 
hood. After 30 minutes, methyl iodide (0.28 mL, 4.5 mmol, 1.05 equiv) was added via syringe 
at room temperature. The mixture was stirred vigorously overnight. The white suspension was 
filtered through a pad of celite and washed with DCM. The volatiles were removed by rotary 
evaporation. Steps iii and iv: The concentrated crude mixture was transferred to a Schlenk 
flask using anhydrous DCE (10 mL, 0.4 M). To this solution K2CO3 (587 mg, 4.25 mmol, 1 
equiv) was added followed by dropwise addition of 1-chloro ethylchloroformate (1.38 mL, 
12.75 mmol, 3 equiv). The reaction mixture was refluxed for 5 hours under N2 atmosphere. 
After cooling to room temperature, the solution was concentrated via rotary evaporation and 
placed under vacuum for 1 hour. The residue was dissolved in methanol (10 mL) and heated 
to 60 ºC overnight under a N2 atmosphere. The reaction mixture was transferred to a 20-mL 
scintillation vial and the solvent was removed via rotary evaporation to afford crude int-S12. 
Step v: The crude int-S12 was mixed with α-bromo 2-methylpropanamide S1 (1.6 g, 4.25 
mmol, 1 equiv), K2CO3 (1.9 g, 14 mmol, 3.3 equiv) and NaI (0.32 g, 2.12 mmol, 0.5 equiv) in 
MeCN (18 mL) and heated to 60 ºC for 18 hours. The reaction was cooled to room temperature, 
diluted with EtOAc (~5 mL), and filtered through a pad of silica gel using 100% EtOAc (~80 
mL). The filtrate was concentrated under reduced pressure. Purification via column 
chromatography (gradient elution from 0% to 10% THF in hexanes). Collection of fractions 
containing product showed minor impurities by NMR and the product was further purified by 
a subsequent column chromatography (0% to 80% THF in DCM) to afford product 6b as a 
white solid. 
Isolated Yield: 5%  
Rf: 0.3 (10% THF in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C19H22F7N2O2: 443.1564; Found: 443.1564. 
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1H NMR (CDCl3, 700 MHz): δ 9.97 (s, 1H), 3.86 (dd, J = 7.1, 2.8 Hz, 1H), 3.59 (app. s, 1H), 
3.55 (m, 1H), 3.27 (s, 3H), 2.02–1.86 (multiple peaks, 2H), 1.76–1.58 (multiple peaks, 4H) 
1.53–1.40 (multiple peaks, 8H). 
13C NMR (CDCl3, 176 MHz): δ 177.13, 86.03, 63.32, 59.77, 57.59, 56.44, 37.62, 31.69, 31.05, 
27.03, 22.47, 17.72. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 




Step 1: A round-bottom flask was charged with 9-azabicyclo[3.3.1]nonan-3-one hydrochloride 
(500 mg, 2.84 mmol, 1 equiv), toluene sulfonic acid (594 mg, 3.12 mmol, 1.1 equiv), ethylene 
glycol (1.7 mL, 28.4 mmol, 10 equiv) and benzene (14 mL, 0.2 M). The flask was equipped 
with a Dean-Stark trap and heated to 110 ºC overnight. The reaction was cooled to room 
temperature, followed by addition of Na2CO3 (1.18 g) and brine (26 mL). The aqueous layer 
was extracted with chloroform (3 x 75 mL). The organic layer was dried over Na2SO4, 
decanted, and concentrated via rotary evaporation. Intermediate int-S13 was carried forward 
without analysis or purification. 
Step 2: Int-S13 was used as starting amine reagent following general procedure A to isolate 
compound S13 as a white solid. 
Isolated Yield: 19% (over the two steps) 
Rf: 0.13 (5% EtOAc in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C21H24F7N2O3: 485.1670; Found: 485.1671. 
1H NMR (CDCl3, 700 MHz): δ 10.87 (s, 1H), 3.89 (m, 4H), 3.46 (d, J = 10.5 Hz, 2H), 2.34 (t, 
J = 12.6 Hz, 2H), 2.07 (m, 1H), 1.85–1.77 (multiple peaks, 4H), 1.66 (app. d, J = 14.7 Hz, 1H), 
1.49 (s, 6H), 1.30 (d, J = 13.3 Hz, 2H). 
13C NMR (CDCl3, 176 MHz): δ 178.1, 108.9, 64.7, 64.0, 45.8, 38.4, 29.5, 26.7, 14.3. 
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The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 




Compound S14 was isolated as a pale yellow solid following general procedure A. 
Isolated Yield: 50%  
Rf: 0.29 (10% EtOAc in Hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C17H18F7N2O: 399.1302; Found: 399.1304.  
1H NMR (CDCl3, 700 MHz): δ 10.21 (s, 1H), 3.61 (m, 2H), 1.74 (m, 4H), 1.45–1.39 (multiple 
peaks, 10H). 
13C NMR (CDCl3, 176 MHz): δ 176.58, 61.23, 56.78, 30.94, 24.43. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 




Compound S15 was isolated in 75% yield as a white solid following general procedure A. 
Isolated Yield: 75%  
Rf: 0.42 (10% EtOAc in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C19H22F7N2O: 427.1615; Found: 427.1619. 
1H NMR (CDCl3, 700 MHz): δ 9.73 (s, 1H), 3.15 (m, 2H), 2.14 (m, 2H), 1.96 (m, 4H), 1.71 
(m, 2H), 1.64 (dd, J = 14.0, 6.3 Hz, 4H), 1.47 (s, 6H). 
13C NMR (CDCl3, 176 MHz): δ 177.26, 65.21, 48.13, 30.09, 25.62, 20.54. 
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The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 




Compound S16 was isolated as a white solid following general procedure A. 
HRMS: ESI+ (m/z): [M+H+] calcd for C17H18F7N2O2: 415.1251; found: 415.1255. 
1H NMR (CDCl3, 700 MHz): δ 9.76 (s, 1H), 3.76 (dd, J = 9.8 Hz, J = 2.1 Hz, 2H), 3.68 (d, J = 
9.8 Hz, 2H), 2.03 (m, 1H), 1.87 (m, 1H), 1.35 (s, 6 H).  
13C NMR (CDCl3, 176 MHz): δ 175.6, 75.6, 63.8, 58.3, 28.6, 23.4. The carbon resonances of 
the directing group (perfluoroarene, C7F7) appear as complex multiplets and are not listed. 
19F 
NMR and LC-MS were used to confirm characterization of structure.   




Compound S17 was isolated as a white solid following general procedure A. 
HRMS: ESI+ (m/z): [M+H+] calcd for C18H20F7N2O2: 429.1408; found: 429.1413. 
1H NMR (CDCl3, 700 MHz): δ 9.54 (s, 1H), 3.97 (d, J = 11.2 Hz, 2H), 3.88 (d, J = 11.2 Hz, 
2H), 2.60 (m, 1H), 2.01 (m, 1H), 1.77 (m, 1H), 1.53 (s, 6 H).  
13C NMR (CDCl3, 176 MHz): δ 1756.2, 72.4, 65.1, 50.0, 29.1, 25.8, 20.2. The carbon 
resonances of the directing group (perfluoroarene, C7F7) appear as complex multiplets and are 
not listed. 19F NMR and LC-MS were used to confirm characterization of structure.   




5.4.3 Ligand Evaluation and Optimization of Arylation Conditions for S1 
General Procedure B: Ligand evaluation reaction conditions in Table 5.1. Under ambient 
conditions, a 0.02 M stock solution of Pd(OAc)2 (23 mg Pd(OAc)2 in 5 mL of DCM) was 
prepared. An aliquot of this solution was transferred to a vial (4 mL capacity, 150 μL, 0.003 
mmol Pd, 10 mol %). DCM was removed by heating the open vial to 45 ºC for 5 minutes. To 
the concentrated Pd(OAc)2, the appropriate ligand (0.0015 mmol, 5 mol%), substrate S1 (13.8 
mg, 0.03 mmol, 1 equiv) and CsOPiv (21.1 mg, 0.09 mmol, 3 equiv) were added. To this 
mixture, PhI (0.1 mL, 0.9 mmol, 30 equiv) was added via plastic syringe. The vial was 
equipped with a stirbar, sealed with a Telfon-lined screw cap, and heated to an external 
temperature of 150 ºC in a preheated aluminum block. After 18 hours, the reaction was cooled 
to room temperature and diluted with DCM (2.5 mL). Hydrazine monohydrate (50 μL) was 
added and the solution was vigorously stirred for 15 minutes. A 0.2 M stock solution of 1,3,5-
trimethoxybenzene (168 mg, 1 mmol) dissolved in DCM (5 mL) was prepared. An aliquot of 
this solution (150 μL, 0.03 mmol) was added to the reaction as the GC internal standard. The 
reaction solution was then filtered through a pipette packed with Celite and was analyzed by 
GC-FID. Yield of 1a was determined based on a 10-point calibration curve. Variations of this 
procedure were used in all optimization reactions (Tables 5.1) where the yield was determined 
by GC-FID.  
 
General Procedure C: Reaction optimization in Table 5.2. Under ambient conditions, a 0.02 
M stock solution of Pd(OAc)2 (23 mg Pd(OAc)2 in 5 mL of DCM) and a 0.02 M stock solution 
of quinaldic acid (17.3 mg of quinaldic acid (L9) in 5 mL of DCM) were prepared. An aliquot 
of the Pd(OAc)2 solution was transferred to a vial (4 mL capacity, 150 μL, 0.003 mmol Pd, 10 
mol %) followed by an aliquot of the quinaldic acid (L9) solution (75 μL, 0.0015 mmol, 5 mol 
%). DCM was removed by heating the open vial to 45 ºC for 5 minutes. To the concentrated 
reaction mixture, solid substrate S1 (13.8 mg, 0.03 mmol, 1 equiv), CsOPiv (21.1 mg, 0.09 
mmol, 3 equiv) and PhI (1–30 equiv) were added. The reaction mixture was then diluted with 
tAmylOH (0.25 mL, if indicated in Table 5.2). The vial was equipped with a stirbar, sealed 
with a Telfon-lined screw cap and heated to the indicated temperature in Table 2 in a preheated 
aluminum block. After 18 hours, the reaction was cooled to room temperature and diluted with 
DCM (2.5 mL). Hydrazine monohydrate (50 μL) was added and the solution was vigorously 
stirred for 15 minutes. A 0.2 M stock solution of 1,3,5-trimethoxybenzene (168 mg, 1 mmol) 
dissolved in DCM (5 mL) was prepared. An aliquot of this solution (150 μL, 0.03 mmol) was 
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added to the reaction as the GC internal standard. The reaction solution was then filtered 
through a pipette packed with Celite and was analyzed by GC-FID. Yield of 1a was determined 
based on a 10-point calibration curve. 
 
5.4.4 Optimization of Arylation Conditions for S10 
General procedure D: Reaction optimization of S10 Under ambient conditions, a 0.02 M 
stock solution of picolinic acid (12.3 mg picolinic acid (L8) dissolved in 5 mL of MeOH) and 
a 0.02 M stock solution of Pd(OAc)2 (23 mg of Pd(OAc)2 dissolved in 5 mL of DCM) were 
prepared. An aliquot of the picolinic acid stock solution was transferred to a vial (4 mL 
capacity, 75 μL, 0.0015 mmol ligand, 5 mol %). MeOH was removed by heating the open vial 
to 68 ºC for 10 minutes. To the concentrated picolinic acid (L8), an aliquot of the Pd(OAc)2 
stock solution (150 μL, 0.003 mmol Pd, 10 mol %) was added. DCM was removed by gently 
heating the open vial to 45 ºC for 5 minutes. To the concentrated reaction mixture, solid 
substrate S10 (12.4 mg, 0.03 mmol, 1 equiv), CsOPiv (21.1 mg, 0.09 mmol, 3 equiv) and PhI 
(3–45 equiv) were added. The reaction mixture was then diluted with tAmylOH (0.25 mL, if 
indicated in Table 5.5). The vial was equipped with a stirbar, sealed with a Telfon-lined screw 
cap, and heated to the indicated temperature in Table 5.5 in a preheated aluminum block. After 
18 hours, the reaction was cooled to room temperature and diluted with DCM (2.5 mL). 
Hydrazine monohydrate (50 μL) was added and the solution was vigorously stirred for 15 
minutes. A 0.2 M stock solution of 1,3,5-trimethoxybenzene (168 mg, 1 mmol) dissolved in 
DCM (5 mL) was prepared. An aliquot of this solution (150 μL, 0.03 mmol) was added to the 
reaction as the GC internal standard. The reaction solution was then filtered through a pipette 
packed with Celite and was analyzed by GC-FID. Yield of 10a is uncalibrated. 
 
In the cases where quinaldic acid (L9) was used, a 0.02 M stock solution of quinaldic acid 
(17.3 mg of quinalidic acid (L9) in 5 mL of DCM) was prepared and an aliquot (75 μL, 0.0015 
mmol, 5 mol %) was added to the 4-mL vial. Different volumes of ligand stock solution were 









Table 5.5. Optimization of C‒H Arylation for S10 
 
 
entry ligand (mol %)a temp solvent PhI (equiv) conv. yield 10ab 
1 L8 (5) 150 °C neat 45 > 99% 41 
2 L8 (10) 150 °C neat 45 87% 47 
3 L9 (5) 150 °C neat 45 97% 31 
4 L9 (20) 150 °C neat 45 94% 33 
5 L8 (5) 140 °C neat 45 91% 51 
6 L8 (10) 140 °C neat 45 51% 21 
7 L8 (5) 130 °C neat 45 74% 38 
8 L8 (10) 130 °C neat 45 53% 28 
9 L8 (5) 140 °C tAmylOH 45 72% 26 
10 L8 (5) 140 °C tAmylOH 15 96% 24 
11 L8 (5) 140 °C tAmylOH 3 94% 18 
12 ----- 140 °C neat 45 47% 4 
Conditions from general procedure D. a L8 = picolinic acid; L9 = quinaldic acid. b Uncalibrated GC yields. 
 
5.4.5 Synthesis and Characterization of Products of Ligand Promoted 
Functionalization 
General Procedure E: Isolation of 1a and 1b. A 4-mL vial was charged with solid substrate 
S1 (115.1 mg, 0.25 mmol, 1 equiv), Pd(OAc)2 (5.6 mg, 0.025 mmol, 10 mol %), CsOPiv (176 
mg, 0.75 mmol, 3 equiv), quinaldic acid (L9, 2.2 mg, 0.013 mmol, 5 mol %), iodoarene (0.075 
mmol, 3 equiv) and tAmylOH (2.1 mL, 0.12 M). The vial was equipped with a magnetic stirbar, 
sealed with a Teflon-lined screw cap, and heated to an external temperature of 100 ºC in an 
aluminum heating block. After 18 h, the reaction was cooled to room temperature and diluted 
with DCM (1 mL). Hydrazine hydrate (0.7 mL) was added to the solution. The mixture was 
allowed to stir for 30 min at room temperature to remove Pd from the product. The mixture 
was filtered through Celite and washed with DCM (10 mL). The volatiles were removed by 
rotary evaporation and the residue was purified via column chromatography (0% to 10% 
EtOAc in hexanes) affording the desired product. See each substrate for specific notes. 
 
General Procedure F: Under ambient conditions, a 0.1 M stock solution of picolinic acid 
(24.6 mg picolinic acid (L8) dissolved in 2 mL of methanol) was prepared. An aliquot of this 
solution was transferred to a vial (4 mL capacity, 50 μL, 0.005 mmol picolinic acid L8, 5 mol 
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%). Methanol was removed by heating the open vial to 68 ºC for approximately 15 minutes 
(Note: leftover methanol can lead to Pd-catalyst decomposition). To the concentrated picolinic 
acid (L8), solid substrate S10 (41.2 mg, 0.1 mmol, 1 equiv), Pd(OAc)2 (2.3 mg, 0.01 mmol, 10 
mol %), CsOPiv (70.2 mg, 0.3 mmol, 3 equiv), and iodoarene (45 equiv) were added. The vial 
was equipped with a magnetic stirbar, sealed with a Teflon-lined screw cap, and heated to an 
external temperature of 140 ºC.  After 18 h, the reaction was cooled to room temperature and 
diluted with DCM (2.5 mL). Hydrazine hydrate (0.4 mL) was added to the solution. The 
mixture was allowed to stir for 30 min at room temperature to remove Pd from the product. 
The mixture was filtered through Celite and washed with DCM (10 mL). The volatiles were 
removed by rotary evaporation, and the residue was purified via column chromatography 
(commonly mixtures of EtOAc:Hex or THF:Hex) affording the desired product. See each 




Compound 1a was isolated as a white solid following general procedure E at 100 ºC or 120 
ºC. 
Isolated Yield: 67% (100 ºC), 77% (at 120 ºC) 
Rf: 0.31 (10% EtOAc in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C28H24F7N2O: 537.1771; Found: 537.1772. 
1H NMR (CDCl3, 400 MHz): δ 7.50–7.37 (multiple peaks, 3H), 7.34 (m, 2H), 7.30–7.23 
(multiple peaks, 3H), 7.14 (m, 2H), 3.75 (t, J = 4.1 Hz, 2H), 3.67 (t, J = 4.4 Hz, 1H), 3.02 (d, 
J = 10.7 Hz, 2H), 2.58 (dd, J = 10.9, 4.0 Hz, 2H), 1.01 (s, 6H).  
13C NMR (CDCl3, 176 MHz): δ 176.20, 146.22, 139.08, 129.06, 128.45, 126.93, 126.26, 
121.88, 63.74, 51.96, 43.88, 42.59, 21.57. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 




Compound 1b was isolated as a white solid following general procedure E at 100 ºC or 120 
ºC. NMR characterization matched the literature report.X 




Compound 2 was isolated following previously reported conditions with addition of 5 mol % 
L8.10 




Compound 3 was isolated following previously reported conditions with addition of 5 mol % 
L8.10 









Compound 4 was isolated following previously reported conditions with addition of 5 mol % 
L8.10 




Compound 5 was isolated following previously reported conditions with addition of 5 mol % 
L8.10 




Compound 6 was isolated following previously reported conditions with addition of 5 mol % 
L8 and 20 mol % L9.10 






Compound 7 was isolated following previously reported conditions with addition of 5 mol % 
L8.10 




Compound 8 was isolated following previously reported conditions with addition of 5 mol % 
L8.10 




Compound 9 was isolated following previously reported conditions with addition of 5 mol % 
L8.10 





Compound 10b was isolated as a yellow semi-solid following general procedure F. 
Isolated Yield: 49%  
Rf: 0.10 (5% EtOAc in Hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C25H26F7N2O2: 519.1877; Found: 519.1875. 
1H NMR (CDCl3, 401 MHz): δ 9.81 (br s, 1H), 7.15 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 
2H), 3.79 (s, 3H), 3.59 (m, 2H), 2.97 (tt, J = 10.8, 4.0 Hz, 1H), 2.00–1.81 (multiple peaks, 8H), 
1.39 (s, 6H). 
13C NMR (CDCl3, 176 MHz): δ 176.07, 158.20, 137.35, 128.04, 114.07, 63.96, 57.11, 55.43, 
42.92, 34.72, 30.09, 23.90.  
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 




Compound 10c was isolated as a colorless oil following general procedure F. 
Isolated Yield: 60%  
Rf: 0.10 (5% THF in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C25H26F7N2O2: 519.1877; Found: 519.1881. 
1H NMR (CDCl3, 500 MHz): δ 7.24 (t, J = 7.8 Hz, 1H), 6.84 (d, J = 7.8 Hz, 1H), 6.82–6.75 
(multiple peaks, 2H), 3.81 (s, 3H), 3.61 (m, 2H), 3.01 (p, J = 8.7 Hz, 1H), 2.04–1.82 (multiple 
peaks, 8H), 1.39 (s, 6H). 
13C NMR (CDCl3, 176 MHz): δ 175.66, 159.53, 146.62, 129.27, 119.21, 113.01, 110.98, 63.59, 
56.70, 54.91, 42.17, 35.25, 29.71, 23.50.  
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The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 




Compound 10d was isolated as a colorless oil following general procedure F. 
Isolated Yield: 40%  
Rf: 0.37 (100% DCM) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C25H26F7N2O: 503.1928; Found: 503.1926.  
1H NMR (CDCl3, 700 MHz): δ 7.13 (app. s, 4H), 3.59 (m, 2H), 2.99 (m, 1H), 2.32 (s, 3H), 
1.99–1.92 (multiple peaks, 2H), 1.90–1.82 (multiple peaks, 6H), 1.39 (s, 6H). 
The N–H proton in the amide is not observed. 
13C NMR (CDCl3, 176 MHz): δ 176.09, 142.24, 136.03, 129.36, 127.05, 63.94, 57.10, 42.76, 
35.15, 30.08, 23.88, 21.12.  
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 
19F NMR (CDCl3, 376 MHz): δ –56.00 (t, J = 21.6 Hz, 3F), –141.14 (m, 2F),  




Compound 10e was isolated as a light yellow oil following general procedure F. 
Isolated Yield: 47%  
Rf: 0.07 (5% THF in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C26H28F7N2O3: 549.1983; found 549.1990. 
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1H NMR (CDCl3, 400 MHz): δ 6.86–6.72 (multiple peaks, 3H), 3.89 (s, 3H), 3.86 (s, 3H), 3.60 
(m, 2H), 2.96 (m, 1H), 2.03–1.78 (multiple peaks, 8H), 1.39 (s, 6H). 
The N–H proton in the amide is not observed. 
13C NMR (CDCl3, 176 MHz): δ 175.90, 149.07, 147.66, 137.94, 118.84, 111.46, 110.70, 63.97, 
57.07, 56.08, 55.95, 42.85, 35.20, 30.07, 23.86. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 




Compound 10f was isolated as a colorless oil following general procedure F. 
Isolated Yield: 46%  
Rf: 0.71 (20% THF in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C25H25BrF7N2O2: 597.0982; Found: 597.0977. 
1H NMR (CDCl3, 700 MHz): δ 7.45 (d, J = 8.1 Hz, 1H), 6.77 (m, 1H), 6.72 (dd, J = 8.1, 2.0 
Hz, 1H), 3.90 (s, 3H), 3.61 (m, 2H), 2.99 (tt, J = 11.8, 6.2 Hz, 1H), 2.02–1.94 (multiple peaks, 
2H), 1.91–1.80 (multiple peaks, 6H), 1.39 (s, 6H). 
The N–H proton in the amide is not observed. 
13C NMR (CDCl3, 176 MHz): δ 175.75, 156.01, 146.29, 133.35, 120.49, 111.19, 109.39, 63.99, 
56.99, 56.23, 42.54, 35.67, 30.06, 23.85. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 








Compound 10g was isolated as a white solid following general procedure F. 
Isolated Yield: 47%  
Rf: 0.29 (100% CHCl3) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C25H23F10N2O: 557.1645; Found: 557.1644. 
1H NMR (CDCl3, 400 MHz): δ 9.75 (br s, 1H), 7.57 (d, J = 8.1 Hz, 2H), 7.34 (d, J = 8.1 Hz, 
2H), 3.63 (m, 2H), 3.08 (m, 1H), 2.06–1.78 (m, 8H), 1.40 (s, 6H). 
13C NMR (CDCl3, 176 MHz): δ 175.81, 149.28, 128.85 (q, JC-F = 32.4 Hz), 127.54, 125.64 (q, 
JC-F = 3.7 Hz), 124.36 (q, JC-F = 271.8 Hz), 64.00, 56.99, 42.36, 35.59, 30.08, 23.88. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 
19F NMR (CDCl3, 376 MHz): δ –56.02 (t, J = 21.7 Hz, 3F), –62.44 (s, 3F), –140.96 (m, 2F), –




Compound 10h was isolated as a colorless semi-solid following general procedure F. 
Isolated Yield: 44%  
Rf: 0.19 (5% THF in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C26H22F13N2O: 625.1519; found 625.1524. 
1H NMR (CDCl3, 500 MHz): δ 9.72 (s, 1H), 7.74 (s, 1H), 7.68 (s, 2H), 3.66 (m, 2H), 3.17 (tt, 
J = 11.9, 5.9 Hz, 1H), 2.09–1.78 (multiple peaks, 8H), 1.41 (s, 6H). 
13C NMR (CDCl3, 126 MHz): δ 175.53, 147.69, 131.94 (q, J = 32.9 Hz), 127.47 (m), 123.51 
(q, J = 272.6 Hz), 120.63 (m), 64.02, 56.84, 42.28, 35.61, 30.05, 23.84. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
 169 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 
19F NMR (CDCl3, 376 MHz): δ –56.01 (t, J = 21.5 Hz, 3F), –62.88 (s, 6F), –140.97 (m, 2F), –




Compound 10i was isolated as a light yellow oil following general procedure F with 20 mol 
% Pd(OAc)2 and 10 mol% L8. 
Isolated Yield: 34%  
Rf: 0.77 (100% DCM) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C25H23F10N2O2: 573.1594; found 573.1592. 
1H NMR (CDCl3, 401 MHz): δ 7.22 (d, J = 8.8 Hz, 2H), 7.15 (d, J = 8.8 Hz, 2H), 3.62 (app. s, 
2H), 3.04 (tt, J = 11.9, 6.2 Hz, 1H), 2.02–1.76 (multiple peaks, 8H), 1.39 (s, 6H). The N–H 
proton in the amide is not observed. 
13C NMR (CDCl3, 176 MHz): δ 175.88, 147.76 (m), 143.91, 128.40, 121.23, 63.99, 57.01, 
42.62, 35.05, 30.09, 23.90. 
The carbon resonances corresponding to the perfluoroarene (C7F7) and CF3O are not listed due 
to complexities in the region between 105 ppm and 150 ppm. 19F NMR and HRMS were used 
to confirm the presence of these groups. 
19F NMR (CDCl3, 376 MHz): δ –56.01 (t, J = 21.7 Hz, 3F), –57.96 (s, 3F), –140.95 (m, 2F), –




Compound 10j was isolated as a colorless semi-solid following general procedure F. 
Isolated Yield: 42%  
Rf: 0.46 (100% CHCl3) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C24H19F12N2O: 579.1300; found: 579.1305.     
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1H NMR (CDCl3, 700 MHz): δ 9.73 (s, 1H), 3.62 (m, 2H), 3.50 (tt, J = 12.2, 6.0 Hz, 1H), 2.23 
(app. t, J = 7.2 Hz, 2H), 2.00 (m, 2H), 1.86 (m, 2H), 1.75 (m, 2H), 1.39 (s, 6H). 
13C NMR (CDCl3, 176 MHz): δ 175.86, 63.89, 56.82, 39.16, 29.82, 25.82, 23.79. 
The carbon resonances corresponding to the perfluoroarenes (C7F7 and C6F5) in this compound 
appear as a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F 
coupling. Due to the complexities of these groups, the peaks are not listed. 19F NMR and HRMS 
were used to confirm the presence of both ring systems. 
19F NMR (CDCl3, 376 MHz): δ –56.04 (t, J = 21.7 Hz, 3F), –141.07 (m, 2F), –143.55 (app. d, 




Compound 10k was isolated as a colorless oil following general procedure F. 
Isolated Yield: 54%  
Rf: 0.10 (5% EtOAc in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C27H26F7N2O2: 543.1877; found 543.1879. 
1H NMR (CDCl3, 700 MHz): δ 9.88 (br s, 1H), 7.33–7.30 (multiple peaks, 2H), 7.06 (dd, J = 
8.4, 1.8 Hz, 1H), 6.32 (s, 1H), 3.61 (m, 2H), 3.09 (p, J = 9.1 Hz, 1H), 2.44 (s, 3H), 2.02–1.83 
(multiple peaks, 8H), 1.40 (s, 6H). 
13C NMR (CDCl3, 176 MHz): δ 176.11, 156.02, 153.62, 139.47, 129.51, 122.43, 118.21, 
110.57, 102.58, 63.95, 57.17, 43.26, 35.57, 30.10, 23.89, 14.24. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 




Compound 11 was isolated as a colorless semi-solid following general procedure F. 
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Isolated Yield: 50%  
Rf: 0.19 (5% THF in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C25H24F7N2O2: 517.1721; found: 517.1718. 
1H NMR (CDCl3, 401 MHz): δ 7.15 (d, J = 8.2 Hz, 2H), 6.85 (d, J = 8.2 Hz, 2H), 6.05 (s, 2H), 
3.88 (app. s, 2H), 3.79 (s, 3H), 2.89 (m, 1H), 1.87–1.76 (multiple peaks, 4H), 1.29 (s, 6H).  
The N–H proton in the amide is not observed. 
13C NMR (CDCl3, 176 MHz): δ 175.49, 158.16, 137.40, 130.64, 128.64, 113.99, 64.14, 61.44, 
55.40, 35.86, 35.24, 24.20. 
The carbon resonances corresponding to the perfluoroarenes (C7F7 and C6F5) in this compound 
appear as a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F 
coupling. Due to the complexities of these groups, the peaks are not listed. 19F NMR and HRMS 
were used to confirm the presence of both ring systems. 




Compound 12 was isolated as a colorless oil following general procedure F. 
Isolated Yield: 40%  
Rf: 0.42 (2% EtOAc in DCM) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C26H28F7N2O3: 549.1983; found: 549.1978. 
1H NMR (CDCl3, 401 MHz): δ 10.00 (s, 1H), 7.12 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 
2H), 3.97 (dd, J = 7.2, 2.6 Hz, 1H), 3.79 (s, 3H), 3.76–3.68 (multiple peaks, 2H), 3.31 (s, 3H), 
2.75 (m, 1H), 2.12 (m, 1H), 2.00 (m, 1H), 1.91–1.67 (multiple peaks, 4H), 1.54 (s, 3H), 1.50 
(s, 3H). 
13C NMR (CDCl3, 176 MHz): δ 176.91, 158.32, 137.19, 127.92, 114.16, 85.79, 63.11, 59.76, 
56.89, 56.52, 55.44, 39.20, 38.44, 37.96, 35.30, 27.18, 23.33. 
The carbon resonances corresponding to the perfluoroarenes (C7F7 and C6F5) in this compound 
appear as a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F 
coupling. Due to the complexities of these groups, the peaks are not listed. 19F NMR and HRMS 
were used to confirm the presence of both ring systems. 




Compound 13 was isolated as a yellow oil following general procedure F with 20 mol % 
Pd(OAc)2 and 10 mol % L8. 
Isolated Yield: 54%  
Rf: 0.31 (20% EtOAc in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C28H30F7N2O4: 591.2088; found: 591.2087. 
1H NMR (CDCl3, 700 MHz): δ 10.90 (s, 1H), 7.15 (d, J = 8.4 Hz, 2H), 6.87 (d, J = 8.4 Hz, 
2H), 3.93 (app. s, 4H), 3.80 (s, 3H), 3.63 (app. d, J = 10.5 Hz, 2H), 3.27 (m, 1H), 2.44 (t, J = 
12.6 Hz, 2H), 1.94 (d, J = 14.7 Hz, 2H), 1.88 (m, 2H), 1.60–1.52 (multiple peaks, 8H). 
13C NMR (CDCl3, 176 MHz): δ 177.8, 158.3, 138.1, 128.1, 114.2, 108.7, 64.8, 64.1, 55.4, 46.5, 
38.9, 37.6, 31.4, 26.8. 
The carbon resonances corresponding to the perfluoroarenes (C7F7 and C6F5) in this compound 
appear as a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F 
coupling. Due to the complexities of these groups, the peaks are not listed. 19F NMR and HRMS 
were used to confirm the presence of both ring systems. 




Compound 14 was isolated as a colorless oil following general procedure F with 5 mol % L9. 
Isolated Yield: 42%  
Rf: 0.26 (5% THF in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C24H24F7N2O2: 505.1721; found: 505.1720. 
1H NMR (CDCl3, 401 MHz): δ 9.18 (s, 1H), 7.21 (d, J = 8.3 Hz, 2H), 6.70 (d, J = 8.3 Hz, 2H), 
3.80 (m, 1H), 3.65–3.53 (multiple peaks, 4H), 2.91 (dd, J = 9.0, 4.4 Hz, 1H), 2.13 (m, 1H), 
1.95–1.55 (multiple peaks, 5H), 1.40 (s, 3H), 1.38 (s, 3H). 
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13C NMR (CDCl3, 176 MHz): δ 176.35, 157.89, 136.57, 128.03, 113.78, 64.81, 61.14, 56.99, 
55.06, 47.83, 37.03, 30.72, 30.13, 25.42, 23.91. 
The carbon resonances corresponding to the perfluoroarenes (C7F7 and C6F5) in this compound 
appear as a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F 
coupling. Due to the complexities of these groups, the peaks are not listed. 19F NMR and HRMS 
were used to confirm the presence of both ring systems. 




Compound 15a was isolated as a white solid following general procedure F with 20 mol % 
L9. 
Isolated Yield: 15%  
Rf: 0.10 (5% THF in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C24H24F7N2O2: 505.1721; found: 505.1720. 
1H NMR (CDCl3, 500 MHz): δ 9.70 (br s, 1H), 7.21 (d, J = 8.5 Hz, 4H), 6.89 (d, J = 8.5 Hz, 
4H), 3.81 (s, 6H), 3.69 (tt, J = 12.7, 6.4 Hz, 2H), 3.51 (m, 2H), 2.15–1.96 (multiple peaks, 8H), 
1.62 (s, 6H). 
13C NMR (CDCl3, 176 MHz): δ 176.63, 158.24, 138.93, 127.78, 114.16, 65.27, 55.44, 49.36, 
38.38, 37.55, 26.11. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR, X-ray, and HRMS 
were used to confirm the presence of this ring system. 








Compound 15b was isolated as a colorless oil following general procedure F with 20 mol % 
L9. 
Isolated Yield: 24%  
Rf: 0.16 (5% THF in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C26H26F7N2O2: 531.1877; found: 531.1872. 
1H NMR (CDCl3, 700 MHz): δ 9.77 (br s, 1H), 7.15 (d, J = 8.3 Hz, 2H), 6.86 (d, J = 8.3 Hz, 
2H), 6.06 (dt, J = 9.9, 3.0 Hz, 1H), 5.92 (m, 1H), 3.79 (s, 3H), 3.61 (m, 1H), 3.42 (app. s, 1H), 
3.21 (tt, J = 12.4, 6.2 Hz, 1H), 2.47 (dd, J = 18.9, 7.0 Hz, 1H), 2.03–1.96 (multiple peaks, 2H), 
1.93–1.78 (multiple peaks, 3H), 1.49 (s, 3H), 1.43 (s, 3H). 
13C NMR (CDCl3, 126 MHz): δ 176.52, 158.17, 137.72, 130.41, 128.51, 128.04, 114.04, 65.12, 
55.42, 50.53, 47.29, 43.76, 37.82, 33.61, 28.91, 24.83, 23.28. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR and HRMS were used 
to confirm the presence of this ring system. 




Compound X was isolated as a white solid following general procedure F with 20 mol % L9. 
Isolated Yield: 31%  
Rf: 0.13 (5% THF in hexanes) 
HRMS: ESI+ (m/z): [M+H]+ calcd for C31H34F7N2O4: 631.2401; found: 631.2397. 
1H NMR (CDCl3, 700 MHz): δ 9.47 (s, 1H), 7.14 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 
6.05 (ddd, J = 10.3, 4.6, 1.8 Hz, 1H), 5.95 (dd, J = 10.3, 2.3 Hz, 1H), 5.49 (d, J = 6.8 Hz, 1H), 
3.86 (m, 1H), 3.80 (s, 3H), 3.37 (app. s, 1H), 3.29 (tt, J = 12.5, 4.5 Hz, 1H), 2.16 (m, 1H), 1.99 
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(td, J = 12.8, 4.2 Hz, 1H), 1.80 (m, 1H), 1.76 (td, J = 13.3, 4.6 Hz, 1H), 1.55 (s, 3H), 1.46 (s, 
3H), 1.24 (s, 9H). 
13C NMR (CDCl3, 176 MHz): δ 178.37, 175.69, 158.29, 137.27, 133.79, 128.04, 127.95, 
114.16, 68.00, 65.15, 55.41, 51.20, 48.78, 39.02, 36.23, 36.06, 33.39, 27.38, 25.78, 23.59. 
The carbon resonances corresponding to the perfluoroarene (C7F7) in this compound appear as 
a complex series of multiplets between 105 ppm to 155 ppm as a result of 13C/19F coupling. 
Due to the complexities of the system, the peaks are not listed. 19F NMR, X-ray, and HRMS 
were used to confirm the presence of this ring system. 
19F NMR (CDCl3, 376 MHz): δ –56.03 (t, J = 21.7 Hz, 3F), –140.86 (m, 2F), –143.63 (m, 2F). 
 
Compound (16a):   
  
Compound 16a was isolated as a white solid following general procedure F. The compound 
was recyrstallized from methanol for X-ray crystallography. 
Isolated Yield: 24% (12.3 mg)  
HRMS: ESI+ (m/z): [M+H+] calcd for C22H26F7N2O4: 515.1775; found: 515.1778. 
1H NMR (CDCl3, 700 MHz): δ 9.30 (s, 1H), 4.71 (s, 1H), 3.88 (d, J = 10.5 Hz, 1H), 3.74 (d, J 
= 10.5 Hz, 1H), 3.41 (d, J = 6.3 Hz, 1H), 3.33 (d, J = 6.3 Hz, 1H), 2.19 (m, 1H), 2.12 (m, 1H), 
1.95 (m, 1H), 1.90 (m, 1H), 1.75 (m, 1H), 1.40 (s, 3H), 1.37 (s, 3H), 1.24 (s, 9H).  
13C NMR (CDCl3, 176 MHz): δ 175.8, 174.9, 95.0, 74.4, 63.8, 59.6, 57.4, 39.0, 28.1, 27.1, 
24.8, 24.5, 22.9. The carbon resonances of the directing group (perfluoroarene, C7F7) appear 
as complex multiplets and are not listed. 19F NMR and LC-MS were used to confirm 








Compound (16b):  
  
Compound 16a was isolated as a yellow solid following general procedure F. The compound 
was recyrstallized from hexanes for X-ray crystallography. 
Isolated Yield: 6% (3.0 mg) 
HRMS: ESI+ (m/z): [M+H+] calcd for C24H24F7N2O3: 521.1670; found: 532.1675. 
1H NMR (CDCl3, 700 MHz): δ 8.67 (s, 1H), 7.28 (d, J = 8.4 Hz, 2H), 6.74 (d, J = 8.4 Hz, 2H), 
4.77 (s, 1H), 4.27 (d, J = 10.5 Hz, 1H), 3.82 (d, J = 7.0 Hz, 1H), 3.70 (d, J = 10.5 Hz, 1H), 3.62 
(s, 3H), 3.37 (d, J = 7.0 Hz, 1H), 2.25 (m, 1H), 2.12 (m, 1H), 2.06 (m, 1H), 1.92 (m, 1H), 1.29 
(s, 3H), 1.27 (s, 3H).  
13C NMR (CDCl3, 176 MHz): δ 175.3, 158.3, 133.1, 126.6, 113.9, 81.6, 72.1, 63.4, 61.7, 58.3, 
55.1, 29.7, 28.1, 23.6, 23.2. The carbon resonances of the directing group (perfluoroarene, 
C7F7) appear as complex multiplets and are not listed. 
19F NMR and LC-MS were used to 
confirm characterization of structure.   
 
Compound (10l):   
 
Compound 10l was isolated as a light yellow oil following general procedure F, replacing the 
iodoarene with 3 equiv AgOAc. 
Isolated Yield: 30% (3.7 mg) 
HRMS: ESI+ (m/z): [M+H+] calcd for C18H18F7N2O: 411.1302; found: 411.1307.  
1H NMR (CDCl3, 700 MHz): δ 9.84 (s, 1H), 6.03 (m, 1H), 5.51 (m, 1H), 3.64 (m, 2H), 3.55 (t, 
J = 5.6 Hz, 1H), 2.64 (dd, J = 17.5 Hz, J = 1.4 Hz, 1H), 2.06 (m, 1H), 1.98 (m, 1H), 1.90 (m, 
2H), 1.70 (m, 1H), 1.42 (s, 3H), 1.39 (s, 3H). 
13C NMR (CDCl3, 176 MHz): δ 176.3, 134.5, 123.3, 62.9, 55.1, 35.7, 31.0, 27.5, 24.4, 22.7. 
The carbon resonances of the directing group (perfluoroarene, C7F7) appear as complex 
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multiplets and are not listed. 19F NMR and LC-MS were used to confirm characterization of 
structure.   
19F NMR (CDCl3, 377 MHz): δ -56.0 (t, J = 21.5 Hz, 3F), -141.3 (m, 2F), -143.8 (m, 2F). 
 
Compound (17):  
 
Compound 10l was isolated as a light yellow solid following general procedure F, replacing 
the iodoarene with 3 equiv AgOAc. 
Isolated Yield: % (4.7 mg) 
HRMS: ESI+ (m/z): [M+H+] calcd for C18H18F7N2O2: 427.1251; found: 427.1255.  
1H NMR (CDCl3, 700 MHz): δ 9.84 (s, 1H), 6.03 (m, 1H), 5.51 (m, 1H), 3.64 (m, 2H), 3.55 (t, 
J = 5.6 Hz, 1H), 2.64 (dd, J = 17.5 Hz, J = 1.4 Hz, 1H), 2.06 (m, 1H), 1.98 (m, 1H), 1.90 (m, 
2H), 1.70 (m, 1H), 1.42 (s, 3H), 1.39 (s, 3H). 
13C NMR (CDCl3, 176 MHz): δ 175.8, 129.4, 127.4, 76.4, 76.4, 69.8, 64.9, 51.3, 48.9, 28.1, 
24.1, 22.9. The carbon resonances of the directing group (perfluoroarene, C7F7) appear as 
complex multiplets and are not listed. 19F NMR and LC-MS were used to confirm 
characterization of structure.   
19F NMR (CDCl3, 377 MHz): δ -56.0 (t, J = 21.5 Hz, 3F), -140.9 (m, 2F), -143.9 (m, 2F). 
 
5.4.6 Initial Rates and Reaction Profile with S1  
General Procedure G: Reaction conditions for kinetic studies. Under ambient conditions, 
if ligand was used, a 0.02 M stock solution of L9 (quinaldic acid, 17.3 mg dissolved in 5 mL 
of DCM) was prepared. An aliquot of this solution was transferred to a vial (4 mL capacity, 75 
μL, 0.0015 mmol ligand, 5 mol %). MeOH was removed by heating the open vial to 68 ºC for 
10 minutes or DCM was removed by heating the open vial to 45 ºC for 5 minutes. To the 
concentrated carboxylate ligand, a Pd(OAc)2 aliquot (150 μL, 0.003 mmol Pd, 10 mol %) of a 
0.02 M stock solution (23 mg Pd(OAc)2 in 5 mL of DCM) was added. DCM was removed by 
heating the open vial to 45 ºC for 5 minutes.  
 
To the vial containing the resulting solids, substrate S1 (13.8 mg, 0.03 mmol, 1 equiv) and 
CsOPiv (21.1 mg, 0.09mmol, 3 equiv) were added, followed by PhI (10 μL, 0.09 mmol, 3 
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equiv) and tAmylOH (0.25 mL). The vial was equipped with a stirbar, tightly sealed with a 
Teflon-lined screw cap and heated to 100 ºC in a preheated aluminum block. At the desired 
reaction time (measured by a stopwatch), the reaction was flash-cooled in a liquid nitrogen 
bath until frozen solid (35 seconds). The reaction was then allowed to warm up to room 
temperature and diluted with DCM (2.5 mL). Hydrazine monohydrate (50 μL) was added and 
the solution was vigorously stirred for 15 minutes. A 0.2 M stock solution of 1,3,5-
trimethoxybenzene (168 mg, 1 mmol) dissolved in DCM (5 mL) was prepared. An aliquot of 
this solution (150 μL, 0.03 mmol) was added to the reaction as the GC internal standard. The 
reaction solution was then filtered through a pipette packed with Celite and was analyzed by 
GC-FID. Yields and concentrations of 1a were used to obtain reaction rate profiles and initial 
rates in Figure 5.5 and 5.6.  
 
5.4.7 Kinetic Isotope Experiment Studies 
KIE without ligand: Intermolecular KIE was performed following General Procedure G 
with addition of S1 (13.8 mg, 0.03 mmol, 1 equiv, 0.12 M) or d5-S1 (14 mg, 0.03 mmol, 1 
equiv, 0.12 M). 
 
Figure 5.8. KIE of S1 versus d5-1 Without Ligand 
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KIE with 5 mol % quinaldic acid (L9): Intermolecular KIE was performed following 
General Procedure G using L9 and with addition of S1 (13.8 mg, 0.03 mmol, 1 equiv, 0.12 
M) or d5-S1 (14 mg, 0.03 mmol, 1 equiv, 0.12 M). 
y = 0.00019x - 0.00119
R² = 0.98994
[d4-1]


























Figure 5.9. KIE of S1 versus d5-1 with 5 mol % L9 
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5.4.8 Product Inhibition Experiments with S1 
General Procedure G was used for Table 5.3 with the following modifications/details: To 
each vial, a varying amount of 1b was added (1.7 mg–12.8 mg, 0.003–0.0225 mmol, 0.1–0.75 
equiv, 0.012–0.09 M). The amount of 1b is indicated in each entry of Table5. 3. Reactions 
were stopped after 45 minutes and immediately flash-cooled in a liquid nitrogen bath until 
frozen solid (35 seconds). 
 
General procedure G was used for Figure 5.101 without ligand additive. Product 1b (8.5 mg, 
0.015 mmol, 0.5 equiv, 0.06 M) was added to the reaction mixture to obtain the data shown in 
the red line  





y = 0.00039x - 0.00078
R² = 0.99580
[d4-1]

























General procedure G was used for Figure 5.11 with 5 mol% L9 (0.006 M). Product 1b (8.5 
mg, 0.015 mmol, 0.5 equiv, 0.06 M) was added to the reaction mixture to obtain the data shown 
in the red line.  
Figure 5.11. Overlay of Initial Rate of 1a versus Time in Absence (blue) and Presence of 1b 




5.4.9 Catalyst Recovery Experiment with S1 
General Procedure E: Under ambient conditions, an aliquot of Pd(OAc)2 aliquot (150 μL, 
0.003 mmol Pd, 10 mol %) from a 0.02 M stock solution (23 mg Pd(OAc)2 in 5 mL of DCM) 
was added to a vial (4 mL capacity). DCM was removed by heating the open vial to 45 ºC for 
y = 0.00064x - 0.00197
R² = 0.99682















2b (0.06 M) additive
No product added
y = 0.00129x - 0.00151
R² = 0.98880















0.06 M of 2b
No product added
0.06 M 1b
0.06 M 1b 
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5 minutes. To the vial containing the resulting solid, substrate S1 (13.8 mg, 0.03 mmol, 1 equiv) 
and CsOPiv (21.1 mg, 0.09 mmol, 3 equiv) were added, followed by PhI (10 μL, 0.09 mmol, 
3 equiv) and tAmylOH (0.25 mL). The vial was equipped with a stirbar, sealed with a Teflon-
lined screw cap and heated to 100 ºC in a preheated aluminum block. After four hours (240 
minutes), the reaction was removed from the heating source and cooled to room temperature. 
The reaction mixture was opened to air and solid quinaldic acid (L9, 0.260 mg, 0.0015 mmol, 
5 mol %) was added. The reaction was then reheated to 100 ºC. At the desired reaction time 
(measured by a stopwatch), the reaction was flash cooled in a liquid nitrogen bath and diluted 
with DCM (2.5 mL). Hydrazine monohydrate (50 μL) was added and the solution was 
vigorously stirred for 15 minutes. A 0.2 M stock solution of 1,3,5-trimethoxybenzene (168 mg, 
1 mmol) dissolved in DCM (5 mL) was prepared. An aliquot of this solution (150 μL, 0.03 
mmol) was added to the reaction as the GC internal standard. The reaction solution was then 
filtered through a pipette packed with Celite and was analyzed by GC-FID. The concentration 
of 1a over time was used to plot the reaction profiles of Figure 5.7.  
 
5.4.10 Precipitate Experiments  
Isolation procedure for precipitate: Under ambient conditions, a 0.02 M stock solution of 
Pd(OAc)2 (23 mg, 0.1 mmol) dissolved in DCM (5 mL) was prepared. An aliquot of this 
solution was transferred to a vial (4 mL capacity, 150 μL, 0.003 mmol Pd, 10 mol %). DCM 
was removed by heating the open vial to 45 ºC for 5 minutes. To the concentrated Pd(OAc)2, 
substrate S1 (13.8 mg, 0.03 mmol, 1 equiv) and CsOPiv (21.1 mg, 0.09 mmol, 3 equiv) were 
added, followed by PhI (10 μL, 0.09 mmol, 3 equiv) and tAmylOH (0.25 mL). The vial was 
equipped with a stirbar, sealed with a Teflon-lined screw cap and heated to 100 ºC in a 
preheated aluminum block. During the course of 90 minutes the reaction color changed from 
bright yellow to black. At this point, the reaction was removed from the heating source and 
cooled to room temperature. The stirbar was removed from the vial with a magnetic retriever. 
The vial was resealed and centrifuged (5000 rpm, 5 minutes). The dark precipitate settled to 
the bottom of the vial and the supernatant was carefully removed with a pipette. The dark 
precipitate was washed with tAmylOH (0.1 mL), re-centrifuged, and solvent was removed with 
a syringe. The remaining precipitate was used for subsequent reactions. The supernatant was 
first passed through a pipette packed with a small piece of glass fiber filter paper before use 
the subsequent reactions.  
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Reaction with isolated dark precipitate: To the vial containing precipitate, if indicated in 
Table 5.6, quinalidic acid (L9, 0.260 mg, 0.0015 mmol, 5 mol%) or picolinc acid (L8, 0.190 
mg, 0.0015 mmol, 5 mol%) were added. Solid substrate S1 (13.8 mg, 0.03 mmol, 1 equiv), 
CsOPiv (21.1 mg, 0.09 mmol, 3 equiv) and 4-iodoanisole (21 mg, 0.09 mmol, 3 equiv) were 
added. To this mixture, tAmylOH (0.25 mL) was added. The vial was equipped with a stirbar, 
sealed with a Teflon-lined screw cap and heated to 100 ºC in a preheated aluminum block. 
After 18 hours, the reaction was cooled to room temperature and diluted with DCM (2.5 mL). 
Hydrazine monohydrate (50 μL) was added and the solution was vigorously stirred for 15 
minutes. A 0.2 M stock solution of 1,3,5-trimethoxybenzene (168 mg, 1 mmol) dissolved in 
DCM (5 mL) was prepared. An aliquot of this solution (150 μL, 0.03 mmol) was added to the 
reaction as the GC internal standard. The reaction solution was then filtered through a pipette 
packed with Celite and was analyzed by GC-FID. Yields of 1b are shown in Table 5.6 along 
with reaction details. 
 
Reaction with supernatant after removal of precipitate: The supernatant was further reacted 
as follows: To the vial containing the supernatant, if indicated in Table 5.6, solid quinaldic 
acid (L9, 0.260 mg, 0.0015 mmol, 5 mol %) or picolinic acid (L8, 0.190 mg, 0.0015 mmol, 5 
mol %) were added. Additional CsOPiv (14 mg, 0.06 mmol, 2 equiv) and PhI (3.5 μL, 0.03 
mmol, 1 equiv) were added. The vial was equipped with a stirbar, sealed with a Teflon-lined 
screw cap, and heated to 100 ºC in a preheated aluminum block. After 18 hours, the reaction 
was cooled to room temperature and diluted with DCM (2.5 mL). Hydrazine monohydrate (50 
μL) was added and the solution was vigorously stirred for 15 minutes. A 0.2 M stock solution 
of 1,3,5-trimethoxybenzene (168 mg, 1 mmol) dissolved in DCM (5 mL) was prepared. An 
aliquot of this solution (150 μL, 0.03 mmol) was added to the reaction as the GC internal 
standard. The reaction solution was then filtered through a pipette packed with Celite and was 
analyzed by GC-FID. Yield of 1a is shown in Table 5.6 along with reaction details. 
 
Table 5.6. Experiments with Precipitate and Supernatant 
entry ligand catalyst source conversion yield 1a yield 1b 
1 ---- precipitate 20% --- 10% 
2 L9 precipitate 81% --- 47% 
3 L8 precipitate 71% --- 60% 
4 ---- supernatant 61% 39% --- 
5 L9 supernatant 96% 73% --- 
6 L8 supernatant 77% 56% --- 
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5.5. Data for X-Ray Crystallography30 
Structure Determination for 16a 
 
 Colorless plates of ml6052 were grown from a methanol solution of the compound 
at 70 deg. C.  A crystal of dimensions 0.14 x 0.12 x 0.04 mm was mounted on a Rigaku 
AFC10K Saturn 944+ CCD-based X-ray diffractometer equipped with a low temperature 
device and Micromax-007HF Cu-target micro-focus rotating anode ( = 1.54187 A) 
operated at 1.2 kW power (40 kV, 30 mA).  The X-ray intensities were measured at 85(1) 
K with the detector placed at a distance 42.00 mm from the crystal.  A total of 2028 images 
were collected with an oscillation width of 1.0 in  The exposure times were 1 sec. for 
the low angle images, 6 sec. for high angle.  Rigaku d*trek images were exported to 
CrysAlisPro for processing and corrected for absorption.  The crystal was determined to be 
a two-component non-merohedral twin.  Components from both domains as well as 
overlaps were used as the basis for a HKLF5 reflection file for refinement.  The integration 
of the data yielded a total of 85620 reflections to a maximum 2 value of 139.52 of which 
19462 were independent and 14820 were greater than 2(I).  The final cell constants (Table 
1) were based on the xyz centroids of 28433 reflections above 10(I).  Analysis of the data 
showed negligible decay during data collection.  The structure was solved and refined with 
the Bruker SHELXTL (version 2016/6) software package, using the space group P2(1)/c with 
Z = 8 for the formula C22H25N2O4F7.  All non-hydrogen atoms were refined anisotropically 
with the hydrogen atoms placed in idealized positions.  Full matrix least-squares 
refinement based on F2 converged at R1 = 0.0887 and wR2 = 0.2366 [based on I > 2sigma(I)], 
R1 = 0.1043 and wR2 = 0.2458 for all data.  Additional details are presented in Table 1 and 
are given as Supporting Information in a CIF file.  Acknowledgement is made for funding 
from NSF grant CHE-0840456 for X-ray instrumentation. 
G.M. Sheldrick (2015) "Crystal structure refinement with SHELXL", Acta Cryst., C71, 3-8 
(Open Access). 
CrystalClear Expert 2.0 r16, Rigaku Americas and Rigaku Corporation (2014), Rigaku 
Americas, 9009, TX, USA 77381-5209, Rigaku Tokyo, 196-8666, Japan. 
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Structure Determination for 16b 
 
 Colorless plates of ml6052ar were grown from a hexanes solution of the compound 
at 68 deg. C.  A crystal of dimensions 0.22 x 0.22 x 0.02 mm was mounted on a Rigaku 
AFC10K Saturn 944+ CCD-based X-ray diffractometer equipped with a low temperature 
device and Micromax-007HF Cu-target micro-focus rotating anode ( = 1.54187 A) 
operated at 1.2 kW power (40 kV, 30 mA).  The X-ray intensities were measured at 85(1) 
K with the detector placed at a distance 42.00 mm from the crystal.  A total of 2028 images 
were collected with an oscillation width of 1.0 in  The exposure times were 1 sec. for 
the low angle images, 5 sec. for high angle.  Rigaku d*trek images were exported to 
CrysAlisPro for processing and corrected for absorption.  The integration of the data yielded 
a total of 33581 reflections to a maximum 2 value of 138.52 of which 4127 were 
independent and 4079 were greater than 2(I).  The final cell constants (Table 1) were 
based on the xyz centroids 26893 reflections above 10(I).  Analysis of the data showed 
negligible decay during data collection.  The structure was solved and refined with the 
Bruker SHELXTL (version 2016/6) software package, using the space group P2(1)/n with Z 
= 4 for the formula C24H23N2O3F7.  All non-hydrogen atoms were refined anisotropically 
with the hydrogen atoms placed in a combination of refined and idealized positions.  Full 
matrix least-squares refinement based on F2 converged at R1 = 0.0389 and wR2 = 0.1004 
[based on I > 2sigma(I)], R1 = 0.0392 and wR2 = 0.1007 for all data.  Additional details are 
presented in Table 1 and are given as Supporting Information in a CIF file.  
Acknowledgement is made for funding from NSF grant CHE-0840456 for X-ray 
instrumentation. 
G.M. Sheldrick (2015) "Crystal structure refinement with SHELXL", Acta Cryst., C71, 3-8 
(Open Access). 
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CrystalClear Expert 2.0 r16, Rigaku Americas and Rigaku Corporation (2014), Rigaku 
Americas, 9009, TX, USA 77381-5209, Rigaku Tokyo, 196-8666, Japan. 
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